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Ac acetyl 
acac acetylacetone 
AL-PS Amano lipase from 
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Ar aryl 
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A Introduction 
1 The 2-pyrone scaffold - a widespread motif in nature and synthesis 
 
2-Pyrone (1) is a six-membered unsaturated cyclic ester with similar reactivity like 1,3-dienes 
and lactones. The core structure is present in a broad variety of natural products found in various 
facets of life, e.g., bacteria, microbes, fungi, plants, marine organisms or animals.1 Additionally, 
natural products containing the 2-pyrone scaffold are involved in different biological processes 
and display many biological activities like anti-HIV, antitumor, telomerase inhibition, 
antimicrobial, antifungal, cardiotonic, pheromonal, cytotoxic, neurotoxic, and phytotoxic 
effects.1,2 Some prominent examples of natural products containing the 2-pyrone moiety are 
depicted in Figure 1. 
 
Figure 1. Natural products containing the 2-pyrone moiety.1,3–5 
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Furthermore, the high functional group density of the 2-pyrone moiety displayed over the 
six-membered cyclic skeleton offers outstanding opportunities for the synthesis of complex 
molecules due to its versatile reactivity e.g. cycloadditions, ring opening reactions or 
cross-coupling reactions (Figure 2).  
 
 
Figure 2. Reactivity of 2-pyrones. 
 
2 Synthesis of 2-pyrones 
2.1 Transition-metal-catalyzed synthesis 
 
Transition-metal-catalysis provides various elegant pathways for the synthesis of complex 
molecules including the synthesis of 2-pyrone derivatives. Pale et al.6 described a 
straightforward gold-catalyzed rearrangement of β-alkynyl propiolactones 11 to substituted 
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2-pyrones 12 (Scheme 1). The starting materials are prepared by condensation of acyl chlorides 
to aldehydes, providing diverse 2-pyrone derivatives in two steps.7 
 
 
 
Scheme 1.Gold-catalyzed cycloisomerization to substituted 2-pyrones 12.6 
 
Schreiber et al.8 investigated the gold-catalyzed dimerization of propiolic acids 14 to afford 
2-pyrone derivatives 13. After slightly changing the reactions conditions and the addition of 
other alkynes it was additionally possible to obtain 2-pyrones of type 15 in good yields 
(Scheme 2). This strategy offers a simple and efficient route to various multiple substituted 
2-pyrone derivatives. 
 
 
Scheme 2. Syntheses of 2-pyrones using gold-catalyzed coupling reactions.8 
 
Propiolates 17 can serve as suitable starting materials for the synthesis of 2-pyrone derivatives 
as well. Jeganmohan et al.9 presented the ruthenium-catalyzed homodimerization of propiolates 
17 giving different types of 2-pyrones depending on the residue of the propiolates 17: while 
alkyl substituted ones furnish mainly 16, aryl substituted propiolates deliver 18 (Scheme 3). 
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Scheme 3. Homodimerization of substituted propiolates 17.9 
 
Similar behavior was observed after addition of a terminal alkyne 20, affording 5,6-substituted 
2-pyrones of type 19 or 21 depending on the substrates used (Scheme 4). 
 
 
Scheme 4. Heterodimerization of substituted propiolates 17.9 
 
Boruah et al.10 described the ruthenium-catalyzed decarbonylative addition reaction of 
anhydrides 22 with alkynes 23 to arrive at substituted 2-pyrones 24. The decarbonylative 
addition is highly regioselective, a broad substrate scope is covered, and good yields were 
obtained (Scheme 5). 
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Scheme 5. Ruthenium-catalyzed decarbonylative addition.10 
 
Additionally, palladium-catalysis is widely used for the synthesis of 2-pyrones. Jiang et al.11 
used palladium-catalysis for the oxidative annulation of internal alkynes 23 with acrylic acid 25 
under mild conditions using O2 as the oxidant. The process yields 5,6-substituted 2-pyrones 26 
with high regioselectivity in good to excellent yields (Scheme 6). 
 
 
Scheme 6. Palladium-catalyzed oxidative annulation.11 
 
In addition to this, Loh et al.12 reported the palladium-catalyzed difunctionalization of internal 
alkynes via 6-endo cyclization and alkenylation of enynoates 27. Various enynoates 27 and 
electron-deficient alkenes 28 were utilized for the syntheses of 2-pyrone derivatives 29. The 
reaction is highly regioselective, compatible with many functional groups and good yields were 
obtained (Scheme 7). 
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Scheme 7. Highly regioselective 6-endo cyclization and alkenylation of enynoates.12 
 
2.2 Transition-metal-free synthesis 
 
Since its discovery, the iodolactonization has been one of the most efficient ways to synthesize 
lactones.13 In 2001, Rossi et al.14 used this strategy for the synthesis of 2-pyrone derivatives 31 
starting from acids 30, which themselves are easily prepared by Sonogashira coupling. 
Butenolides 32 are observed as byproducts, depending on the reactions conditions 2-pyrones 
31 are still the major products (Scheme 8). The halogenated 2-pyrones 31 can be used for 
further reactions, e.g., cross-coupling reactions or dehalogenation reaction to arrive at 
6-substituted 2-pyrones. 
 
 
Scheme 8. 2-Pyrone synthesis via iodolactonization.14 
 
Kwon et al.15 reported a phosphine-catalyzed synthesis of 6-substituted 2-pyrones starting from 
commercially available aldehydes 33 and ethyl allenoate 34. Sterically demanding 
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trialkylphosphines are required to shift the equilibrium toward the E-isomeric zwitterion to 
form 2-pyrones 35. Various aldehydes such as aromatic or aliphatic ones undergo the 
transformation in moderate to excellent yield (Scheme 9). 
 
 
Scheme 9. Phosphine-catalyzed synthesis of 2-pyrones 35.15 
 
A successful development of an organocatalyzed synthesis was described by Smith et al.16 for 
the synthesis of substituted 2-pyrone derivatives 38. A broad variety of di- and trisubstituted 
2-pyrones were realized (including biologically relevant compounds) with high selectivity and 
yield via an isothiourea-mediated Michael addition/lactonization/thiol elimination cascade 
sequence starting from phenylthio acetic acids 36 and α,β-unsaturated trifluoromethyl ketones 
37 (Scheme 10). 
 
 
Scheme 10. Isothiourea-mediated synthesis of trifluoromethyl substituted 2‑pyrones 38.16 
 
Moreover, cyclopropanes are known as useful synthetic precursors in organic chemistry. Gong 
et al.17 developed a methodology for the synthesis of 2-pyrone derivatives 41 using 
cyclopropanes 39 and amines 40 as starting materials. This base-promoted domino reaction 
A Introduction 
8 
 
provides a simple strategy for the transition-metal-free construction of the 2-pyrone skeleton in 
high yields (Scheme 11). 
 
 
Scheme 11. 2-Pyrone synthesis starting from cyclopropanes 39.17 
 
The carboxylative cyclization of substituted propenyl ketones 42 using carbon dioxide offers 
an additional facile transition-metal-free variant for the synthesis of 2-pyrones 43 (Scheme 12). 
Especially, carbon dioxide is non-toxic and easily obtained from renewable resources. 
Therefore it is a highly interesting reagent in the meanings of green chemistry. 
 
 
Scheme 12. Carboxylative cyclization of substituted propenyl ketones 42 using CO2.
18  
 
3 Reactivity of 2-pyrones 
3.1 Ring opening 
 
2-Pyrones possess properties of unsaturated lactones, therefore they undergo hydrolysis by 
aqueous alkali to yield the corresponding ring opening products. In general, nucleophiles are 
added to the 2-pyrone scaffold either at the carbonyl group (e.g. Grignard reagents) or in a 1,4- 
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or a 1,6-addition fashion under ring opening.19 The latter is true for the addition of cyanide to 
2-pyrone (1), which was already described in 1965 by Vogel et al.20 (Scheme 13). 
 
 
Scheme 13. Nucleophilic ring opening of 2-pyrone (1).20 
 
Nowadays, chemists are particularly interested in ring opening reactions of the 2-pyrone moiety 
since the resulting products are highly valuable compounds for organic synthesis. In 2013, 
Fürstner et al. reported an unusual behavior of Grignard reagents in the reaction with 2-pyrone 
derivatives under iron catalysis (Scheme 14).21  
 
 
Scheme 14. Iron-catalyzed ring opening reaction.21 
 
Iron catalysis superseded the conventional reactivity of the Grignard reagent and turned it into 
a cross-coupling process with the lactone moiety as a nontraditional leaving group. This offers 
access to di-unsaturated acid derivatives, which are of high importance for the synthesis of 
many natural products. Additionally, the stereochemistry of the acid derivatives 
(2Z,4E vs. 2E,4E) can be controlled by varying the temperature before work up, and the 
reaction is compatible with a multitude of functional groups. With this strategy in hand, the 
synthesis of cytotoxic tryptamine derivative Granulatamide B 49, isolated from the gorgonian 
A Introduction 
10 
 
Eunicella granulate, was accomplished (Scheme 15). Additionally, a Pateamine A analogue 
with in vivo anticancer activity was developed by the same working group using the 
iron-catalyzed 2-pyrone ring opening as a key step.22 
 
 
Scheme 15. Synthesis of Granulatamide B 49.21 
 
Concomitantly, Dechoux et al.23 demonstrated a highly regio-, chemo- and stereoselective 
synthesis of conjugated 2Z,4Z or 2Z,4E dienoic acids 52. Herein, the nature of the Grignard 
reagent is of crucial importance for the outcome of the reaction. With alkenyl, alkynyl and 
aromatic Grignard reagents mainly dienoic acid 52 formation was observed, while with alkyl 
Grignard reagents unsaturated lactones 53 were obtained. Furthermore, the stereochemical 
outcome of the reaction for the dienoic acids was explained by thermodynamic control masking 
the kinetic torquoselectivity (Scheme 16). 
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Scheme 16. Stereoselective synthesis of conjugated dienoic acids 52.23 
 
In addition to this, Dechoux et al.24 developed a route for the synthesis of β,γ-unsaturated 
carboxylic acids 54 with highly regio-, chemo- and stereoselectivity starting from (±)-50 by 
employing a one-pot double alkyl-alkyl or alkyl-hydride 1,6-addition (Scheme 17). 
 
 
Scheme 17. Metal-catalyzed addition of two Grignard reagents to 2-pyrone 54.24 
 
In contrast, the palladium-catalyzed double-decarboxylative addition provides an entirely 
different strategy for the ring opening reaction of the 2-pyrone scaffold yielding conjugated 
dienoic esters 58.25 Dienoic esters 58 are known as useful compounds for organic synthesis, 
and the only byproduct of the reaction is carbon dioxide (Scheme 18).  
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Scheme 18. Double-decarboxylative addition to 2-pyrone 55.25 
 
3.2 [2+2] Cycloaddition 
3.2.1 Intermolecular [2+2] cycloaddition 
 
There are some examples for the light-induced intermolecular [2+2] cycloaddition with 
2-pyrones known in the literature, but all of them face the same general problems: The low 
selectivity between the two double bonds of the 2-pyrone moiety and the competing 
intramolecular [2+2] cycloaddition or [4+2] cycloaddition. Therefore, in most cases, low yields 
and several byproducts are obtained. All products obtained in the [2+2] cycloaddition of 
2-pyrones 59 and alkene 60 by Tanabe et al.26 are depicted in Scheme 19. 
 
Scheme 19. Intermolecular [2+2] cycloaddition.26 
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3.2.2 Intramolecular [2+2] cycloaddition 
 
Due to precoordination of the reactants, intramolecular reactions show higher efficiency. The 
intramolecular [2+2] cycloaddition of 65 gave site- and regiospecific adducts in excellent yields 
dependent on the length of the side chain (Scheme 20).27 However, byproduct 67, arising from 
a prior intramolecular [2+2] cycloaddition of the 2-pyrone ring and subsequent hydrolysis was 
obtained. 
 
 
Scheme 20. Intramolecular [2+2] cycloaddition with the side chain.27 
 
The intramolecular [2+2] cycloaddition of the 2-pyrone scaffold itself offers outstanding 
possibilities for the synthesis of many different valuable chemicals. Already in 1964, the 
intramolecular [2+2] cycloaddition of 1, which provides access to cyclobutadiene derivatives 
was described by Corey et al.28 (Scheme 21).  
 
 
Scheme 21. Intramolecular [2+2] cycloaddition.28 
 
The synthetic potential of 68 was used first by McKendry et al.29 in 1969, for the synthesis of 
(2Z,4E)-alkoxypentadienoic acids 69 and chlorocyclobutene carboxylic acids 70 (Scheme 22). 
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Scheme 22. Synthesis of dienoic acid 69 and chlorocyclobutene carboxylic acids 70.29 
 
In the following years, the chemistry of 68 did not attract much attention until 2010, when 
Maulide et al.30 rediscovered the potential of 68 and since then much fascinating chemistry has 
been done with it (Scheme 23).31 
 
 
Scheme 23. Versatile chemistry of 68.31 
  
A Introduction 
15 
 
The palladium-catalyzed allylic alkylation of 68 offers access to functionalized cyclobutenes. 
Several nucleophiles were added such as malonate anions and azlactones.32 The obtained 
products are highly functionalized mono- and bicyclic building blocks for the synthesis of 
complex compounds. Additionally, high levels of diastereoselectivity were achieved, and the 
transfer of the methodology to an asymmetric version led to the discovery of a family of highly 
enantioselective, diastereodivergent, catalytic processes. This enables access to each of the four 
stereoisomeric products starting from a racemic lactone and was rationalized by mechanistic 
studies. The received cyclobutenes can be opened by electrocyclic ring-opening reactions 
giving rise to diene and polyene frameworks, which themselves were then used for the synthesis 
of polyenic natural products.31  
 
3.3 [4+2] Cycloaddition 
 
The Diels-Alder reaction offers an atom-economical and straightforward route for the synthesis 
of complex structures of defined geometry while producing nearly no waste via the reaction of 
a diene and a dienophile. 
Interestingly, 2-pyrones are known to act as both, diene and dienophile in [4+2] cycloadditions. 
However, just a few examples of 2-pyrone acting as dienophile are reported in the literature and 
an electron withdrawing substituent in 5-position is necessary. The first reported 
[4+2] cycloadditions with a 2-pyrone derivative 50 serving as dienophile is shown in 
Scheme 24.33 
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Scheme 24. 2-Pyrone 50 as dienophile in a [4+2] cycloaddition.33 
 
The 2-pyrone scaffold containing a cyclic diene structure is classically known as active diene 
component in [4+2] cycloadditions, although the 2-pyrones moiety also possesses aromatic 
character. The [4+2] cycloaddition of 2-pyrone (1) with alkynes provides highly strained 
bicyclooctadiens 73, which easily form aromatic products 74 after extrusion of CO2. The 
cycloadducts 75 generated with alkenes are generally more stable and can be isolated in some 
cases. These structurally and stereochemically rich compounds can be used as synthetic 
intermediates. After extrusion of CO2 dihydrobenzenes 76 are obtained, and additional 
elimination then leads to aromatic compounds 77 as well (Scheme 25).34  
 
 
Scheme 25. 2-Pyrone (1) as diene in [4+2] cycloadditions.34 
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Due to its diverse opportunities for organic synthesis,34,3 2-pyrones have frequently been used 
as dienes in [4+2] cycloadditions, ever since Diels and Alder35 published that 2-pyrones could 
act as diene in [4+2] cycloadditions in 1931. The [4+2] cycloadditions of 2-pyrones are mainly 
used for the synthesis of aromatic and heteroaromatic compounds or natural products. 
Therefore, one recent example for every mentioned usage is given in the following.  
Garg et al.36 developed a methodology that offers access to oxygen-containing strained alkynes 
79, demonstrating their chemical potential (among others) via a [4+2] cycloaddition with 
2-pyrone (1). With this strategy in hand, it was possible to introduce an additional benzene ring 
to oxygen-containing strained alkynes (Scheme 26). The same group already used similar 
strategies for nitrogen-containing strained alkynes before.37 
 
 
Scheme 26. [4+2] cycloaddition of 4,5-Benzofuranyne 79 with 2-pyrone (1).36  
 
Additionally, the [4+2] cycloaddition provides a straightforward way for the synthesis of 
heteroaromatic compounds such as phosphines. Müller et al.38 developed a convenient route to 
functionalized phosphines via [4+2] cycloaddition of 3-bromo-2-pyrone (81) with a 
phosphaalkyne and using Negishi cross-coupling to introduce a phenyl substituent into the final 
product 83 (Scheme 27). 
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Scheme 27. Synthesis of functionalized phosphinines.38 
 
Synder et al.39 utilized the potential of 2-pyrone derivatives for the elegant preparation of 
indolines and hydroindolines. Starting from 2-pyrone 84, an amine was introduced containing 
either an alkyne or an alkene moiety. The following intramolecular [4+2] cycloaddition of 85 
or 87 then afforded indolines 86 and hydroindolines after extrusion of CO2. Additionally, 
hydroindolines could be hydrolyzed to obtain structure 88, which is present in a broad variety 
of natural products (Scheme 28). 
 
 
Scheme 28. [4+2] cycloaddition routes to indolines and hydroindolines.39 
 
Finally, this strategy was employed for the total synthesis or formal total synthesis of three 
natural products: 7-mesembrenone (89), mesembrine (90) and gracilamine (91), depicted in 
Scheme 29. 
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Scheme 29. Natural products 7-mesembrenone (89), mesembrine (90) and gracilamine (91).39 
 
3.4 Lactamization 
 
2-Pyridones are a widespread motif in nature, and due to their versatile reactivity, they are 
useful materials for the synthesis of complex molecules and additionally they are known to act 
as a ligand in coordination chemistry.40,41–44 
2-Pyrones are easily converted into the corresponding lactams by reaction with ammonia to 
arrive at the N-unsubstituted 2-pyridones 93, while the reaction with primary amines yields 
N-substituted 2-pyrone derivatives 92 (Scheme 30).45  
 
 
Scheme 30. Lactamization of 2-pyrone (1).45 
 
2-Pyridone derivatives are known to act as a diene in [4+2] cycloadditions similar to 
2-pyrones.34 2-Pyridone exists as two tautomers, which can form dimers similar to the base-
pairing in DNA or RNA (Scheme 31).46 
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Scheme 31. Tautomerization and dimerization of 2-pyridone 93.46 
 
As shown before, many procedures for the synthesis of 2-pyrones are available, and due to the 
facile transformation of the latter into 2-pyridones 92, these procedures can serve for the 
synthesis of 2-pyridones 92 as well. The transfer of 2-pyrones in 2-pyridones is frequently used 
in research, especially in the search for new bioactive substances. In many cases, substances 
containing the 2-pyridone motif exhibit interesting activities such as antifungal, antibacterial, 
insecticidal and cytotoxic activity, selected examples are depicted in Scheme 32.41–44  
 
 
Scheme 32. Bioactive 2-pyridone derivatives.41–44 
 
3.5 Ligand 
 
Catalysis is one of the main interests in chemistry, and there is an ongoing search for new 
strategies and catalysts. As the 2-pyrone scaffold offers versatile opportunities for the 
complexation of metals it served as ligand in many different complexes with various metals, 
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e.g., Fe,47 Os,48 Co,49 Re50 or Mo.51 In Scheme 33, 2-pyrone is illustrated as a ligand in two 
different complexes possessing different hapticity: in 98 a η1-2-pyrone and in 99 a η4-2-pyrone 
ligand is shown. 
 
 
Scheme 33. 2-Pyrone (1) as versatile ligand.47,50 
 
Furthermore, some complexes containing a 2-pyrone ligand show interesting properties. 
Complex 99 exhibits excellent CO-releasing properties, its intrinsic stability influences the 
extent and rate of CO release revealing highly interesting bioactive properties.52 This behavior 
can be affected by choice of substituents at the 2-pyrone scaffold.53  
 
3.6 Conjugate addition 
 
The 2-pyrone moiety contains an α,β-unsaturated carbonyl group, which offers the opportunity 
for conjugate addition. The resulting 3,4-dihydro 2-pyrones have attracted much interest due to 
their biological activities and their use in synthesis.54 Furthermore, the conjugate addition was 
used for the introduction of substituents into the 2-pyrone ring. During the synthesis of 
Lasalocid A, Ireland et al.55 investigated the conjugate addition of Grignard reagents in the 
absence of any copper source. Surprisingly, the conjugate addition of organocuprates failed 
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before. 2-Pyrone 55 underwent conjugate addition with 100 and after MnO2 promoted 
dehydrogenation 102 was obtained in 52% yield over 2 steps (Scheme 34).  
 
Scheme 34. Conjugate addition of Grignard reagent.55 
 
Akiba et al.56 enhanced the reactivity of 2-pyrones towards conjugate addition with 
organocopper reagents by silylation using tert-butyldimethylsilyl triflate to yield the 
corresponding pyrylium salt 104. After silylation, several substituents were introduced by 
conjugate addition. This reaction was affected by the steric hindrance of the organocopper 
reagents. Finally, the silylated adducts 105 could be hydrolyzed to afford the substituted 
3,4-dihydro 2-pyrones 106 (Scheme 35). 
 
 
Scheme 35. Conjugate addition of organocopper reagents to pyrylium salt 104.56 
 
In 2013, Feringa et al. developed the asymmetric conjugate addition of alkyl Grignard reagents 
to 2-pyrones opening access to chiral 3,4-dihydro 2-pyrones 107. The conjugate addition is 
catalyzed by copper using a ferrocenyl-based bisphosphine ligand 108. The used catalytic 
system provided excellent enantioselectivity (up to >99:1 er) with various Grignard reagents 
(Scheme 36). 
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Scheme 36. Asymmetric conjugate addition of alkyl Grignard reagents to 2-pyrones.54 
 
3.7 Cross-coupling 
 
The synthesis of 2-pyrone derivatives is of high interest, and cross-coupling reactions offer an 
important and routinely applied option for their synthesis. The 2-pyrone moiety exhibits both 
aromatic and alkenic chemical properties. In cross-coupling reactions, the 2-pyrone scaffold is 
used as the organometallic nucleophilic component or the halide/pseudohalide electrophilic 
component.  
2-Pyrones are used in combination with various metals, Meinwald et al.57 investigated the 
synthesis of 5-substituted 2-pyrones 111. Their studies showed that the synthesis of 5-
substituted 2-pyrones gives higher yields when using organotin reagent 110 and coupling it 
with enol triflates, rather than using bromide 109 and transfer it to the corresponding 
5-substituted 2-pyrones via the cross-coupling reaction with organotin compounds 
(Scheme 37). Additionally, this concept was proven for 3-bromo-2-pyrone giving rise to 
3-substituted 2-pyrones in the same study. 
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Scheme 37. Reaction of 5-trimethylstannyl-2-pyrone 110.57 
 
In an analogous manner, the 2-pyrone-5-boronate 112 was synthesized by reacting bromide 109 
with pinacolborane by Jones et al.58 The Suzuki coupling of 112 with various aryl and 
heteroaryl halides or triflates provided 5-aryl- or 5-heteroaryl-2-pyrones in good yields 
(Scheme 38). The same work group also developed a high yielding route to bufadienolide type 
steroids by using this strategy.59 
 
 
Scheme 38. Suzuki coupling of 2-pyrone 112.58 
 
Rossi et al.60 showed the palladium-catalyzed reaction of 5-iodozinc-2-pyrones 113 with 
various organic electrophiles. The required iodides 31 are received via iodolactonization as 
discussed earlier. Afterward, the iodides 31 are transferred into the corresponding organozinc 
iodides 113 (Scheme 39). Additionally, hydrolysis of the organozinc iodides 113 allows the 
facile synthesis of 6-substituted 2-pyrones. 
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Scheme 39. Reaction of 5-iodozinc-2-pyrones 113.60 
 
Additionally, halides or pseudohalides of different 2-pyrones are frequently used in palladium-
catalyzed cross-coupling reactions, offering facile access to valuable substituted 2-pyrones. 
Rossi et al.61 investigated the Sonogashira coupling of chloride 114 and different alkynes 115 
(Scheme 40). Additionally, 4-halogenated 2-pyrones were used under Sonogashira coupling 
conditions to introduce substituents in the 2-pyrone scaffold.62 
 
 
Scheme 40. Sonogashira coupling of 2-pyrone 114.61 
 
Furthermore, Suzuki coupling of 2-pyrone triflate 117 with various boron reagents resulted in 
the desired 3-substituted-2-pyrones 119. The strategy developed by Maulide et al.63 offers a 
facile opportunity for the rapid synthesis of different 3-substituted 2-pyrones on multigram 
scale (Scheme 41). Similarly, the Suzuki coupling of 4-bromo 2-pyrones with arylboronates 
proceeds in excellent yields.64 It was even possible to switch to the more affordable nickel 
catalysis in the reaction of 4-tosyl 2-pyrones with arylboronates, giving rise to 4-substituted 
2-pyrones.65 
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Scheme 41. Suzuki coupling of 2-pyrone (±)-117.63 
 
Tosylated 2-pyrone 120 also reacted in a Heck coupling with enamides and butyl vinyl ether to 
yield the expected 2-pyrone 121 in excellent yields (Scheme 42).66 
 
 
Scheme 42. Heck coupling of 2-pyrone 120.66 
 
Cho et al.67 developed the regioselective Stille coupling of 3,5-dibromo-2-pyrone 122 with 
various stannanes. Depending on the reaction conditions, it was possible to form the desired 
isomer nearly exclusively (Scheme 43).  
 
 
Scheme 43. Regioselective Stille coupling of 3,5-dibrome-2-pyrone 122.67 
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3.8 C-H activation 
 
While cross-coupling reactions offer a versatile way for introducing substituents into the 
2-pyrone scaffold, they also require suitable prefunctionalization. Therefore, the appropriate 
C-H activation of less functionalized substrates is an even more efficient strategy. In 2010, 
Fairlamb et al.68 developed the first synthetic methodology for the catalytic 
C-H functionalization of 2-pyrones. The intramolecular palladium-catalyzed reaction proceeds 
regioselectively at the 3-position of the 2-pyrone moiety to yield 126 (Scheme 44).  
 
 
Scheme 44. Palladium-catalyzed regioselective C–H functionalization of 2-pyrone 125.68 
 
The same work group expanded the scope for the intramolecular reaction by varying the length 
of the side chain. By changing the reaction conditions, they were also able to improve the 
system so that no phosphine ligands are necessary anymore (Scheme 45).69  
 
 
Scheme 45. C–H functionalization of 2-pyrone 127.69 
 
Interestingly, if the 3-position is blocked, e.g., with a methyl group cyclization occurs at the 
5-position of the 2-pyrone in excellent yields. Surprisingly, if 3-bromo 2-pyrone is used, 
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cyclization occurs also at the 5-position, but an additionally hydrodebromination process is 
observed in 3-position to yield 129 (Scheme 46). 
 
 
Scheme 46. Reactivity towards different blocking substituents in 3-position.69 
 
McGlacken et al.70 investigated the double C-H activation of 132 without any activating group. 
Their developed synthetic route offers simple access to cyclized products of type 126 with 
excellent regioselectivity (Scheme 47).  
 
 
Scheme 47. Cyclization of 2‑pyrones 132 via a double C-H activation.70 
 
In addition to this, Yousuf et al.71 developed an intermolecular approach for the C-H activation 
of 2-pyrone derivatives in 3-position without using an activating group (Scheme 48).  
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Scheme 48. C-H activation of 2-pyrone derivatives and intermolecular C-C coupling.71 
 
The reaction proceeds with high regioselectivity and broad substrate scope, opening facile 
access to potentially useful 2-pyrone derivatives 134. 
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1 Synthesis of 2-pyrones starting from renewable resources 
1.1 Introduction 
 
The production pathways in the chemical industry are mainly based on non-renewable 
resources like natural gas, oil and coal.72 However, these feedstocks are not infinitely available, 
and there is a high demand to develop alternative routes based on renewable resources. This is 
particularly the case, for the synthesis of many fine chemicals like, e.g. 2-pyrones. 
The 2-pyrone scaffold is present in a number of natural products, and 2-pyrones have been 
proven to be useful building blocks for the synthesis of complex molecules and, therefore, they 
are valuable starting materials for organic chemistry.30,31,34 The synthesis of substituted 
2-pyrones is of broad interest, as a number of elegant methods have been developed over the 
years to access this class of compounds as discussed earlier. Among these, the thermal 
rearrangement of cyclopentadienone epoxide (136) stands out, as it provides an 
atom-economical approach to 2-pyrone (1),73 this rearrangement proceeds through a 
6 electrocyclic reaction via a vinyl ketene 135 (Scheme 49).74–76 
 
 
Scheme 49. Synthetic approach toward 2-pyrone (1). 
 
Although the mechanism of the reaction is well studied, this rearrangement did not attract much 
attention for the synthesis of 2-pyrone derivatives. This could be due to difficulties to access 
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the required starting materials, often requiring harsh reaction conditions resulting in low 
yields.74–76 In particular, cyclopentadienone epoxide ((±)-136) cannot be synthesized from 
cyclopentadienone due to the high tendency of the latter to dimerize. As a well-known surrogate 
for cyclopentadienone,77 therefore, enone (±)-138, a suitable precursor for the synthesis of 
different 2-pyrones, which can be synthesized from renewable resources, was explored in this 
work. 
The key compound enone (±)-138 for the synthesis of the 2-pyrone moiety can be produced via 
a reaction sequence starting from hemicellulose. Hemicellulose is an inexpensive renewable 
resource based on non-edible sources like e.g. bagasse and bran. Bagasse is a residue of 
sugarcane processing, and bran is a byproduct of the rice milling process. Additionally, waste 
from deciduous and coniferous wood waste, municipal solid wastes and waste from the pulp 
and paper industry can serve as a source for hemicellulose. Hemicellulose, a polysaccharide, is 
composed of many different sugar monomers, e.g., Xylose, Arabinose, Glucose, Mannose and 
Galactose.78 Xylose (139) is the main component in hemicellulose and can be readily accessed 
through treatment of hemicellulose with acids. Further dehydration of aforementioned Xylose 
(139) gives rise to furfural (140).78 Furfural (140) is considered as a platform chemical, having 
found use in the production of biofuels or solvents (Scheme 50). 79 As it is readily available 
through the aforementioned process, it is an ideal starting material for the sustainable synthesis 
of fine chemicals.  
 
Scheme 50. Synthesis of 141 starting from renewable resources. 
B Main Part 
32 
 
Furfuryl alcohol (141), being produced from furfural (140) by catalytic reduction on ton scale, 
offers particularly attractive opportunities for the production of fine chemicals and drugs due 
to the versatile skeletal transformations it can undergo, e.g., by the Piancatelli or the 
Achmatowicz rearrangement.80,81 The Piancatelli rearrangement is believed to proceed through 
a sequence that concludes with a 4π conrotatory electrocyclic ring closure of a pentadienyl 
cation 147 (Scheme 51).80 
 
 
Scheme 51. Proposed mechanism of the rearrangement of furfuryl alcohols by Piancatelli.80 
 
4-Hydroxy-2-cyclopentenone ((±)-150), is a versatile starting material and available via the 
Piancatelli rearrangement from renewable resources, hence it can serve as starting material for 
the sustainable synthesis of the 2-pyrone motif.82 Recently, Reiser et al.83 reported that the 
Piancatelli rearrangement of furfuryl alcohol (141) to 4-hydroxy-2-cyclopentenone ((±)-150) 
could be conducted on large scale and high yield using a microreactor setup (Figure 3). 
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Figure 3. Microreactor for the Piancatelli rearrangement.83  
 
Furfuryl alcohol (141), dissolved in toluene and water is injected via a high-pressure pump and 
thoroughly mixed with a blender. The mixture is then heated in an oven and after a contact time 
of less than 1 min two separate layers are obtained. The aqueous phase contains 
4-hydroxy-2-cyclopentenone ((±)-150), which is isolated in 87% yield and 97% purity after 
evaporation of water. With this strategy in hand, 4-hydroxy-2-cyclopentenone ((±)-150) can be 
used as starting material for the synthesis of enone (±)-138 in multigram scale, which itself 
serves as a key compound in the aforementioned synthesis of the 2-pyrone scaffold. For the 
rearrangement to the final 2-pyrone moiety a flash vacuum thermolysis (FVT) setup is used 
(Figure 4). 
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Figure 4. Setup for flash vacuum thermolysis. 
 
FVT is a special application of gas-phase thermolysis, which typically uses temperatures 
between 400 and 1100 °C. The apparatus consists of a quartz tube containing the starting 
material on the one end, an oven in the middle and a cooling trap on the other end. The starting 
material is then evaporated by external heating and sucked through the high-temperature zone 
of the oven by a vacuum. Because the substrate is sucked very quickly through the heated area, 
high-temperature exposure periods are only very short (between 10-3-1 s). This allows the use 
of very high temperatures of up to 650 °C, without destroying the compound, thus enabling 
access to reactions pathways and compounds which are not accessible by other strategies.84 
 
1.2 Synthesis of unsubstituted 2-pyrone 
 
As mentioned in the introduction, the basic structure, unsubstituted 2-pyrone (1), is a versatile 
and valuable starting material for organic chemistry, its aforementioned reactivity offers many 
different transformations e.g. for the synthesis of (-)-Leodomycin D (151) or Rosiglitazone 
(152) (Scheme 52).85,86 
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Scheme 52. Examples of compounds obtained using 2-pyrone (1) as starting material.85,86 
 
The synthesis of 2-pyrone (1) starting from renewable resources like furfuryl alcohol (141) 
offers an inexpensive and sustainable route to this interesting compound. As mentioned before, 
furfuryl alcohol (141) can be rearranged in a continuous flow system with a microreactor setup 
in 87% yield (Scheme 53). Gaining a better leaving group for the subsequent elimination, 
(±)-150 was acetylated to (±)-15387 in good yields using acetic anhydride and catalytic amounts 
of toluenesulfonic acid. The following [4+2] cycloaddition of acetate (±)-153 with 
cyclopentadiene proceeds in the presence of zinc(II)chloride and after basic work up, enone 
(±)-138 is obtained in excellent yield.88 The latter is an interesting starting material for many 
different syntheses89,90 itself and readily available by this route in multigram scale. Enone 
(±)-138 was epoxidized with hydrogen peroxide to yield 86% of the expected 
epoxide (±)-137.91 Finally, epoxide (±)-137 was subjected to FVT, causing a retro-Diels-Alder 
reaction and the subsequent rearrangement yielded 1 in 94% with a purity of >99% 
(GC-analysis) without any further purification. Notably, this purity is achieved without any 
chromatographic work up, (±)-150, (±)-153, (±)-138 were distilled, while (±)-137 was extracted 
after completion of the reaction. 
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Scheme 53. Synthesis of 2-pyrone (1) from furfuryl alcohol (141) 
 
1.3 Synthesis of naturally occurring 6-substituted alkyl 2-pyrones 
 
Besides the synthesis of unsubstituted 2-pyrone (1), attempts were made to introduce 
substituents into the final 2-pyrone moiety. One strategy was to start the synthesis with furfuryl 
alcohol derivatives (±)-142. Substituted furfuryl alcohol derivatives are readily available using 
a Grignard reaction starting from furfural (140). This strategy leads to 6-substituted 
2-pyrones 2, which are known e.g. as natural products. Introducing n-propyl-, n-pentyl- and 
n-heptyl residues yield three naturally occurring 6-substituted 2-pyrones 2, which were reported 
as a metabolite from strains of Trichoderma viride (Scheme 54).5,92  
The reaction of furfural (140) with the corresponding Grignard reagents yielded the substituted 
furfuryl alcohol derivatives (±)-142 in good to excellent yields. The subsequent Piancatelli 
rearrangement was performed under microwave irradiation, which is perfectly suitable for 
small-scale reactions. Reiser et al.83 demonstrated the great advance of transferring the 
Piancatelli rearrangement to a microwave setup in 2010. Using microwave irradiation, the 
reaction of (±)-142 to (±)-149 is achieved within minutes and with improved yields compared 
to the conventional reflux conditions (Table 1). 
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Entry R time (min) dr (cis/trans) yield (%) 
1 Ph 2 1:5 96 
2 CH2CH=CHMe 5 1:12 73 
3 Et 15 1:7 54 
4 n-pentyl 15 1:7 65 
5 n-dodecyl 30 - 0 
Conditions: (±)-142 (1.5 mmol) in H2O (6 mL), microwave irradiation (300 W) under closed vessel 
conditions (200-210 °C, 15 bar)  
 
Table 1. Rearrangement of furfuryl alcohol derivatives (±)-142.83 
 
In this work, a water/acetone mixture was used for reasons of solubility, giving rise to 
5-substituted 4-hydroxy-2-cyclopentenones (±)-149. Acetylation with acetic anhydride gave 
the corresponding acetates (±)-154 in excellent yields. The following Diels-Alder reaction 
proceeded with zink(II)chloride followed by elimination. Enones (±)-155 contain two double 
bonds displaying different reactivity. The double bond next to the electron-withdrawing 
carbonyl group is much more electron-poor. Therefore, nucleophilic epoxidation should occur 
at the double bond next to the carbonyl group with nucleophilic reagents, while the electrophilic 
epoxidation takes place on the other double bond with electrophilic reagents like m-CPBA.93 
Such a nucleophilic epoxidation of unsaturated carbonyl compounds can e.g. be performed in 
the presence of hydrogen peroxide under basic conditions. At the same time, this provides an 
efficient and environmentally friendly option for the epoxidation of the synthesized enones 
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(±)-155 since no catalyst is needed and the only byproduct formed during the reaction is water. 
In the last step, the epoxides (±)-156 were rearranged by flash FVT to afford the three naturally 
occurring 6-substituted 2-pyrones 2 in quantitative yield (Scheme 54). 
 
 
Scheme 54. Synthesis of 6-substituted 2-pyrones 2 from furfural (140). 
 
1.4 Synthesis of 6-substituted α-hydroxyalkyl 2-pyrones 
 
Enone (±)-138 offers the opportunity to introduce substituents into the final 2-pyrone moiety, 
however, the double bond of the enone (±)-138 still needs to be available for epoxidation after 
the substitution. The Baylis-Hillman reaction offers an atom economic and versatile tool for the 
substitution of enones while retaining the required double bond in the product after the 
transformation. The Baylis-Hillman reaction requires three essential components: an activated 
alkene, alkyne or allene, an electrophile and a catalyst. Over the last years, a broad variety of 
combinations of these three components was investigated and used in organic synthesis. The 
diversity of the Baylis-Hillman reaction is indicated in Scheme 55.94–96 
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Scheme 55. Overview over the Baylis-Hillman reaction.95 
 
The mechanism of the Baylis-Hillman reaction proceeds through a Michael-initiated 
addition-elimination sequence. An amine-catalyzed reaction mechanism is illustrated in 
Scheme 56. The tertiary amine attacks the activated alkene 157 via nucleophilic addition, 
resulting in a zwitterionic enolate 158. This enolate 158 attacks the aldehyde in an aldol fashion 
to generate 159. Subsequent proton migration and release of the catalyst provides the desired 
product 161. 
 
 
Scheme 56. Mechanism of the Baylis-Hillman reaction.96 
 
Eddols et al.89 already used the Baylis-Hillman reaction for the substitution of enone (±)-138 
to obtain β-hydroxy alkylated enones (±)-162 which were derivatized afterward. An 
alkylcuprate conjugate addition followed by a spontaneous β-elimination yielded exocyclic 
alkenes (±)-163. Finally, a retro-Diels–Alder reaction released the corresponding 
cross-conjugated cyclopentadienone (±)-164 (Scheme 57). 
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Scheme 57. Preparation of cross-conjugated cyclopentadienones.89 
 
The Baylis-Hillman reaction of (±)-138 and aldehydes (Table 2), precedented by Eddols et al.,89 
smoothly gave rise to adducts (±)-165 that were envisioned to be suitable precursors for the 
synthesis of 6-substituted 2-pyrones. Expanding the scope previously reported,89 different 
aliphatic and aromatic aldehydes with both electron withdrawing and donating groups yielded 
the target compounds in good yields. Sterically less hindered aliphatic and aromatic aldehydes 
with electron withdrawing groups proved to be more reactive, resulting in significantly reduced 
reaction times. 
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entry R (±)-165 time (d) yield (%) 
1 Me a 3 84 
2 Et b 3 79 
3 i-Pr c 7 85 (87)a 
4 n-Pr d 3 83 
5 n-Bu e 3 80 
6 n-Hex f 3 82 
7 Ph g 2 83 (89)a 
8 4-Cl-Ph h 1 79 
9 4-NO2-Ph i 1 86 
10 4-MeO-Ph j 7 85 
11 2-Furyl k 3 90 
a Taken from reference 89 
Table 2. Baylis-Hillman reaction of enone (±)-138 with various aldehydes. 
 
Theoretically, the outcome of this reaction could lead to the formation of four different 
stereoisomers (a set of two diastereomers), as illustrated in Figure 5. However, when submitted 
to NMR analysis, no indication of diastereomeric proton signals was found. Hence, it is 
plausible to assume that just one pair of enantiomers is formed during the reaction. 
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Figure 5. Theoretically possible products of the Baylis-Hillman reaction.  
 
On these grounds, the Baylis-Hillman reaction to (±)-165 must take place with complete 
diastereoselectivity. This can be rationalized taking into account that the phosphine catalyst 
adds to the enone (±)-138 from its sterically less hindered convex side, followed by an aldol 
reaction of the resulting (±)-166 via a Zimmermann-Traxler-type transition state 167, due to 
steric hindrance 168 is not formed (Scheme 58).  
 
 
Scheme 58. Diastereoselective Baylis-Hillman reaction. 
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The relative stereochemistry could be unambiguously assigned by X-ray crystallography of 
(±)-165g (Figure 6). 
 
 
Figure 6. Crystal structure of (±)-165g. 
 
With the Baylis-Hillman adducts in hand, the next step was the epoxidation of the double bond 
of the enone system. The aforementioned system, using hydrogen peroxide under basic 
conditions, proved to be highly effective for different enones. Applying these conditions to the 
substituted enones (±)-165 lead to epoxidized products (±)-170 within 30 min with excellent 
yields, chemo- and diastereoselectivity. Furthermore, steric or electronic properties of the 
substituent did not show any influence on the epoxidation (Table 3). 
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entry R (±)-170 yield (%) 
1 Me a 91 
2 Et b 92 
3 i-Pr c 97 
4 n-Pr d 95 
5 n-Bu e 92 
6 n-Hex f 96 
7 Ph g 96 
8 4-Cl-Ph h 91 
9 4-NO2-Ph i 89 
10 4-MeO-Ph j 92 
11 2-Furyl k 97 
 
Table 3. Epoxidation of Baylis-Hillman adducts (±)-165. 
 
Epoxidation of (±)-165 occurred exclusively from the convex face of the enone, which was 
ascertained by X-ray crystallography of (±)-170g (Figure 7). 
 
 
Figure 7. Crystal structure of (±)-170g. 
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These epoxides (±)-170 could then be subjected to flash vacuum thermolysis, triggering 
extrusion of cyclopentadiene by a retro-Diels-Alder reaction and the subsequent rearrangement 
to 2-pyrones (±)-171 (Table 4). A temperature of 650 °C at 0.02 mbar was found to be 
necessary, as lower temperatures resulted in the incomplete conversion of the starting materials. 
High yields (88-98%) and no byproducts or decomposition were generally observed. The only 
exception was the furyl substituted derivative (±)-171k, which was formed in only 62% yield. 
In this case, significant amounts of polymeric material were formed during the FVT, indicating 
the thermal lability of 2-pyrone (±)-171k.  
 
 
entry R (±)-171 yield (%) 
1 Me a 98 
2 Et b 92 
3 i-Pr c 96 
4 n-Pr d 92 
5 n-Bu e 91 
6 n-Hex f 90 
7 Ph g 98 
8 4-Cl-Ph h 97 
9 4-NO2-Ph i 88 
10 4-MeO-Ph j 98 
11 2-Furyl k 62 
 
Table 4. Rearrangement to 6-substituted α-hydroxyalkyl 2-pyrones (±)-171. 
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As with the previous compounds, the structure of 2-pyrones (±)-171 were confirmed by X-ray 
crystallography of (±)-171j (Figure 8). 
 
Figure 8. Crystal structure of (±)-171j. 
 
1.5 Enzymatic Resolution 
 
Enzymes are widely used in organic chemistry; especially lipases have excellent abilities in e.g. 
the kinetic resolution of racemic compounds. The active center of the lipases forms a special 
environment, which allows distinguishing between the two enantiomers affected by steric 
effects. Remarkably, lipases tolerate a broad range of unnatural substrates, and they are stable 
and active in organic solvents without cofactors. Furthermore, they are commercially available 
in free and immobilized form, which makes lipases even more attractive for organic synthesis.97 
Since 2-pyrones are valuable building blocks in organic chemistry, furthermore the enzymatic 
resolution of (±)-171 was investigated to arrive at enantiomerically pure compounds. 
Novozym 435 (Candida antarctica lipase B) is a widely used lipase because of its outstanding 
stability and activity in hydrophobic organic media.97 Kocovsky et al.98 used the great abilities 
Novozym 435 offers for the kinetic resolution of substituted secondary alcohols bearing an allyl 
and different aryl substituents. Using isopropenyl acetate as acylation agent in toluene gave 
excellent results (Scheme 59).  
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Scheme 59. Resolution of racemic alcohols by Novozym 435.98 
 
The 6-substituted α-hydroxyalkyl 2-pyrones (±)-171 synthesized in this work have a similar 
steric structure compared to (±)-172, and therefore the conditions of Kocovsky et al.98 were 
tested. The difference in size of the two substituents of the secondary alcohol is essential for 
the resolution. The more difference the two substituents exhibit, the better the resolution 
proceeds. Therefore, (±)-171a having the biggest difference in size of the two substituents at 
the secondary alcohol, was tested under these conditions first (Scheme 60). 
The kinetic resolution of 2-pyrone (±)-171a gave (S)-171a with > 99% ee in 38% yield. The 
stereochemistry was assigned by applying Kazlauskas’ rule.99 
 
 
Scheme 60. Resolution of (±)-171a by Novozym 435. 
 
Kazlauskas’ rule is a stereoselectivity model applicable for lipase-catalyzed reactions of 
secondary alcohols, offering a way to predict which enantiomer reacts faster (Figure 9). 
According to Kazlauskas’ rule enantiomer A reacts faster due to higher matching to the active 
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site of the lipase, therefore acylation of A is faster. Applying this rule the kinetic resolution of 
(±)-171a gives (S)-171a and (R)-174. 
 
 
Figure 9. Kazlauskas’ rule for secondary alcohols.99 
 
This assignment was proven unambiguously by X-ray crystallography after derivatization of 
(S)-171a to (S)-175 (Scheme 61). 
 
 
Scheme 61. Derivatization and Crystal structure of (S)-175. 
 
Encouraged by the promising results with (±)-171a, it was tried to use 2-pyrone (±)-171e 
containing a longer alkyl side chain under the same conditions. However, even after 7 d mainly 
starting material was recovered, and the isolated 2-pyrones showed poor enantiomeric excess 
(Scheme 62). Therefore it was concluded, that these conditions are not suitable for 2-pyrone 
(±)-171e containing a longer side chain and a new pathway had to be found.  
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Scheme 62. Resolution of (±)-171e by Novozym 435. 
 
The enzymatic hydrolysis of racemic acetates, synthesized from secondary alcohols, is another 
effective route for the synthesis of enantiomerically pure secondary alcohols. Yusufoğlu et 
al.100 used Amano lipase from Burkholderia cepacia (AL-PS) for the enzymatic hydrolysis of 
secondary acetates (±)-177 bearing a phenyl substituent and a side chain of 11-19 carbon atoms 
(Scheme 63).  
 
 
Scheme 63. Enzymatic hydrolysis of the racemic acetates (±)-177.100 
 
The size of the phenyl substituent is comparable with the one of the 2-pyrone moiety. Hence, 
the strategy was changed to an enzymatic hydrolysis of the racemic acetate (±)-179, which was 
prepared from (±)-171e with acetic anhydride in 95% yield. Hydrolysis of (±)-179 with AL-PS 
in a buffer/acetone mixture provided (S)-179 with >99% ee in 39% yield (Scheme 64). 
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Scheme 64. Acetylation of (±)-171e and enzymatic hydrolysis of (±)-179. 
 
Furthermore, an even more sterically demanding phenyl substituent was chosen for the 
enzymatic hydrolysis. Therefore 2-pyrone (±)-171g was acetylated to (±)-180 in 90% yield 
(Scheme 65). However, after 7 d no enzymatic hydrolysis was observed, which leads to the 
conclusion that a phenyl substituent might be too sterically demanding for the active site of the 
enzyme. 
 
 
Scheme 65. Acetylation of (±)-171g and attempted enzymatic hydrolysis of (±)-180. 
 
1.6 Tsuji-Trost reaction 
 
The Tsuji-Trost reaction is a metal-catalyzed asymmetric allylic alkylation reaction, which is 
widely applied in many different syntheses using various types of nucleophiles, leaving groups 
and metals (Scheme 66).  
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Scheme 66. Tsuji-Trost reaction. 
 
This reaction offers a versatile opportunity for organic syntheses to arrive at enantiomerically 
pure compounds. The mechanism of the reaction is illustrated in Scheme 67.  
 
 
Scheme 67. Mechanism of the Tsuji-Trost reaction.101 
 
Reiser et al.102 demonstrated the palladium-catalyzed kinetic resolution of the O-Boc derivative 
of 4-hydroxy-2-cyclopentenone (±)-186 with high enantioselectivity as well as its application 
in synthesis (Scheme 68). 
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Scheme 68. Palladium-catalyzed allylic substitutions of (±)-186.102 
 
First, the α-hydroxy group of the 6-substituted 2-pyrones was converted into a better leaving 
group. Therefore, (±)-171e was convert into its corresponding tosyl (±)-189b, acetate (±)-179 
and O-Boc derivative (±)-190 in excellent yields (Scheme 69).  
 
 
Scheme 69. Synthesis of 2-pyrone derivatives containing a good leaving group. 
 
The synthesized substrates for the Tsuji-Trost reaction were tested under the optimized 
conditions for the kinetic resolution of (±)-186 with p-methoxyphenol as a nucleophile.103 
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Unfortunately, in all cases no conversion was observed even after 2 d of reaction time 
(Scheme 70). 
 
 
Scheme 70. Attempted palladium-catalyzed allylic substitutions. 
 
This might be due to the aromatic character the 2-pyrone ring exhibits. Therefore the π-allyl 
complex cannot be formed, and no product formation is observed.  
 
1.7 Oxidation of the -hydroxy group and total synthesis of Gibepyrone F 
 
A α-ketone functionality is a known structure in natural occurring 6-substituted 2-pyrones 
(Figure 1).104 This scaffold is readily accessible by oxidation of the α-hydroxy group of the 
α-hydroxyalkyl 2-pyrones (±)-171. Karp et al.105 showed the oxidation of the α-hydroxy group 
of substituted isocoumarin (±)-193 using MnO2 (Scheme 71). 
 
 
Scheme 71. Oxidation of substituted isocoumarin as reported by Karp et al.105 
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This strategy turned out to be suitable also for the oxidation of the α-hydroxy group of 
6-substituted 2-pyrones. Therefore, three different 6-subtituted 2-pyrones bearing different 
substituents were oxidized under these conditions in good yields (Scheme 72). The varying 
steric hindrance of the side chain of the α-hydroxyalkyl 2-pyrones 171a, 171e, 171g did not 
display any influence to the reaction, and a carbonyl group was introduced straightforwardly.  
 
 
Scheme 72. Oxidation of α-hydroxyalkyl 2-pyrones 171a, 171e, 171g. 
 
Interestingly, by the introduction of a methyl substituent in 3-postion of (±)-195a it would be 
possible to obtain the natural occurring 3,6-substituted 2-pyrone Gibepyrone F 3a, which was 
identified in cultures of Gibberella fujikuroi.104 Having a look at the retrosynthesis, an 
additional methyl substituent has to be introduced in α-position to the carbonyl group, between 
the 6- and the 5-membered ring in epoxide (±)-197 (Scheme 73). 
 
 
Scheme 73. Retrosynthesis of Gibepyrone F 3a. 
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The initial strategy for addition of the additional methyl group to the final compound was 
starting the synthesis with a methyl substituted furfuryl alcohol derivative (±)-199, which was 
synthesized by reduction of 198 (Scheme 74). In the next step, (±)-199 was rearranged to 
(±)-200 using the above-mentioned microreactor setup in 73% yield. The 5-substituted 
4-hydroxy-2-cyclopentenone derivative (±)-200 was isomerized to the 2-substituted 
derivative (±)-201 by adsorption on Al2O3.
106 This isomerization gives the methyl substituent 
in the desired position. Acylation of (±)-201 with acetic anhydride yielded (±)-202 in 81%. 
Unfortunately, the following Diels-Alder reaction did not lead to any conversion. This might 
be due to the increased steric hindrance at the dienophile.  
 
 
Scheme 74. Attempted synthesis of (±)-203. 
 
De et al.107 reported that the methylation of (±)-138 using various methods gave an inseparable 
mixture of many different compounds, which probably arose from isomerization of the initially 
methylated product (Scheme 75). 
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Schema 75. Attempted methylation of (±)-138 as reported by De et al.107 
 
Therefore, the substituent in 6-position was introduced first via a Baylis-Hillman reaction to 
yield (±)-165a. Afterward, the alcohol of (±)-165a was protected by a TMS group to afford 
(±)-204 in excellent yield. Methylation using LDA and methyl iodide gave (±)-205. 
Epoxidation and deprotection proceeded in one step under basic conditions with hydrogen 
peroxide to yield quantitatively (±)-197. Epoxide (±)-197 was rearranged to the corresponding 
3,6-substituted 2-pyrone (±)-196, which was finally oxidized to Gibepyrone F 3a in good yield 
(Scheme 76). 
 
 
Scheme 76. Total synthesis of Gibepyrone F 3a. 
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1.8 Elimination of the -hydroxy group 
 
Elimination of the α-hydroxy group offers the opportunity to introduce a double bond into the 
side chain of the synthesized α-hydroxyalkyl 2-pyrones (±)-171, which is a known motif in 
natural products (Figure 1).5 The 2-pyrones (±)-171b, (±)-171e, and (±)-171f allowed the facile 
synthesis of Sibirinone (7a) and related natural products 7b-c, which have been found in 
cultures of fungi. Sibirinone (7a) was isolated from Hypomyces semitranslucens,108 7b and 7c 
were reported as a metabolite from strains of Trichoderma viride along with their elegant 
synthesis starting from propargyl bromide and propiolic acid.5,92 Additionally, 7c was found in 
the marine isolate of fungus Botrytis sp,109 while 7b is also a component of the queen 
recognition pheromone of fire ants Solenopsis invicta.110 
Attempting the direct elimination of water from (±)-171e under acidic conditions failed. Daoubi 
et al.111 showed the elimination of the α-bromide group of 2-pyrone (±)-206 using basic 
conditions (Scheme 77). 
 
 
Scheme 77. Bromine elimination of (±)-206 by Daoubi et al.111 
 
Therefore, the α-hydroxy group had to be converted into a better leaving group comparable to 
the quality of bromide. This was achieved by tosylation of the α-hydroxy group. The tosyl group 
is an even better leaving group than bromide and elimination under the stated conditions 
smoothly gave rise to the desired 2-pyrones 7 (Scheme 80). The compounds were exclusively 
obtained in the naturally occurring (E)-configuration in excellent yield and purity (Scheme 78). 
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Scheme 78. Synthesis of Sibirinone (7a) and related natural products. 
 
1.9 Synthesis of 5-substituted alkyl 2-pyrones 
 
After introducing substituents in 3- and 6-position, it was attempted to further expand the scope 
of the synthesis of substituted 2-pyrones to other positions. 5-Substituted 2-pyrones represent 
another interesting class of substituted 2-pyrones displaying a wide range of biological activity, 
e.g. bufadienolides. Bufadienolides contain a steroid structure, one example 6 is depicted in 
Figure 1.1 A retrosynthetic analysis shows that the substituent needs to be inserted at the double 
bond of the enone moiety in β-position to the carbonyl group (Scheme 79). 
 
 
Scheme 79. Retrosynthesis of 5-substituted 2-pyrones 111. 
 
Oda et al.112 demonstrated the facile synthesis of ether (±)-210 from (±)-209 using Meerwein's 
reagent (Scheme 80).  
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Scheme 80. Synthesis of ether (±)-210.112 
 
This concept was expanded to the Diels-Alder adduct (±)-211 yielding (±)-212, which was 
envisioned to be a suitable precursor for the synthesis of 5-substituted 2-pyrones (Scheme 81). 
The synthesis of Diels-Alder adduct (±)-211 from 4-hydroxy-2-cyclopentenone ((±)-150) is 
described in the next chapter. 
 
 
Scheme 81. Synthesis of ether (±)-212. 
 
The use of EtMgBr as nucleophile gave rise to the desired product (±)-213, which was obtained 
in 82% yield. Nucleophilic epoxidation of (±)-213 with hydrogen peroxide proceeded in 
excellent yield, but extended reaction time was required compared to the substrates used before 
(Scheme 82). This might be due to higher steric hindrance since the initial step of the 
nucleophilic epoxidation contains a conjugate addition of the hydroperoxide anion to the enone. 
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Scheme 82. Synthesis of epoxide (±)-214. 
 
With the epoxide (±)-214 in hand, FVT was conducted under the previously suitable conditions. 
The starting material was converted completely, but surprisingly more than one product was 
observed. The rearrangement yielded two different monosubstituted 2-pyrones a 5-, and a 
3-substituted compound in a ratio of 1:2. (Scheme 83). 
 
 
Scheme 83. FVT of epoxide (±)-214.  
 
Zwanenburg et al.113 also observed the formation of two different 2-pyrones as byproducts 
during the synthesis of cyclopentadienone epoxide (±)-218. Analogously, the two byproducts 
emerged to be the corresponding 5-, and 3-substituted 2-pyrones in a ratio of 2:3 (Scheme 84). 
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Scheme 84. FVT of epoxide (±)-217.113 
 
This observation was rationalized by a [1,5] sigmatropic H-shift of ketene 222 to ketene 223. 
After electrocyclization of the two different ketene intermediates 5-, and 3-substituted 
2-pyrones are obtained (Scheme 85). 
 
 
Scheme 85. Mechanism and [1,5] sigmatropic H-shift.113 
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Following the previously described methods to obtain 6-substitutedd 2-pyrones, no 
[1,5] sigmatropic H-shift can occur due to the missing hydrogen atom. Additionally, the 
reaction was tried with a phenyl substituent (Scheme 86).  
 
Scheme 86. Synthesis and FVT of epoxide (±)-225. 
 
The Grignard reaction of (±)-212 with PhMgBr resulted only in traces of the desired product. 
Therefore, the more reactive PhLi was used to introduce a phenyl substituent. Using a modified 
protocol developed by Ogino et al.114 gave the product (±)-224 with improved yield of 94%. 
Epoxidation of (±)-224 to (±)-225 proceeded smoothly within 24 h with 95% yield. 
Surprisingly, FVT of (±)-225 gave a complex mixture of more than two compounds. 
 
In summary, a high yielding sequence for the synthesis of different 2-pyrone derivatives 
including unsubstituted 2-pyrone (1) in high purity from renewable resources was developed. 
It was possible to introduce substituents in 3- and 6-postion furnishing different natural 
products. Synthesized α-hydroxyalkyl 2-pyrones (±)-171 were enzymatically resolved to arrive 
at enantiomerically pure compounds. The hydroxy group of the racemic compounds was 
eliminated and additionally oxidized to receive natural products. During the synthesis of 
α-hydroxyalkyl 2-pyrones (±)-171 diastereoselectivity of the performed Baylis-Hillman 
reaction was observed and explained by a Zimmermann-Traxler transition state. 
  
B Main Part 
63 
 
2 Synthesis of γ-alkylidenebutenolides 
2.1 Introduction 
 
The butenolide motif is abundant in nature and compounds containing this motif display a 
number of biologically, and medically interesting properties. Especially, butenolides containing 
an exocyclic double bond, called γ-alkylidenebutenolides, exhibit great activities such as 
cytotoxicity, antibiotic activity or inhibition of cholesterol biosynthesis.115 A selection of 
different naturally occurring γ-alkylidenebutenolides is depicted in Figure 10. 
 
 
Figure 10. Naturally occurring butenolides containing an exocyclic double bond.115,116  
 
Hence, the synthesis of the γ-alkylidenebutenolide scaffold is of tremendous interest especially 
since there are not many syntheses known in literature until today.117  
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2.2 Oxidation of 4-hydroxy-2-cyclopentenone 
 
Oxidation of 4-hydroxy-2-cyclopentenone ((±)-150) furnishes dione 234, which is known as 
versatile starting material for many different syntheses and it especially displays exceptional 
properties as a dienophile in Diels-Alder reactions.118,119 Therefore, dione 234 was extensively 
studied by DePuy et al.120 using CrO3 for the oxidation of diol (±)-233 (Scheme 87). The 
oxidant CrO3 is highly toxic and high amounts are needed for the oxidation of diol (±)-233, 
which is not desirable regarding sustainability. 
 
 
Scheme 87. Synthesis of dione 234 using chromium trioxide.120  
 
Another way to synthesize dione 234 is the oxidation of 4-hydroxy-2-cyclopentenone ((±)-150), 
which was achieved using MnO2 as an oxidant (Scheme 88).
121 MnO2 is considerable less toxic 
than CrO3, but this reaction as well needs highly overstoichiometric amounts of this oxidizing 
reagent, which produces high amounts of metallic waste. 
 
 
Scheme 88. Oxidation of (±)-150 by MnO2.
121 
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Producing large amounts of metallic waste does not match with the concept of green chemistry 
and sustainability.122 Hence, a sustainable protocol for the oxidation of 
4-hydroxy-2-cyclopentenone ((±)-150) to dione 234 was searched. Additionally, the used 
conditions need to be mild, since dione 234 is not stable under basic conditions and decomposes 
at temperatures above 40 °C rapidly.120,123 Liang et al.124 demonstrated a mild aerobic oxidation 
of various alcohols using catalytic amounts of FeCl3∙6H2O, TEMPO, and NaNO2 (Scheme 89). 
 
 
Scheme 89. Aerobic oxidation of various alcohols.124 
 
The proposed overall mechanism can be formulated as a cascade of two redox cycles 
(Scheme 90). The Fe3+-TEMPO species is able to oxidize the alcohol to the corresponding 
carbonyl compound yielding the reduced form, Fe2+-TEMPOH. The NaNO2 salt acts herein as 
a source for NO2, which regenerates the Fe
3+-TEMPO species. Finally, the resulting NO is 
easily reoxidized by O2 to close the catalytic cycle.
124 
 
 
Scheme 90. Mechanism of iron-catalyzed aerobic oxidation.124 
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The aerobic oxidation of 4-hydroxy-2-cyclopentenone ((±)-150) would offer a sustainable 
opportunity for the synthesis of dione 234. The described oxidation was tested under similar 
conditions giving rise to 69% of the desired product 234 (Scheme 91). 
 
 
Scheme 91. Iron-catalyzed aerobic oxidation of (±)-150. 
 
In conclusion, dione 234 was synthesized in good yield from 4-hydroxy-2-cyclopentenone 
(±)-150 using a combination of FeCl3∙6H2O (5mol%), TEMPO-OH (5mol%), NaNO2 (3mol%) 
and O2 (1 atm) as the oxidant. 
 
2.3 Keto-enol tautomerism 
 
Besides its broad abilities as starting material for several syntheses, 234 and related compounds 
exhibit interesting behavior regarding their keto-enol tautomerism (Scheme 92).  
 
 
Scheme 92. Keto-enol tautomerism. 
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Dione 234 appears to about 100% in its keto form and not in its enol form 237, which is a 
hydroxy derivative of cyclopentadienone. Unsubstituted cyclopentadienone has a very high 
tendency to dimerize. Therefore, the enol form 237 might be unfavored for electronic reasons. 
In contrast, the reduced dihydro derivative 238 is approximately completely in its enol form 
239 under similar conditions.120 The Diels-Alder adduct of (±)-211 and cyclopentadiene is an 
interesting compound to investigate this behavior more intensively. Because of its ability to 
“mask” the double bond and therefore convert the molecule completely into its enol form being 
reversible by retro-Diels-Alder reaction (Scheme 93).  
 
 
Scheme 93. Diel-Alder and retro-Diels-Alder reaction of dione 234. 
 
For the synthesis of Diels-Alder adduct (±)-211 a slightly changed protocol developed by 
DePuy et al.120 was applied (Scheme 94). Benzene was replaced by toluene due to safety 
reasons. Furthermore, three equivalents of cyclopentadiene were used instead of equimolar 
amounts to increase the yield of the adduct (±)-211.  
 
 
Scheme 94. Synthesis of Diels-Alder adduct (±)-211.120 
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The strategy was to fix the molecule (±)-211 in its enol form by protecting the hydroxyl group 
and subsequently performing a retro-Diels-Alder reaction. The transfer of the Diels-Alder 
adduct (±)-211 into its enol ether offers an opportunity to keep the molecule in its enol form. 
Oda et al.112 described the reaction of a Diels-Alder adduct (±)-209 into the corresponding enol 
ether (±)-210 using Meerwein's reagent as mentioned earlier. In this way, compound (±)-211 
was transferred into the corresponding enol ether (±)-212 in 94% yield (Scheme 95). 
 
 
Scheme 95. Synthesis of enol ether (±)-212. 
 
With enol ether (±)-212 in hand, the FVT was performed to induce the retro-Diels-Alder 
reaction. However, the only detected product under these conditions was dione 234; this might 
be due to the lability of enol ether (±)-212 (Scheme 96). The retro-Diels-Alder reaction took 
place, but the ether bond was also cleaved giving rise to dione 234 and ethylene. 
 
 
Scheme 96. Retro-Diels-Alder reaction of enol ether (±)-212. 
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Another option to fix the enol form is to convert the Diels-Alder adduct (±)-211 into an enol 
ester. The protocol described by Zwanenburg et al.125 afforded acetyl ester (±)-240a in 
quantitative yield using acetic anhydride (Scheme 97). 
 
 
Scheme 97. Synthesis of acetyl ester (±)-240a.125 
 
Surprisingly, FVT of acetyl ester (±)-240a yielded E-butenolide 241a and Z-butenolide 242a 
(Scheme 98). The γ-alkylidenebutenolides 241a and 242a share the same molecular formula 
with the theoretical retro-Diels-Alder product of 243. 
 
 
Scheme 98. FVT of acetyl ester (±)-240a. 
 
Stereoisomers 241a and 242a were easily separable by column chromatography, and their 
structure was unambiguously assigned by X-ray crystallography (Figure 11). 
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Figure 11. Crystal structure of γ-alkylidenebutenolides 241a and 242a. 
 
2.4 Mechanism 
 
This unusual and interesting reaction behavior have never been observed before. Therefore, the 
mechanism was studied more in detail. First, another enol ester was synthesized to see if the 
reaction is still working and giving a hint for the reaction mechanism. Since higher substituted 
anhydrides are not suitable for the reaction conditions used before first the strategy for the enol 
ester synthesis had to be changed. An acid chloride mediated esterification using propionyl 
chloride gave enol ester (±)-240b in 98% yield (Scheme 99). 
 
 
Scheme 99. Esterification of (±)-211 using propionyl chloride. 
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With enol ester (±)-240b in hand, FVT was performed giving rise to E-butenolide 241b and 
Z-butenolide 242b (Scheme 100). 
 
 
Scheme 100. FVT of propionyl ester (±)-240b. 
 
Surprisingly, the additional carbon, in this case, is located outside of the five-membered ring 
on the side chain. In the next step, dione 234 was deuterated to obtain additional insight into 
the mechanism of the rearrangement. Dione 234 is easily deuterated in 2-postion by stirring in 
deuterated water due to the acidic protons located at this position, the addition of 
cyclopentadiene yielded deuterated Diels-Alder adduct (±)-244 in 76% yield (Scheme 101). 
 
 
Scheme 101. Synthesis of deuterated enol ester (±)-245. 
 
Deuterated compound (±)-244 was transferred into the corresponding enol ester (±)-245 using 
propionyl chloride. Subsequently, the deuterated enol ester (±)-245 was subjected to FVT to 
obtain butenolides 246 and 247 having the deuterium on the exo-methylene group 
(Scheme 102). 
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Scheme 102. FVT of deuterated enol ester (±)-245. 
 
Orvane et al.126 described the thermal rearrangement of butenolide 227 to dione 234, which 
would be exactly the inverse reaction assumed for the rearrangement of enol esters to 
butenolides (Scheme 103). For this mechanism, a biradical 249, which leads after 
recombination to dione 234 is proposed. In addition to this, the reaction of diones to butenolides 
was already observed under photochemical conditions.127 
 
 
Scheme 103. Rearrangement of butenolide 227 to dione 234.126 
 
Moreover, isomerization of enol esters 250 to triketone 251 was demonstrated by Lakhvich et 
al.,128 which would describe the observed shift of the additional residue in the rearrangement 
(Scheme 104).  
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Scheme 104. Isomerization of enol esters 250 to triketones 251.128 
 
Taking literature evidence and results of the investigation of the rearrangement in account the 
following mechanism was proposed (Scheme 105). In the first step, (±)-240 undergoes a 
retro-Diels-Alder reaction with the loss of cyclopentadiene. The cyclopentadienone derivative 
252 rearranges to 253, which undergoes ring opening giving rise to biradical 254. Finally, 
recombination of biradical 255 yields a mixture of E-/Z-butenolides 241 and 242. 
 
 
Scheme 105. Proposed mechanism for the rearrangement of enol ester (±)-240. 
 
2.5 Variation of the reaction conditions 
 
The Diels-Alder, as well as the retro-Diels-Alder reaction, are highly affected by the 
HOMO/LUMO ratio of diene and dienophile. Hence, two additional Diels-Alder adducts were 
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synthesized containing different dienes to investigate the influence of the retro-Diels-Alder 
reaction, the first proposed step of the mechanism. 
Dione 234 reacted with furan to obtain Diels-Alder adduct (±)-209 in 73% yield and with 
dimethylbutadiene to obtain (±)-256 in 70% yield, respectively (Scheme 106). 
 
 
Scheme 106. Synthesis of Diels-Alder adducts. 
 
The synthesized Diels-Alder adducts were transferred into the corresponding acetyl ester using 
acetic anhydride as described before for Diels-Alder adduct (±)-240a. The received acetyl esters 
are depicted in Scheme 107. 
 
 
Scheme 107. Synthesized acetyl esters. 
 
These acetyl esters were tested in FVT at a constant temperature to compare the influence of 
the diene for the rearrangement (Table 5). The best results were obtained for the most reactive 
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diene in this row, the cyclopentadiene adduct (±)-240a. The furan adduct (±)-257 yielded 
approximately half of the yield of the cyclopentadiene adduct (±)-240a and the 
dimethylbutadiene adduct (±)-258 only gave traces of the desired products.  
 
 
entry ester yield (%) E/Z 
1 
 
31 61:39 
2 
 
16 75:25 
3 
 
traces - 
 
Table 5. FVT of different enol esters. 
 
In the following, the behavior of acetyl ester (±)-240a using different temperatures in the FVT 
was examined (Table 6). At 550 °C, no formation of γ-alkylidenebutenolides was observed. In 
this case, it seems that the initial retro-Diels-Alder reaction did not take place and therefore no 
product formation was detected. At higher temperatures than 650 °C lower yields were 
obtained. 
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entry temperature (°C) yield (%) E/Z 
1 
 
550 
 
0 - 
2 
 
650 
 
31 61:39 
3 
 
750 
 
16 75:25 
4 
 
850 
 
traces - 
 
Table 6. FVT of (±)-240a at different temperatures. 
 
In conclusion, the best reactions conditions found were using cyclopentadiene derived enol 
esters at 650 °C oven temperature in the FVT. The reaction provided about 30% yield of an E/Z 
mixture of γ-alkylidenebutenolides. The starting materials were easily synthesized in high 
yields, and the obtained butenolides are highly interesting materials, which have never been 
synthesized before. Except from Seltzer et al.129 who described a very low yielding reaction to 
receive 241a and 242a (Scheme 108). 
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Scheme 108. Synthesis of γ-alkylidenebutenolides 241a and 242a by Seltzer et al.129 
 
2.6 Synthesis of enol esters and rearrangement to γ-alkylidenebutenolides 
 
First of all different enol esters were synthesized using the reaction conditions mentioned before 
(Table 7). Esterification of (±)-211 gave excellent yields in all cases with various acid chlorides 
used. Hence, enol esters with different steric hindrance and functional groups were obtained.  
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entry R (±)-240 yield (%) 
1 Mea) a 100 
2 Et b 98 
2 i-Pr c 100 
3 t-Bu d 100 
4 Allyl e 100 
5 n-Pent f 94 
6 Ph g 91 
7 4-OMe-Ph h 96 
8 OEt i 100 
a) (±)-240a was prepared using Ac2O as described above. 
 
Table 7. Synthesis of various enol esters. 
 
Additionally, the structure of enol esters (±)-240 was clearly proven by X-ray crystallography 
of (±)-240g (Figure 12). 
 
 
Figure 12. Crystal structure of (±)-240g. 
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With a broad selection of enol esters in hand, the synthesized derivatives were subjected to FVT 
(Table 8). 
 
 
entry R 241 + 242 yield (%) E/Z 
1 Me a 34 62:38 
2 Et b 34 71:29 
3 i-Pr c 27 70:30 
4 t-Bu d 35 63:37 
5 Allyl e - - 
6 n-Pent f 35 66:34 
7 Ph g 31 100:0 
8 4-OMe-Ph h 35 100:0 
9 OEt i - - 
 
Table 8. FVT of various enol esters. 
 
All alkyl substituents tested gave a similar yield of 27-35%. The steric hindrance of the 
substituents did not affect the E/Z-ratio. In contrast, aromatic substituents yielded exclusive the 
corresponding E-butenolides in about 30% yield. The reactions with allyl and ethoxy residues 
did not show any formation of the expected products. 
Additionally, it was found that Z-butenolides 242 isomerize into the corresponding 
E-butenolides 241 in solution (Figure 13). Therefore, pure Z-butenolide 242a was dissolved in 
deuterated chloroform, and the amount of E- and Z-butenolide was monitored via 
NMR-spectroscopy. After one day, approximately 20% of the Z-butenolide 242a was 
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transferred into the E-isomer 241a. With progressing time, the isomerization was becoming 
slower and after about five days the E-isomers 241a is the major product in solution. After 14 d 
the Z/E-ratio was 38:62. The addition of toluenesulfonic acid as an acid catalyst could not 
accelerate the observed isomerization. 
 
 
 
Figure 13. Isomerization of Z-Butenolide 242a. 
 
In summary, a highly interesting rearrangement of enol esters to γ-alkylidenebutenolides was 
discovered, the reaction was studied, and a mechanism was proposed. The starting materials 
were straightforwardly synthesized from renewable resources in high yields. Unfortunately, the 
γ-alkylidenebutenolides were obtained as E/Z mixtures and in low yields of about 30%, which 
could not be improved during this studies. 
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3 Redox isomerization of 4-hydroxy-2-cyclopentenone derivatives 
3.1 Introduction 
 
Carbonyl compounds are important substrates in organic synthesis and redox isomerization of 
readily accessible allylic alcohols (±)-260 provides an elegant opportunity for their atom 
economic synthesis. This isomerization reaction, which typically does not generate any 
byproducts, is grounded on the ability of transition metals to induce the migration of 
carbon-carbon double bonds to yield the corresponding enolate 261 followed by 
tautomerization to carbonyl compound 262 (Scheme 109).130 
 
 
Scheme 109. Isomerization of allylic alcohols.130 
 
Three different mechanisms for the redox isomerization of allyl alcohols are proposed: an alkyl 
mechanism, a η3-allyl-mechanism, and a η3-oxo-allyl-mechanism. The η3-allyl-mechanism is 
depicted in Scheme 110.131 
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Scheme 110. The η3-allyl-mechanism.131 
 
The catalytic cycle starts with coordination of the metal to the double bond of the allyl alcohol 
264. A formal oxidative addition of one of the C-H bonds of the double bond leads to π-allyl 
metal-hydride intermediate 265. Reductive elimination furnishes η2-enol complex 266. The 
decoordination to 267 followed by tautomerization of the free enol yields the final carbonyl 
compound 268 and regenerates the metal to close the catalytic cycle.131 
The redox isomerization of 4-hydroxy-2-cyclopentenone ((±)-150) would furnish 
1,3-cyclopentanedione 238, which is known as valuable starting material for many biologically 
active substances such as prostaglandins, antibiotics, fragrances or herbicides (Figure 14).132 
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Figure 14. Biological active compounds synthesized from 1,3-cyclopentanedione derivatives. 
 
The redox isomerization of 4-hydroxy-2-cyclopentenone derivatives would open a simple and 
useful access to substituted 1,3-cyclopentanediones. 
 
3.2 Synthesis of 4-hydroxy-2-cyclopentenone derivatives 
 
Several 4-hydroxy-2-cyclopentenone derivatives were straightforwardly synthesized starting 
from furfural (140) as mentioned earlier. Via a Grignard reaction various substituted furfuryl 
alcohol derivatives (±)-142 were accessible and subsequent Piancatelli rearrangement yielded 
5-substituted 4-hydroxy-2-cyclopentenones (±)-149.80 The aforementioned Piancatelli 
rearrangement can be improved by using microwave irradiation. Therefore, furfuryl alcohol 
B Main Part 
84 
 
derivatives (±)-142 were converted into the corresponding 5-substituted 
4-hydroxy-2-cyclopentenone (±)-149 using microwave irradiation in good yields (Table 9). 
 
 
entry R (±)-142 +(±)-149 yield (±)-142 (%) yield (±)-149 (%) 
1 n-Pr a 76 64 
2 n-Pent b 89 74 
3 n-Hept c 86 44 
4 Et d 62 76 
5 i-Pr e 55 69 
6 Allyl f 61 57 
 
Table 9. Microwave-assisted synthesis of 4-hydroxy-2-cyclopentenone derivatives. 
 
Unsubstituted 4-hydroxy-2-cyclopentenone ((±)-150) and the 5-methyl-substituted derivative 
(±)-200 were synthesized using the aforementioned microreactor setup. Additionally, a 
2-methyl-substituted derivative ((±)-201 was obtained by isomerization of compound (±)-200 
on Al2O3.
106 
 
3.3 Redox isomerization 
 
Noyori et al.133 performed the asymmetric redox isomerization of 4-hydroxy-2-cyclopentenone 
((±)-150) using complex (R)-276 to obtain 238 and the valuable enantiomer (R)-150 with good 
enantiomeric excess (Scheme 111).  
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Scheme 111. Kinetic resolution of 4-hydroxy-2-cyclopentenone ((±)-150).133 
 
Since diketone 238, and its derivatives are highly valuable materials, it would be interesting to 
perform the redox isomerization without any enantiomeric discrimination. Preferably, with 
water as a solvent since the products are hardly soluble in it and the previous Piancatelli 
rearrangement is also performed in aqueous medium. This would give the opportunity to carry 
out two reactions in one step. The redox isomerization of allylic alcohols using water as solvent 
is well known in the literature and some ruthenium-based catalysts show high activity for 
various substrates.134 A very active ligand was described by Gimeno et al.135 with a turnover 
frequency value of about 60 000 h-1 (Scheme 112). 
 
 
Scheme 112. Redox isomerization catalyzed by an imidazole-based ruthenium complex.135 
 
These reactions conditions were adopted for the redox isomerization of 
4-hydroxy-2-cyclopentenone ((±)-150) and three different catalysts were tested (Scheme 113). 
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Scheme 113. Ruthenium-based catalysts. 
 
These catalysts have been shown good activities in the redox isomerization of allyl alcohols. 
As a starting point, 10 mol% of catalyst were used because previous studies showed that higher 
substituted double bonds require higher catalyst amounts (Table 10).134,135  
 
 
entry complex yield (%) 
1 279 57 
2 280 80 
3 281 7 
 
Table 10. Redox isomerization of (±)-150 with different catalysts. 
 
Complex 280 showed the best activity for the chosen substrate (±)-150 providing 80% of the 
expected product 238. In the next step, the amount of catalyst was varied to optimize the 
reaction conditions (Table 11). 
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entry 280 (mol%) yield (%) 
1 1 17 
2 5 73 
3 10 75 
 
Table 11. Redox isomerization of (±)-150 with different catalyst loadings. 
 
The redox isomerization of (±)-150 gave similar yield with 5 and 10 mol% of catalyst, with 
1 mol% an immense drop in yield was observed. Therefore, 5 mol% catalyst were used in the 
following reactions. Additionally, higher reaction temperatures were identified as beneficial for 
the reaction, therefore the reaction temperature was raised to reflux. With the optimized reaction 
conditions in hand, the redox isomerization of various 4-hydroxy-2-cyclopentenone derivatives 
was investigated (Table 12). 
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entry R1 R2 alcohol product mol% [Ru]cat time (h) yield (%) 
1 H H (±)-150      238 5 8 80 
2 Me H (±)-200      282a 5 15 91 
3 n-Pr  H (±)-149a      282b 5 30 81 
4 n-Pent  H (±)-149b      282c 10 15 72 
5 n-Hept H (±)-149c      282d 10 30 traces 
6 Et H (±)-149d      282e 5 15 86 
7 i-Pr H (±)-149e      282f 10 30 51 
8 Allyl H (±)-149f      282g 5 15 decomposition 
9 H Me (±)-201      282h 5 15 decomposition 
 
Table 12. Redox isomerization of various 4-hydroxy-2-cyclopentenone derivatives. 
 
The redox isomerization of 4-hydroxy-2-cyclopentenone ((±)-150) yielded the expected 
diketone 238 in 80% yield within 8 h. Afterward, 5-substituted 4-hydroxy-2-cyclopentenone 
derivatives were tested. The methyl derivative (±)-200 gave 91% of the desired product by 
elongation of the reaction time to 15 h. The ethyl derivative was isolated in 86% under the same 
conditions in entry 6. By elongation of the side chain to the n-propyl derivative in entry 3 the 
reaction time was extended to 30 h giving the product 282b in 81% yield. The i-propyl 
derivative 282f having the most steric hindrance was obtained after 30 h with 10 mol% of 
catalyst in 51% yield. In the case of the n-pentyl compound, 72% of 282c were isolated after 
15 h using 10 mol% of the catalyst. However, substrates containing an allyl substituent in 
5-position or a substituent in 2-postion showed only decomposition. The n-Heptyl derivative 
was only observed in traces, which might be due to bad solubility in the solvent. All in all the 
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steric hindrance of the used substrates showed high influence on the redox isomerization. The 
bulkier the chosen substituent, the slower is the reaction rate. As a result, either higher amounts 
of catalyst or longer reaction times were required by increasing the spatial demand of the 
substituents.  
 
In conclusion, an efficient way for the synthesis of substituted 1,3-cyclopentanedione 
derivatives starting from renewable resources was developed. The reaction is dependent on the 
steric hindrance and the position of the substituents of the 4-hydroxy-2-cyclopentenone 
derivatives. The best results were obtained with no substituent or small substituents in 
5-position of the 4-hydroxy-2-cyclopentenone derivatives. 
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C Summary 
 
This thesis deals with the synthesis of valuable chemicals starting from renewable resources. 
All syntheses start from 4-hydroxy-2-cyclopentenone ((±)-150) and its derivatives, which can 
be readily obtained from furfural (140), made from agricultural waste like bran or bagasse, via 
a straightforward reaction sequence. Reduction of furfural (140) yields furfuryl alcohol (141), 
which is then efficiently converted to 4-hydroxy-2-cyclopentenone ((±)-150) via a Piancatelli 
rearrangement in a microreactor. Therefore, 4-hydroxy-2-cyclopentenone ((±)-150) and its 
derivatives represent the key building blocks used in this thesis. 
In the first chapter, various substituted 2-pyrones were synthesized from 
4-hydroxy-2-cyclopentenone ((±)-150) and its derivatives, utilizing the thermal rearrangement 
of cyclopentadienone epoxides to 2-pyrone as the key step (Scheme 114).  
 
 
Scheme 114. Overview of the synthesis of 2-pyrones starting from renewable resources. 
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It was possible to obtain unsubstituted 2-pyrone (1) via a short reaction sequence in multigram 
scale with high yield and purity. Using a similar reaction sequence allowed the synthesis of 
naturally occurring 6-substituted alkyl 2-pyrones 2 in excellent yields. Additionally, 
4-hydroxy-2-cyclopentenone ((±)-150) could be converted into various 6-substituted 
α-hydroxyalkyl 2-pyrones (±)-171 via a Baylis Hillman reaction with different aldehydes. The 
so obtained compounds bearing a α-hydroxyalkyl side chain allowed a plethora of 
transformations. The enzymatic resolution provided access to enantiomerically pure 2-pyrones. 
Alternatively, elimination of the α-hydroxy group gave access to naturally occurring 
Sibirinone (7) and related natural products. Oxidation of the α-hydroxy group yielded the 
corresponding carbonyl compounds, which was used for the synthesis of naturally occurring 
Gibepyrone F after introducing a methyl substituent in 3-position. Using a different strategy, 
the synthesis for 5-substituted 2-pyrones yielded a mixture of 3- and 5-substituted 2-pyrones 
119 and 111, which could be explained by a [1,5] sigmatropic H-shift.  
The second chapter deals with the sustainable oxidation of 4-hydroxy-2-cyclopentenone 
((±)-150) to dione 234, which was used for the synthesis of enol esters (±)-240. Investigation 
of the reactivity of these enol esters (±)-240 revealed that they undergo an interesting 
rearrangement when subjected to FVT. The resulting γ-alkylidenebutenolides are highly 
interesting new compounds with high functional group density (Scheme 115). After an 
intensive study of the reaction and its conditions, a plausible mechanism for the rearrangement 
was proposed. Additionally, a broad scope of esters (±)-240 was synthesized and rearranged to 
the corresponding γ-alkylidenebutenolides. The γ-alkylidenebutenolides were obtained in an 
E/Z mixture, which was separable by chromatography in about 30% combined yield.  
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Scheme 115. Synthesis of γ-alkylidenebutenolides. 
 
The final chapter concentrates on the ruthenium-catalyzed redox isomerization of different 
4-hydroxy-2-cyclopentenones (±)-149 to 1,3-cyclopentanedione derivatives 282 in water 
(Scheme 116). These diketone derivatives 282 are highly valuable compounds for the synthesis 
of various complex organic molecules and not many protocols are reported for their synthesis. 
The redox isomerization proved to be suitable for unsubstituted 4-hydroxy-2-cyclopentenone 
((±)-150) and for derivatives with a substitution in 5-position (±)-149 giving the corresponding 
diketones 282 in up to 91% yield. However, the reaction proved to be dependent on the steric 
bulk of the substituent as smaller substituents gave the best results for the isomerization. 
 
 
Scheme 116. Redox isomerization of 4-hydroxy-2-cyclopentenone derivatives. 
 
In conclusion, an efficient synthetic strategy for various valuable compounds was developed, 
namely 2-pyrones, γ-alkylidenebutenolides and 1,3-cyclopentanedione derivatives. All 
compounds could be obtained from the same starting materials, 4-hydroxy-2-cyclopentenone 
and its derivatives, which are readily available from renewable resources. This underlines that 
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4-hydroxy-2-cyclopentenones are useful and reliable platform chemicals for fine chemical 
synthesis. 
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D Zusammenfassung 
 
Diese Dissertation beschäftigt sich mit der Synthese von wertvollen Chemikalien ausgehend 
von erneuerbaren Ressourcen. Alle Synthesen beginnen mit 4-Hydroxy-2-cyclopentenon 
((±)-150) und dessen Derivaten, welche leicht aus Furfural (140), das aus landwirtschaftlichen 
Abfallprodukten wie Kleie und Bagasse gewonnen wird, mit Hilfe einer unkomplizierten 
Reaktionssequenz erhalten werden kann. Reduktion von Furfural (140) ergibt 
Furfurylalkohol (141), welcher mit Hilfe der Piancatelli-Umlagerung in einem Mikroreaktor in 
4-Hydroxy-2-cyclopentenon überführt wird. Deshalb stellen 4-Hydroxy-2-cyclopentenon und 
dessen Derivate einen zentralen Baustein in dieser Dissertation dar.  
Im ersten Kapitel wurden verschiedene substituierte 2-Pyrone aus 4-Hydroxy-2-cyclopentenon 
((±)-150) und dessen Derivaten synthetisiert, wobei die thermische Umlagerung von 
Cyclopentadienonepoxiden zu 2-Pyronen als Schlüsselschritt genutzt wurde (Abbildung 1). 
 
 
Abbildung 1. Übersicht über die Synthese von 2-Pyronen aus erneuerbaren Ressourcen. 
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Es war möglich unsubstituiertes 2-Pyron (1) mit Hilfe einer kurzen Reaktionssequenz im 
Multigrammmaßstab mit hoher Ausbeute und Reinheit zu erhalten. Die Verwendung einer 
ähnlichen Reaktionssequenz ermöglichte die Synthese 6-substituierter Alkyl-2-pyrone in 
exzellenten Ausbeuten. Zusätzlich konnte 4-Hydroxy-2-cyclopentenon ((±)-150) mit Hilfe 
einer Baylis-Hillman Reaktion und verschiedenen Aldehyden in diverse 6-substituierte 
α-Hydroxyalkyl-2-pyrone (±)-171 überführt werden Die so erhaltenen Verbindunngen 
enthalten eine α-Hydroxyalkylseitenkette, die eine Fülle an Transformationen erlaubt. 
Racematspaltung lieferte Zugang zu enantiomerenreinen 2-Pyronen. Alternativ lieferte die 
Eliminierung der α-Hydroxygruppe Zugang zu natürlich vorkommendem Sibirinon (7a) und 
verwandten Naturstoffen. Oxidation der α-Hydroxygruppe ergab die entsprechenden 
Carbonylverbindungen und dies wurde für die Synthese von natürlich vorkommendem 
Gibepyron F nach der Einführung eines Methylsubstituenten in 3-Position genutzt. Die 
Anwendung einer anderen Strategie zur Synthese von 5-substituierten 2-Pyronen ergab ein 
Gemisch aus 3- und 5-substituierten 2-Pyronen 119 und 111, was mit einer sigmatropen [1,5] 
H-Verschiebung erklärt werden konnten.  
Das zweite Kapitel beschäftigt sich mit der nachhaltigen Oxidation von 
4-Hydroxy-2-cyclopentenon ((±)-150) zu Dion 234, das für die Synthese der Enolester (±)-240 
verwendet wurde. Untersuchungen der Reaktivität dieser Enolester (±)-240 zeigten, dass sie 
eine interessante Umlagerung in der FVT eingehen. Die entstandenen γ-Alkylidenebutenolide 
sind hochinteressante neue Verbindungen mit einer hohen Dichte an funktionellen Gruppen 
(Abbildung 2). Nach intensiver Untersuchung der Reaktion und ihrer Bedingungen wurde ein 
plausibler Mechanismus für die Umlagerung vorgeschlagen. Zusätzlich wurde eine breite 
Auswahl an Estern (±)-240 synthetisiert und zu den entsprechenden γ-Alkylidenebutenoliden 
umgelagert. Die γ-Alkylidenebutenolide wurden als E/Z-Mischung erhalten in einer 
Gesamtausbeute von ca. 30%, welche chromatographisch getrennt werden konnten. 
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Abbildung 2. Synthese von γ-Alkylidenebutenoliden. 
 
Das letzte Kapitel konzentriert sich auf die Ruthenium katalysierte Redoxisomerisierung von 
verschiedenen 4-Hydroxy-2-cyclopentenonen (±)-149 zu 1,3-Cyclopentandionderivaten 282 in 
Wasser (Abbildung 3). Diese Diketonderivate 282 sind sehr wertvolle Verbindungen für die 
Synthese von diversen komplexen organischen Molekülen und es sind nicht viele Vorschriften 
für deren Synthese berichtet. Die Redoxisomerisierung erwies sich als geeignet für 
unsubstituiertes 4-Hydroxy-2-cyclopentenonen ((±)-150) und für Derivate mit Substitution in 
5-Position (±)-149, welche die entsprechenden Diketone 282 in bis zu 91% Ausbeute lieferte. 
Jedoch, erwies sich die Reaktion als abhängig von der sterischen Hinderung der Substituenten, 
da kleinere Substituenten die besten Ergebnisse für die Isomerisierung lieferten. 
 
 
Abbildung 3. Redoxisomerisierung von 4-Hydroxy-2-cyclopentenonderivativen. 
 
Zusammenfassend wurde eine effiziente synthetische Strategie zur Synthese verschiedener 
wertvoller Verbindungen wie 2-Pyrone, γ-Alkylidenebutenolide und 
1,3-Cyclopentandionderivate entwickelt. Alle Verbindungen konnten von denselben 
Startmaterialien, 4-Hydroxy-2-cyclopentenon und dessen Derivaten, welche leicht aus 
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erneuerbaren Ressourcen erhalten werden können, gewonnen werden. Dies unterstreicht, dass 
4-Hydroxy-2-cyclopentenone nützliche und zuverlässige Plattformchemikalien für die 
Feinchemikaliensynthese darstellen. 
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E Experimental 
 
1 General information 
 
Commercially available chemicals were purchased in high quality and used without any further 
purification. All reactions were carried out in oven-dried glassware under atmospheric 
conditions unless otherwise stated. DCM, ethyl acetate and hexanes (petroleum ether, PE 
(60/40)) were distilled prior to use. THF and Et2O were received from a MB-SPS solvent 
purification system. Other anhydrous solvents were prepared by established procedures.136 
1H- and 13C-NMR 
NMR spectra were recorded on a BRUKER Avance III 400 Nanobay (400 MHz) and a 
BRUKER Avance 300 (300 MHz) spectrometer at ambient temperature. Chemical shifts are 
reported as δ (ppm) relative to the signal of the solvent. Characterization of the signals: s = 
singlet, d = doublet, t = triplet, q = quartet, quin = quintet, sext = sextet, m = multiplet, bs = 
broad singlet, dd = doublet of a doublet, dt = doublet of a triplet, dq = doublet of a quartet, ddd 
= doublet of a doublet of a doublet. Integration is determined as the relative number of atoms, 
and the coupling constants (J) are given in Hertz (Hz). The multiplicity of the carbon atoms is 
given as (+) = CH3 or CH (positive DEPT signal), (-) = CH2 (negative DEPT signal) and (Cq) 
for quaternary carbon atoms (no DEPT signal). 
Column chromatography 
Column chromatography was performed using Merck Gerduran 60 silica gel (0.063–0.200 mm) 
or Merck flash silica gel 60 (0.040–0.063 mm). 
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Gas chromatography 
Gas chromatography was carried out on a Fisons GC 8000 Series with a flame ionization 
detector (FID). As stationary phase DB1 (100% dimethylpolysiloxane, 30 m, ID 0.25 mm, 
0.25 m Film) was used. GC instrument conditions: Inlet temperature = 250 °C; detector 
temperature = 300 °C. GC method: starting temperature 80 °C, then temperature ramp 
(5 °C/min) for 24 min to 200 °C followed by an isothermal period at 200 °C for 5 min 
HPLC 
HPLC was performed on a Varian 920-LC with a photodiode array (PDA) detector, and a 
specified chiral stationary phase was used. 
IR spectroscopy 
ATR-IR spectroscopy was carried out on a Biorad Excalibur FTS 3000 MX, equipped with a 
Specac Golden Gate Diamond Single Reflection ATR-System or on an Agilent Technologies 
Cary 630 FTIR . Solid and liquid compounds were measured neatly, and wave numbers are 
reported in cm-1. 
Mass spectrometry 
Mass spectrometry was performed in the Central Analytical Department of the University of 
Regensburg on a Jeol AccuTOF GCX, Agilent Q-TOF 6540 UHD, Finnigan MAT SSQ 710 A 
or a ThermoQuest Finnigan TSQ 7000. 
Melting points 
The melting points were measured on a SRS MPA 100 OptiMelt in a silicon oil bath. Values 
thus obtained were not corrected. 
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Microwave 
Microwave reactions were carried out on an Anton-Paar Monowave 300 microwave using 
pressure stable sealed 10 mL or 35 mL vessels. 
Optical rotation 
The optical rotation was determined on an Anton Paar MCP 500 polarimeter at 589 nm 
wavelength (sodium-d-line) in a 1.0 dm measuring cell.  
Thin layer chromatography 
Thin layer chromatography was done using Merck silica gel 60 F254 coated with 0.2 mm silica. 
Visualization was accomplished by UV light (254 nm), and staining was performed with 
vanillin or potassium permanganate solutions followed by heating. 
X-ray-crystallography  
X-Ray crystallography was done by the crystallography laboratory of the University of 
Regensburg. 
Synthesis of literature known compounds 
The following compounds were synthesized according to literature known procedures:  
(±)-150,83 (±)-138,88 (±)-137,91 (±)-211,120 (±)-209,119, 279,135 280.137 
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2 Synthesis of 2-pyrones starting from renewable resources 
 
General Procedure 1: Flash Vacuum Thermolysis: For flash vacuum thermolysis a 
high-quality glass tube (length 90 cm, diameter 1 cm) open at both ends was fixed horizontally 
in a tube furnace connected to a cooling trap and a flask containing the epoxide. The tube 
furnace was heated to 650 °C and connected to a high-vacuum line at 2∙10-2 mbar. The starting 
material was slowly evaporated through the tube furnace, and the product was collected in a 
trap cooled with liquid nitrogen. The product was washed off the cooling trap with DCM, the 
solvent was removed, and the product was dried under reduced pressure to yield the pure 
compound.  
 
General Procedure 2: Grignard reaction of 140 to (±)-142: Magnesium shavings (1.3 equiv) 
were suspended in dry Et2O (2.50 M), and a catalytic amount iodine was added. The bromide 
(1.6 equiv) was dissolved in dry Et2O (1.25 M) and added dropwise to the suspension. When 
the suspension stopped boiling it was refluxed for 1 h and afterward cooled down to 0 °C. A 
solution of furfural (140) (1.0 equiv) in dry Et2O (1.25 M) was slowly dropped into the 
suspension and stirred for 15 min. The reaction was quenched with water, and the phases were 
separated. The water phase was extracted with Et2O (3x), and the combined organic layers were 
dried over MgSO4. The crude was purified via flash chromatography (silica, PE/EA = 10:1). 
 
General Procedure 3: Piancatelli rearrangement of (±)-142 to (±)-149: To a solution of 
furfuryl alcohol (±)-142 (5.00 mmol) in acetone (5 mL) water (15 mL) was added, and the 
mixture was heated in the microwave at 180 °C for 15 min. This procedure was repeated as 
often as necessary, and the combined layers were extracted with DCM (3x). The combined 
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organic layers were dried over MgSO4, and the crude product was purified via flash 
chromatography (silica, PE/EA = 2:1). 
 
General Procedure 4: Acetylation: To a solution of 5-substituted 
4-hydroxy-2-cyclopentenone (±)-149 (20.0 mmol) in DCM (120 mL) Et3N (13.86 mL, 
100 mmol), and Ac2O (9.45 mL, 100 mmol) were added, and the reaction mixture was stirred 
for 18 h at room temperature. The mixture was quenched with water (100 mL), and the phases 
were separated. The water phase was extracted with DCM (3x), and the combined organic 
layers were dried over MgSO4. The crude product was purified via flash chromatography 
(silica, PE/EA = 10:1). 
 
General Procedure 5: Diels-Alder reaction and Elimination of (±)-154 to (±)-155: 
Zink(II)chloride (1.36 g, 10.0 mmol) was suspended in toluene (60 mL), acetate (±)-154 
(10.0 mmol) was added, and the mixture was stirred for 15 min at room temperature. Freshly 
distilled cyclopentadiene (2.48 mL, 30.0 mmol) was added, and the mixture was stirred for 18 h 
at room temperature. The solvent was evaporated, and the crude product was dissolved in 
DCM/MeOH 1:1 (90 mL), 10 M NaOH (15 mL) was added and stirred for 1 h at room 
temperature. The mixture was washed with brine (1x), and the phases were separated. The water 
phase was extracted with DCM (3x), and the combined organic layers were dried over MgSO4, 
and the crude product was purified via flash chromatography (silica, PE/EA = 10:1). 
 
General Procedure 6: Epoxidation: To a solution of the enone (1.0 equiv) in DCM/MeOH 
1:1 (5 M) 2 M NaOH (1.2 equiv), and H2O2 (30% in water, 5.4 equiv) were added, and the 
reaction mixture was stirred at room temperature. The reaction mixture was poured into DCM 
(30 mL) and once washed with brine. The organic layer was dried over MgSO4 and 
concentrated under vacuum to yield the pure compound. 
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General Procedure 7: Baylis-Hillman reaction of (±)-138 to (±)-165: Under nitrogen 
atmosphere enone (±)-138 (1.0 equiv) and the aldehyde (1.5 equiv) were dissolved in dry, 
degassed THF (1 M) at room temperature phenol (0.2 equiv), and Bu3P (0.4 equiv) were added. 
The progress of the reaction was monitored by TLC. After completion of the reaction, the 
solvent was evaporated, and the crude product was purified via flash chromatography by an 
appropriate PE/EA mixture. 
 
General Procedure 8: Oxidation: To a solution of the 2-pyrone (1.0 mmol) in DCM (10 mL) 
MnO2 (2.61 g, 30.0 mmol) was added, and the reaction mixture was stirred at room temperature 
for 20 h. The suspension was filtered through a celite plug, and the solution was concentrated 
under reduced pressure. 
 
General Procedure 9: Tosylation of (±)-171 to (±)-189: To a solution of 2-pyrone (±)-171 
(1.0 mmol) in DCM (10 mL) DMAP (12 mg, 0.10 mmol), Et3N (0.42 mL, 3.00 mmol), and 
4-toluenesulfonyl chloride (229 mg, 1.20 mmol) were added, and the reaction mixture was 
stirred at room temperature. After 20 h saturated KHSO4 solution (20 mL) was added, the water 
phase was extracted with DCM (3x), and the organic phase was dried over MgSO4. The crude 
was purified via flash chromatography (silica, PE/EA = 3:1) to yield (±)-189. 
 
General Procedure 10: Elimination of (±)-189 to 7: To a solution of tosylated compound 
(±)-189 (0.5 mmol) in DMF (5 mL) LiBr (261 mg, 3.00 mmol), and Li2CO3 (222 mg, 
3.00 mmol) were added and the reaction mixture was heated for 1 h at 110 °C. After cooling to 
room temperature H2O (20 mL) was added, the mixture was extracted with ethyl acetate (3x), 
and the combined organic layers were dried over MgSO4. The crude product was purified via 
flash chromatography (silica, PE/EA = 5:1) to yield 7.  
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4-Oxocyclopent-2-en-1-yl acetate ((±)-153):138 
 
A solution of 4-hydroxycyclopent-2-en-1-one ((±)-150) (50.3 g, 513 mmol) in Ac2O (75 mL, 
793 mmol) was cooled to 0 °C and 4-toluenesulfonic acid (100 mg, 0.53 mmol) was added. The 
reaction mixture was stirred at room temperature for 18 h and the product was purified by 
distillation under reduced pressure to give 58.5 g (417 mmol, 81%) of a colorless oil which 
solidified to white crystals: 1H NMR (400 MHz, CDCl3) δH = (dd, J = 5.7, 2.4 Hz, 1H), 6.26 
(dd, J = 5.7, 1.2 Hz, 1H), 5.78 (ddd, J = 6.1, 3.5, 2.2 Hz, 1H), 2.75 (dd, J = 18.7, 6.4 Hz, 1H), 
2.25 (dd, J = 18.7, 2.2 Hz, 1H), 2.03 (s, 3H); 13C NMR (101 MHz, CDCl3) δC = 204.8 (Cq), 
170.3 (Cq), 159.0 (+), 136.9 (+), 71.9 (+), 41.0 (-), 20.8 (+). 
 
2H-Pyran-2-one (1):139 
 
Following general procedure 1 epoxide (±)-137 (11.35 g, 70.0 mmol) was used to afford a 
brownish liquid (6.34 g, 66.0 mmol, 94%): 1H NMR (300 MHz, CDCl3) δH = 7.48 
(ddd, J = 5.1, 2.1, 1.2 Hz, 1H), 7.31 (ddd, J = 9.3, 6.4, 2.2 Hz, 1H), 6.32 (dt, J = 9.5, 1.0 Hz, 
1H), 6.21 (ddd, J = 6.3, 5.3, 1.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) δC = 161.7 (Cq), 152.0 
(+), 142.8 (+), 117.0 (+), 106.0 (+). 
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1-(Furan-2-yl)butan-1-ol ((±)-142a):140 
 
Following general procedure 2 magnesium shavings (2.28 g, 93.6 mmol), 1-bromopropane 
(10.5 mL, 115.2 mmol) and furfural (140) (5.96 mL, 72.0 mmol) to afford (±)-142a (7.62 g, 
54.37 mmol, 76%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.39 – 7.34 (m, 1H), 
6.32 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (dd, J = 3.2, 0.6 Hz, 1H), 4.68 (t, J = 6.8 Hz, 1H), 
1.93 (bs, 1H), 1.87 – 1.79 (m, 2H), 1.53 – 1.28 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 156.9 (Cq), 141.9 (+), 110.1 (+), 105.8 (+), 67.6 (+), 37.6 (-), 
18.8 (-), 13.9 (+). 
 
1-(Furan-2-yl)hexan-1-ol ((±)-142b):141 
 
Following general procedure 2 magnesium shavings (2.28 g, 93.6 mmol), 1-bromopentane 
(14.26 mL, 115.2 mmol) and furfural (140) (5.96 mL, 72.0 mmol) to afford (±)-142b (10.76 g, 
63.98 mmol, 89%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.37 (dd, J = 1.8, 0.8 
Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.23 (dt, J = 3.3, 0.7 Hz, 1H), 4.67 (t, J = 6.8 Hz, 1H), 
1.92 – 1.80 (m, 3H), 1.44 – 1.27 (m, 6H), 0.88 (t, J = 6.9 Hz, 31H); 13C NMR (75 MHz, CDCl3) 
δC = 156.9 (Cq), 141.9 (+), 110.1 (+), 105.8 (+), 67.9 (+), 35.5 (-), 31.6 (-), 25.2 (-), 22.6 (-), 
14.0 (+). 
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1-(Furan-2-yl)octan-1-ol ((±)-142c):142 
 
Following general procedure 2 magnesium shavings (2.28 g, 93.6 mmol),1-bromoheptane 
(18.10 mL, 115.2 mmol) and furfural (140) (5.96 mL, 72.0 mmol) to afford (±)-142c 
(12.08 g, 61.56 mmol, 86%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.37 
(dd, J = 1.8, 0.8 Hz, 1H), 6.32 (dd, J = 3.2, 1.8 Hz, 1H), 6.22 (d, J = 3.2 Hz, 1H), 4.66 (t, 
J = 6.8 Hz, 1H), 1.92 (bs, 1H), 1.89 – 1.81 (m, 2H), 1.44 – 1.24 (m, 10H), 0.87 (t, J = 6.8 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δC = 156.9 (Cq), 141.9 (+), 110.1 (+), 105.8 (+), 67.9 (+), 
35.6 (-), 31.8 (-), 29.4 (-), 29.2 (-), 25.6 (-), 22.7 (-), 14.1 (+). 
 
4-Hydroxy-5-propylcyclopent-2-en-1-one ((±)-149a): 
 
According to general procedure 3 (±)-142a (5.61 g, 40.0 mmol) was used to afford a yellowish 
oil (3.58 g, 25.6 mmol, 64%): 1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.2 Hz, 1H), 
6.19 (dd, J = 5.7, 1.1 Hz, 1H), 4.80 – 4.61 (m, 1H), 2.27 – 2.22 (m, 1H), 2.08 (bs, 1H), 
1.90 – 1.75 (m, 1H), 1.54 – 1.39 (m, 3H), 0.96 (t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 208.2 (Cq), 161.6 (+), 134.4 (+), 76.9 (+), 55.3 (+), 30.7 (-), 20.6 (-), 14.1 (+). 
  
E Experimental  
107 
 
4-Hydroxy-5-pentylcyclopent-2-en-1-one ((±)-149b):83 
 
According to the general procedure 3 (±)-142b (6.73 g, 40.0 mmol) was used to afford a 
yellowish oil (4.95 g, 29.4 mmol, 74%): 1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 
2.2 Hz, 1H), 6.20 (dd, J = 5.8, 1.2 Hz, 1H), 4.75 – 4.62 (m, 1H), 2.28 – 2.18 (m, 1H), 1.97 
(bs, 1H), 1.90 – 1.79 (m, 1H), 1.48 – 1.29 (m, 7H), 0.89 (t, J = 7.0 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 208.1 (Cq), 161.5 (+), 134.4 (+), 76.8 (+), 55.5 (+), 31.9 (-), 
28.6 (-), 27.0 (-), 22.5 (-), 14.1 (+). 
 
5-Heptyl-4-hydroxycyclopent-2-en-1-one ((±)-149c):142 
 
According to general procedure 3 (±)-142c (7.85 g, 40.0 mmol) was used to afford a yellowish 
oil (3.48 g, 17.7 mmol, 44%): 1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.2 Hz, 1H), 
6.20 (dd, J = 5.8, 1.3 Hz, 1H), 4.71 – 4.67 (m, 1H), 2.27 – 2.18 (m, 1H), 1.92 (s, 1H), 1.89 – 1.81 
(m, 1H), 1.52 – 1.41 (m, 3H), 1.34 – 1.23 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 208.0 (Cq), 161.4 (+), 134.5 (+), 76.9 (+), 55.5 (+), 31.8 (-), 
29.7 (-), 29.1 (-), 28.6 (-), 27.4 (-), 22.7 (-), 14.1 (+). 
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4-Oxo-5-propylcyclopent-2-en-1-yl acetate ((±)-154a): 
 
According to general procedure 4 (±)-149a (2.80 g, 20.0 mmol) was used to afford a yellowish 
oil (3.13 g, 17.2 mmol, 86%): Rf = 0.57 (PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δH = 7.49 
(dd, J = 5.8, 2.3 Hz, 1H), 6.29 (dd, J = 5.8, 1.2 Hz, 1H), 5.68 – 5.61 (m, 1H), 2.39 
(ddd, J = 8.5, 5.0, 2.4 Hz, 1H), 2.10 (s, 3H), 1.85 – 1.73 (m, 1H), 1.56 – 1.34 (m, 3H), 0.92 
(t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 207.0 (Cq), 170.6 (Cq), 157.8 (+), 136.2 
(+), 77.6 (+), 51.4 (+), 30.8 (-), 21.0 (+), 20.1 (-), 14.0 (+); IR (/cm-1): 2960, 2937, 2874, 1715, 
1595, 1485, 1372, 1327, 1230, 1170, 1088, 1025, 954, 924, 895, 857, 798, 734; HRMS (APCI) 
m/z calculated for C10H15O3 [MH
+]: 183.1016, found: 183.1026. 
 
4-Oxo-5-pentylcyclopent-2-en-1-yl acetate ((±)-154b): 
 
According to general procedure 4 (±)-149b (3.37 g, 20.0 mmol) was used to afford a yellowish 
oil (3.88 g, 18.5 mmol, 92%): 1H NMR (300 MHz, CDCl3) δH = 7.49 (dd, J = 5.8, 2.3 Hz, 1H), 
6.29 (dd, J = 5.8, 1.2 Hz, 1H), 5.67 – 5.61 (m, 1H), 2.38 (ddd, J = 8.4, 4.9, 2.4 Hz, 1H), 2.10 
(s, 3H), 1.87 – 1.74 (m, 1H), 1.57 – 1.46 (m, 1H), 1.37 – 1.23 (m, 6H), 0.87 (t, J = 6.7 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 207.1 (Cq), 170.6 (Cq), 157.8 (+), 136.2 (+), 77.6 (+), 51.5 
(+), 31.7 (-), 28.6 (-), 26.4 (-), 22.4 (-), 21.0 (+), 14.0 (+). 
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5-Heptyl-4-oxocyclopent-2-en-1-yl acetate ((±)-154c): 
 
According to general procedure 4 (±)-149c (3.93 g, 20.0 mmol) was used to afford a yellowish 
oil (4.11 g, 12.9 mmol, 86%): Rf = 0.55 (PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δH = 7.49 
(dd, J = 5.8, 2.3 Hz, 1H), 6.29 (dd, J = 5.8, 1.2 Hz, 1H), 5.67 – 5.61 (m, 1H), 2.37 (ddd, J = 8.4, 
4.9, 2.4 Hz, 1H), 2.10 (s, 3H), 1.88 – 1.75 (m, 1H), 1.57 – 1.46 (m, 1H), 1.37 – 1.21 (m, 10H), 
0.86 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 207.1 (Cq), 170.6 (Cq), 157.8 (+), 
136.2 (+), 77.6 (+), 51.5 (+), 31.8 (-), 29.5 (-), 29.1 (-), 28.6 (-), 26.7 (-), 22.6 (-), 21.0 (+), 14.1 
(+); IR (/cm-1): 2926, 2855, 1718, 1595, 1581, 1372, 1230, 1170, 1096, 1021, 976, 906, 794, 
723; HRMS (APCI) m/z calculated for C14H23O3 [MH
+]: 239.1642, found: 239.1641. 
 
2-Propyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155a): 
 
Following general procedure 5 acetate (±)-154a (1.82 g, 10.0 mmol) was used to afford a 
colorless oil (1.53 g, 8.11 mmol, 81%): Rf = 0.45 (PE/EA = 10:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.04 – 6.90 (m, 1H), 5.86 (dd, J = 5.5, 2.9 Hz, 1H), 5.74 (dd, J = 5.5, 2.9 Hz, 1H), 
3.27 – 3.22 (m, 1H), 3.21 – 3.17 (m, 1H), 2.93 – 2.88 (m, 1H), 2.80 (t, J = 5.1 Hz, 1H), 
2.08 – 1.92 (m, 2H), 1.72 (dt, J = 8.4, 1.7 Hz, 1H), 1.62 – 1.57 (m, 1H), 1.39 (sext, J = 7.4 Hz, 
2H), 0.85 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.3 (Cq), 157.6 (+), 149.3 
(Cq), 132.6 (+) 132.3 (+), 52.6 (-), 50.8 (+), 45.3 (+), 45.1 (+), 44.1 (+), 26.7 (-), 21.1 (-), 13.8 
(+); IR (/cm-1): 3064, 2960, 2933, 2870, 1692, 1625, 1454, 1338, 1230, 1204, 1126, 1074, 
828, 738, 712; HRMS (EI) m/z calculated for C13H16O [M
+∙]: 188.11957, found: 188.12003. 
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2-Pentyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155b):143 
 
Following general procedure 5 acetate (±)-154b (2.10 g, 10.0 mmol) was used to afford a 
colorless oil (1.69 g, 7.82 mmol, 78%): 1H NMR (300 MHz, CDCl3) δH = 7.06 – 6.90 (m, 1H), 
5.86 (dd, J = 5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.5, 2.9 Hz, 1H), 3.29 – 3.22 (m, 1H), 3.21 – 3.15 
(m, 1H), 2.94 – 2.87 (m, 1H), 2.81 (t, J = 5.1 Hz, 1H), 2.09 – 1.93 (m, 2H), 1.72 
(dt, J = 8.4, 1.7 Hz, 1H), 1.61 – 1.56 (m, 1H), 1.39 – 1.18 (m, 6H), 0.86 (t, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.2 (Cq), 157.5 (+), 149.5 (Cq), 132.6 (+), 132.3 (+), 52.6 
(-), 50.8 (+), 45.3 (+), 45.1 (+), 44.1 (+), 31.5 (-), 27.6 (-), 24.6 (-), 22.4 (-), 14.1 (+).  
 
2-Heptyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155c): 
 
Following general procedure 5 acetate (±)-154c (2.38 g, 10.0 mmol) was used to afford a 
colorless oil (2.02 g, 8.27 mmol, 83%): Rf = 0.50 (PE/EA = 10:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.03 – 6.91 (m, 1H), 5.86 (dd, J = 5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.5, 2.9 Hz, 1H), 
3.28 – 3.22 (m, 1H), 3.22 – 3.17 (m, 1H), 2.94 – 2.88 (m, 1H), 2.81 (t, J = 5.1 Hz, 1H), 
2.09 – 1.95 (m, 2H), 1.72 (dt, J = 8.4, 1.7 Hz, 1H), 1.62 – 1.57 (m, 1H), 1.39 – 1.20 (m, 10H), 
0.86 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.3 (Cq), 157.5 (+), 149.5 (Cq), 
132.6 (+), 132.3 (+), 52.6 (-), 50.8 (+), 45.3 (+), 45.1 (+), 44.1 (+), 31.8 (-), 29.2 (-), 29.1 (-), 
27.9 (-), 24.7 (-), 22.7 (-), 14.1 (+); IR (/cm-1): 3064, 2926, 2855, 1696, 1625, 1461, 1338, 
1293, 1230, 1126, 910, 738, 716; HRMS (EI) m/z calculated for C17H24O [M
+∙]: 244.18217, 
found: 244.18158. 
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6a-Propyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156a): 
 
According to general procedure 6 (±)-155a (753 mg, 4.00 mmol), 2 M NaOH (2.4 mL, 
4.80 mmol) and H2O2 (2.2 mL, 30% in water, 21.6 mmol) were used and stirred for 24 h to 
afford a colorless oil (801 mg, 3.92 mmol, 98%): Rf = 0.47 (PE/EA = 10:1); 1H NMR (300 
MHz, CDCl3) δH = δ 6.04 (dd, J = 5.6, 2.8 Hz, 1H), 5.99 (dd, J = 5.6, 2.8 Hz, 1H), 
3.46 (d, J = 1.6 Hz, 1H), 3.26 – 3.18 (m, 1H), 3.10 – 3.04 (m, 1H), 3.01 – 2.96 (m, 1H), 
2.85 – 2.78 (m, 1H), 1.85 – 1.72 (m, 1H), 1.60 (dt, J = 8.5, 1.7 Hz, 1H), 1.58 – 1.47 (m, 1H), 
1.47 – 1.42 (m, 1H), 1.33 – 1.19 (m, 2H), 0.89 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 210.5 (Cq), 135.1 (+), 133.7 (+), 66.9 (Cq), 65.5 (+), 51.8 (-), 50.0 (+), 45.8 (+), 43.5 (+), 
43.3 (+), 26.9 (-), 17.9 (-), 14.4 (+); IR (/cm-1): 3064, 2963, 2874, 1733, 1457, 1338, 1200, 
1126, 1029, 910, 835, 775, 723; HRMS (EI) m/z calculated for C13H16O2 [M
+∙]: 204.11448, 
found: 204.11452. 
 
6a-Pentyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156b): 
 
According to general procedure 6 (±)-155b (865 mg, 4.00 mmol), 2 M NaOH (2.4 mL, 
4.80 mmol) and H2O2 (2.2 mL, 30% in water, 21.6 mmol) were used and stirred for 24 h to 
afford a colorless oil (897 mg, 3.86 mmol, 97%): Rf = 0.54 (PE/EA = 10:1); 
1H NMR (300 MHz, CDCl3) δH = 6.04 (dd, J = 5.6, 2.8 Hz, 1H), 5.99 (dd, J = 5.6, 2.8 Hz, 1H), 
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3.46 (d, J = 1.6 Hz, 1H), 3.26 – 3.17 (m, 1H), 3.10 – 3.04 (m, 1H), 3.02 – 2.95 (m, 1H), 
2.85 – 2.79 (m, 1H), 1.84 – 1.72 (m, 1H), 1.62 – 1.43 (m, 3H), 1.34 – 1.19 (m, 6H), 0.86 
(t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = δ 210.5 (Cq), 135.1 (+), 133.7 (+), 67.0 
(Cq), 65.5 (+), 51.8 (-), 50.0 (+), 45.8 (+), 43.5 (+), 43.3 (+), 32.0 (-), 24.7 (-), 24.0 (-), 22.4 (-), 
14.0 (+); IR (/cm-1): 3064, 2933, 2862, 1737, 1461, 1420, 1338, 1252, 1126, 1088, 1044, 910, 
842, 775, 723; HRMS (EI) m/z calculated for C15H20O2 [M
+∙]: 232.14578, found: 232.14517. 
 
6a-Heptyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156c): 
 
According to general procedure 6 (±)-155c (978 mg, 4.00 mmol), 2 M NaOH (2.4 mL, 
4.80 mmol) and H2O2 (2.2 mL, 30% in water, 21.6 mmol) were used and stirred for 24 h to 
afford a colorless oil (1.018 g, 3.91 mmol, 98%): Rf = 0.54 (PE/EA = 10:1); 1H NMR (300 
MHz, CDCl3) δH = 6.04 (dd, J = 5.6, 2.8 Hz, 1H), 5.99 (dd, J = 5.5, 2.8 Hz, 1H), 
3.46 (d, J = 1.6 Hz, 1H), 3.29 – 3.17 (m, 1H), 3.10 – 3.03 (m, 1H), 3.01 – 2.94 (m, 1H), 
2.86 – 2.77 (m, 1H), 1.86 – 1.72 (m, 1H), 1.60 (dt, J = 8.5, 1.7 Hz, 1H), 1.58 – 1.47 (m, 1H), 
1.47 – 1.43 (m, 1H), 1.24 (m, 10H), 0.87 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 210.5 (Cq), 135.1 (+), 133.71 (+), 67.0 (Cq), 65.5 (+), 51.8 (-), 50.0 (+), 45.8 (+), 43.5 (+), 
43.3 (+) 31.8 (-), 29.8 (-), 29.1 (-), 24.7 (-), 24.4 (-), 22.6 (-), 14.1 (+); IR (/cm-1): 3064, 2930, 
2855, 1737, 1461, 1338, 1200, 1126, 1088, 1044, 910, 842, 775, 723; HRMS (EI) m/z 
calculated for C17H24O2 [M
+∙]: 260.17708, found: 260.17650. 
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6-Propyl-2H-pyran-2-one (2a):5 
 
Following general procedure 1 epoxide (±)-156a (204 mg, 1.00 mmol) was used to afford a 
colorless oil (138 mg, 1.00 mmol, 100%): 1H NMR (300 MHz, CDCl3) δH = 7.26 (dd, J = 9.4, 
6.5 Hz, 1H), 6.15 (d, J = 9.4 Hz, 1H), 5.97 (dd, J = 6.6, 0.8 Hz, 1H), 2.46 (t, J = 7.5 Hz, 2H), 
1.69 (sext, J = 7.5 Hz, 2H), 0.96 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 166.5 
(Cq), 163.0 (Cq), 143.7 (+), 113.2 (+), 102.8 (+), 35.7 (-), 20.3 (-), 13.5 (+). 
 
6-Pentyl-2H-pyran-2-one (2b):5 
 
Following general procedure 1 epoxide (±)-156b (232 mg, 1.00 mmol) was used to afford a 
colorless oil (165 mg, 0.99 mmol, 99%): 1H NMR (300 MHz, CDCl3) δH = 7.25 (dd, J = 9.4, 
6.5 Hz, 1H), 6.14 (d, J = 9.4 Hz, 1H), 5.97 (dd, J = 6.6, 0.7 Hz, 1H), 2.47 (t, J = 7.6 Hz, 2H), 
1.69 – 1.60 (m, 2H), 1.36 – 1.27 (m, 4H), 0.89 (t, J = 6.9 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 166.8 (Cq), 163.0 (Cq), 143.8 (+), 113.1 (+), 102.6 (+), 33.8 (-), 31.1 (-), 26.6 (-), 22.3 (-), 
13.9 (+). 
 
6-Heptyl-2H-pyran-2-one (2c):5 
 
Following general procedure 1 epoxide (±)-156c (260 mg, 1.00 mmol) was used to afford a 
colorless oil (194 mg, 1.00 mmol, 100%): 1H NMR (300 MHz, CDCl3) δH = 7.25 (dd, J = 9.4, 
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6.6 Hz, 1H), 6.15 (d, J = 9.4 Hz, 1H), 5.96 (dd, J = 6.6, 0.8 Hz, 1H), 2.47 (t, J = 7.5 Hz, 2H), 
1.70 – 1.60 (m, 2H), 1.35 – 1.22 (m, 8H), 0.87 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 166.8 (Cq), 163.0 (Cq), 143.8 (+), 113.1 (+), 102.6 (+), 33.9 (-), 31.7 (-), 28.9 (-) 28.9 (-), 
26.9 (-), 22.6 (-), 14.1 (+). 
 
2-(1-Hydroxyethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165a): 
 
According to general procedure 7 enone (±)-138 (4.39 g, 30.0 mmol), acetaldehyde (2.53 mL, 
45.0 mmol), phenol (0.565 g, 6.0 mmol), and Bu3P (2.96 mL, 12.0 mmol) were used and the 
reaction was complete after 3 d. Purification via flash chromatography (silica, PE/EA = 3:1) 
yielded a colorless oil (4.80 g, 25.6 mmol, 84%): Rf = 0.17 (PE/EA = 3:1); 1H NMR (300 MHz, 
CDCl3) δH = 7.13 – 7.10 (m, 1H), 5.93 (dd, J = 5.6, 2.9 Hz, 1H), 5.79 (dd, J = 5.6, 2.9 Hz, 1H), 
4.48 (q, J = 6.5 Hz, 1H), 3.34 – 3.28 (m, 1H), 3.25 – 3.20 (m, 1H), 2.99 – 2.93 (bs, 1H), 2.87 
(t, J = 5.0 Hz, 1H), 1.75 (dt, J = 8.5, 1.7 Hz, 1H), 1.64 – 1.59 (m, 1H), 1.30 (d, J = 6.5 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.6 (Cq), 157.1 (+), 151.6 (Cq), 132.5 (+), 132.3 (+), 63.9 
(+), 52.7 (-), 51.6 (+), 45.4 (+), 45.2 (+), 44.1 (+), 22.0 (+); IR (/cm-1): 3500 – 3200, 2971, 
2933, 2870, 1742, 1679, 1627, 1453, 1365, 1338, 1118, 1068, 1019, 714; HRMS (ESI) m/z 
calculated for C12H15O2 [MH
+]: 191.1067, found: 191.1067. 
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2-(1-Hydroxypropyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165b): 
 
According to general procedure 7 enone (±)-138 (4.39 g, 30.0 mmol), propionaldehyde 
(3.23 mL, 45.0 mmol), phenol (0.565 g, 6.0 mmol), and Bu3P (2.96 mL, 12.0 mmol) were used 
and the reaction was complete after 3 d. Purification via flash chromatography (silica, PE/EA 
= 3:1) yielded a white solid (4.81 g, 23.6 mmol, 79%): mp 58.7 – 61.5 °C; Rf = 0.30 
(PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) δH = 7.04 (d, J = 2.6 Hz, 1H), 5.85 (dd, J = 5.6, 
2.9 Hz, 1H), 5.72 (dd, J = 5.6, 3.0 Hz, 1H), 4.13 (t, J = 6.5 Hz, 1H), 3.30 – 3.22 (m, 1H), 
3.18 – 3.12 (m, 1H), 2.93 – 2.87 (m, 1H), 2.81 (t, J = 5.0 Hz, 1H), 1.69 (dt, J = 8.5, 1.7 Hz, 
1H), 1.60 – 1.49 (m, 3H), 0.82 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.7 (Cq), 
158.1 (+), 150.0 (Cq), 132.6 (+), 132.4 (+), 69.8 (+), 52.7 (-), 51.6 (+), 45.5 (+), 45.2 (+), 44.1 
(+), 29.2 (-), 9.8 (+); IR (/cm-1): 3500 – 3300, 2963, 2934, 2870, 1677, 1624, 1451, 1332, 
1293, 1251, 1228, 1204, 1086, 1040, 975, 879, 837, 803, 771, 750, 724; HRMS (ESI) m/z 
calculated for C13H17O2 [MH
+]: 205.1223, found: 205.1229. 
 
2-(1-Hydroxy-2-methylpropyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165c):89 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), isobutyraldehyde 
(0.41 mL, 4.50 mmol), phenol (56 mg, 0.6 mmol) and Bu3P (0.30 mL, 1.20 mmol) were used 
and the reaction was complete after 7 d. Purification via flash chromatography 
(silica, PE/EA = 3:1) yielded a white solid (553 mg, 2.53 mmol, 85%): mp 76.3 – 78.0 °C; 
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Rf = 0.69 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.07 (d, J = 2.7 Hz, 1H), 5.92 
(dd, J = 5.6, 2.9 Hz, 1H), 5.79 (dd, J = 5.6, 2.9 Hz, 1H), 3.98 (d, J = 6.5 Hz, 1H), 3.36 – 3.30 
(m, 1H), 3.24 – 3.18 (m, 1H), 3.00 – 2.94 (m, 1H), 2.87 (t, J = 5.0 Hz, 1H), 1.90 – 1.78 (m, 1H), 
1.75 (dt, J = 8.5, 1.7 Hz, 1H), 1.64 – 1.59 (m, 1H), 0.88 (d, J = 6.7 Hz, 3H), 0.81 (d, J = 6.8 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δC = 211.0 (Cq), 159.3 (+), 148.8 (Cq), 132.9 (+), 132.6 (+), 
74.5 (+), 52.8 (-), 51.6 (+), 45.8 (+), 45.1 (+), 44.2 (+), 33.2 (+), 18.9 (+), 17.6 (+); IR (/cm-1): 
3600 – 3300, 2966, 2961, 2929, 2867, 1675, 1618, 1466, 1329, 1294, 1250, 1227, 1202, 1131, 
1070, 1024, 1008, 949, 923, 908, 889, 840, 802, 773, 750, 724; HRMS (ESI) m/z calculated 
for C14H19O2 [MH
+]: 219.1380, found: 219.1377. 
 
2-(1-Hydroxybutyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165d): 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), butyraldehyde 
(0.41 mL, 4.50 mmol), phenol (56 mg, 0.60 mmol) and Bu3P (0.30 mL, 1.20 mmol) were used 
and the reaction was complete after 3 d. Purification via flash chromatography 
(silica, PE/EA = 3:1) yielded a colorless oil (541 mg, 2.48 mmol, 83%): Rf = 0.20 
(PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) δH = 7.04 (d, J = 2.6 Hz, 1H), 5.85 (dd, J = 5.6, 
2.9 Hz, 1H), 5.72 (dd, J = 5.5, 2.9 Hz, 1H), 4.21 (t, J = 6.5 Hz, 1H), 3.28 – 3.22 (m, 1H), 
3.18 – 3.12 (m, 1H), 2.92 – 2.87 (m, 1H), 2.80 (t, J = 5.0 Hz, 1H), 1.69 (dt, J = 8.5, 1.7 Hz, 
1H), 1.59 – 1.44 (m, 3H), 1.38 – 1.19 (m, 2H), 0.84 (t, J = 7.3 Hz, 3H), 
13C NMR (75 MHz, CDCl3) δC = 210.7 (Cq), 157.8 (+), 150.5 (Cq), 132.6 (+), 132.3 (+), 68.1 
(+), 52.7 (-), 51.6 (+), 45.5 (+), 45.2 (+), 44.1 (+), 38.3 (-), 18.6 (-), 13.9 (+); IR (/cm-1): 
3500 – 3200, 2958, 2933, 2872, 1743, 1678, 1623, 1456, 1337, 1294, 1228, 1122, 1070, 1024, 
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957, 839, 805, 748, 714; HRMS (ESI) m/z calculated for C14H19O2 [MH
+]: 219.1380, found: 
219.1380. 
 
2-(1-Hydroxypentyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165e): 
 
According to general procedure 7 enone (±)-138 (4.38 g, 30.0 mmol), valeraldehyde (4.79 mL, 
45.0 mmol), phenol (0.565 g, 6.0 mmol) and Bu3P (2.96 mL, 12.0 mmol) were used and the 
reaction was complete after 3 d. Purification via flash chromatography (silica, PE/EA = 5:1) 
yielded a colorless oil (5.58 g, 24.03 mmol, 80%): Rf = 0.32 (PE/EA = 5:1); 
1H NMR (300 MHz, CDCl3) δH = 7.09 (d, J = 2.6 Hz, 1H), 5.92 (dd, J = 5.6, 2.9 Hz, 1H), 5.78 
(dd, J = 5.6, 2.9 Hz, 1H), 4.25 (t, J = 6.6 Hz, 1H), 3.35 – 3.28 (m, 1H), 3.25 – 3.18 (m, 1H), 
2.99 – 2.93 (m, 1H), 2.87 (t, J = 5.0 Hz, 1H), 2.47 – 2.25 (bs, 1H), 1.75 (dt, J = 8.5, 1.7 Hz, 
1H), 1.66 – 1.51 (m, 3H), 1.42 – 1.19 (m, 4H), 0.88 (t, J = 7.0 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.8 (Cq), 157.9 (+), 150.3 (Cq), 132.6 (+), 132.4 (+), 68.5 
(+), 52.7 (-), 51.6 (+), 45.5 (+), 45.2 (+), 44.1 (+), 35.9 (-), 27.6 (-), 22.5 (-), 14.1 (+); 
IR (/cm-1): 3500 – 3200, 2957, 2929, 2870, 1682, 1458, 1337, 1258, 1205, 1124, 1072, 1043, 
1015, 795, 714; HRMS (ESI) m/z calculated for C15H21O2 [MH
+]: 233.1536, found: 233.1540. 
 
2-(1-Hydroxyheptyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165f): 
 
According to general procedure 7 enone (±)-138 (4.39 g, 30.0 mmol), n-heptanal (6.27 mL, 
45.0 mmol), phenol (0.565 g, 6.0 mmol) and Bu3P (2.96 mL, 12.0 mmol) were used and the 
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reaction was complete after 3 d. Purification via flash chromatography (silica, PE/EA = 5:1) 
yielded a colorless oil (6.44 g, 24.72 mmol, 82%): Rf = 0.53 (PE/EA = 3:1); 
1H NMR (300 MHz, CDCl3) δH = 7.08 (d, J = 2.6 Hz, 1H), 5.89 (dd, J = 5.6, 2.9 Hz, 1H), 5.76 
(dd, J = 5.6, 2.9 Hz, 1H), 4.23 (t, J = 6.6 Hz, 1H), 3.33 – 3.26 (m, 1H), 3.22 – 3.16 (m, 1H), 
2.97 – 2.91 (m, 1H), 2.84 (t, J = 5.0 Hz, 1H), 2.81 – 2.75 (bs, 1H), 1.73 (dt, J = 8.5, 1.7 Hz, 
1H), 1.63 – 1.48 (m, 3H), 1.37 – 1.15 (m, 8H), 0.84 (t, J = 7.0 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.7 (Cq), 157.9 (+), 150.4 (Cq), 132.6 (+), 132.3 (+), 68.4 
(+), 52.7 (-), 51.6 (+), 45.5 (+), 45.2 (+), 44.1 (-), 36.2 (-), 31.8 (-), 29.1 (-), 25.4 (-), 22.6 (-), 
14.1 (+); IR (/cm-1): 3600 – 3200, 3064, 2930, 2859, 1681, 1625, 1457, 1379, 1338, 1293, 
1204, 1126, 1066, 1040, 913, 876, 805, 749, 716; HRMS (ESI) m/z calculated for C17H25O2 
[MH+]: 261.1849, found: 261.1850. 
 
2-(Hydroxy(phenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165g):89 
 
According to general procedure 7 enone (±)-138 (4.39 g, 30.0 mmol), benzaldehyde (4.55 mL, 
45.0 mmol), phenol (0.565 g, 6.0 mmol) and Bu3P (2.96 mL, 12.0 mmol) were used and the 
reaction was complete after 2 d. Purification via flash chromatography (silica, PE/EA = 3:1) 
yielded a white solid (6.28 g, 24.91 mmol, 83%): mp 108.7 – 110.0 °C; Rf = 0.25 
(PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) δH = 7.36 – 7.26 (m, 5H), 6.96 – 6.92 (m, 1H), 
5.90 (dd, J = 5.5, 2.9 Hz, 1H), 5.76 (dd, J = 5.5, 2.9 Hz, 1H), 5.43 – 5.40 (m, 1H), 3.32 – 3.26 
(m, 1H), 3.24 – 3.19 (m, 1H), 2.95 – 2.91 (m, 1H), 2.89 (t, J = 5.0 Hz, 1H), 1.74 (dt, J = 8.5, 
1.7 Hz, 1H), 1.64 – 1.57 (m, 1H); 13C NMR (75 MHz, CDCl3) δC = 210.2 (Cq), 159.3 (+), 150.4 
E Experimental  
119 
 
(Cq), 141.5 (Cq), 132.6 (+), 132.5 (+) 128.4 (+), 127.7 (+), 126.4 (+), 70.2 (+), 52.7 (-), 51.7 
(+), 45.6 (+), 45.2 (+), 44.2 (+); IR (/cm-1): 3500 – 3200, 3065, 3027, 2975, 2937, 2886, 2871, 
1739, 1670, 1618, 1492, 1456, 1411, 1356, 1301, 1252, 1210, 1125, 1090, 1075, 1034, 1007, 
941, 907, 871, 847, 802, 768; HRMS (ESI) m/z calculated for C17H16NaO2 [MH
+]: 275.1043, 
found: 275.1042. 
 
2-((4-Chlorophenyl)(hydroxy)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165h): 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), 4-chlorobenzaldehyde 
(633 mg, 4.50 mmol), phenol (56 mg, 0.60 mmol) and Bu3P (0.30 mL, 1.20 mmol) were used 
and the reaction was complete after 1 d. Purification via flash chromatography 
(silica, PE/EA = 5:1) yielded a white solid (675 mg, 2.35 mmol, 79%): mp 114.6 – 116.3 °C; 
Rf = 0.29 (PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δH = 7.33 – 7.23 (m, 4H), 6.94 
(d, J = 2.1 Hz, 1H), 5.89 (dd, J = 5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.6, 3.0 Hz, 1H), 5.39 (s, 1H), 
3.59 – 3.35 (bs, 1H), 3.32 – 3.27 (m, 1H), 3.24 – 3.19 (m, 1H), 2.96 – 2.91 (m, 1H), 2.89 
(t, J = 5.0 Hz, 1H), 1.75 (dt, J = 8.5, 1.7 Hz, 1H), 1.63 – 1.58 (m, 1H); 
13C NMR (75 MHz, CDCl3) δC = 210.2 (Cq), 159.4 (+), 150.0 (Cq), 140.1 (Cq), 133.5 (Cq), 
132.6 (+), 132.5 (+), 128.5 (+), 127.8 (+), 69.6 (+), 52.8 (-), 51.7 (+), 45.6 (+), 45.3 (+), 44.2 
(+); IR (/cm-1): 3500 – 3200, 3067, 2989, 2968, 2940, 2918, 2899, 2870, 1668, 1616, 1483, 
1341, 1330, 1291, 1248, 1225, 1187, 1122, 1084, 1027, 1003, 847, 821, 800, 711; HRMS (ESI) 
m/z calculated for C17H15ClNaO2 [MNa
+]: 309.0653, found: 309.0657. 
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2-(Hydroxy(4-nitrophenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165i): 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), 4-nitrobenzaldehyde 
(680 mg, 4.50 mmol), phenol (56 mg, 0.60 mmol) and Bu3P (0.30 mL, 1.20 mmol) were used 
and the reaction was complete after 1 d. Purification via flash chromatography 
(silica, PE/EA = 3:1) yielded a yellow solid (763 mg, 2.57 mmol, 86%): mp 138.6 – 140.5 °C; 
Rf = 0.38 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 8.23 – 8.16 (m, 2H), 7.55 – 7.48 
(m, 2H), 6.99 (d, J = 2.3 Hz, 1H), 5.86 (dd, J = 5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.6, 2.9 Hz, 1H), 
5.52 (s, 1H), 3.69 – 3.45 (bs, 1H), 3.37 – 3.31 (m, 1H), 3.26 – 3.20 (m, 1H), 2.99 – 2.94 (m, 
1H), 2.92 (t, J = 5.0 Hz, 1H), 1.76 (dt, J = 8.6, 1.7 Hz, 1H), 1.65 – 1.59 (m, 1H); 
13C NMR (75 MHz, CDCl3) δC = 210.0 (Cq), 160.0 (+), 149.2 (Cq), 148.9 (Cq), 147.3 (Cq), 
132.6 (+) 132.5 (+), 127.1 (+), 123.6 (+), 69.2 (+), 52.8 (-), 51.6 (+), 45.8 (+), 45.3 (+), 44.2 
(+); IR (/cm-1): 3500 – 3300, 3065, 2985, 2941, 2913, 2875, 1666, 1619, 1606, 1515, 1345, 
1293, 1250, 1226, 1187, 1124, 1109, 1079, 1029, 1005, 839, 803, 751, 718; HRMS (ESI) m/z 
calculated for C17H16NO4 [MH
+]: 298.1074, found: 298.1069. 
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2-(Hydroxy(4-methoxyphenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165j): 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), 
4-methoxybenzaldehyde (0.55 mL, 4.50 mmol), phenol (56 mg, 0.60 mmol) and Bu3P 
(0.30 mL, 1.20 mmol) were used and the reaction was complete after 7 d. Purification via flash 
chromatography (silica, PE/EA = 3:1) yielded a colorless oil (716 mg, 2.54 mmol, 85%): 
Rf = 0.24 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) δH = 7.25 – 7.20 (m, 2H), 6.97 – 6.93 
(m, 1H), 6.89 – 6.82 (m, 2H), 5.92 (dd, J = 5.6, 2.9 Hz, 1H), 5.77 (dd, J = 5.6, 2.9 Hz, 1H), 5.36 
(s, 1H), 3.79 (s, 3H), 3.32 – 3.25 (m, 1H), 3.24 – 3.19 (m, 1H), 2.95 – 2.91 (m, 1H), 
2.88 (t, J = 5.0 Hz, 1H), 1.74 (dt, J = 8.5, 1.7 Hz, 1H), 1.63 – 1.58 (m, 1H); 
13C NMR (75 MHz, CDCl3) δC = 210.2 (Cq), 159.1 (Cq), 159.1 (+), 150.7 (Cq), 133.8 (Cq), 
132.6 (+), 132.5 (+), 127.7 (+), 113.7 (+), 69.7 (+), 55.3 (+), 52.7 (-), 51.7 (+), 45.5 (+), 45.2 
(+), 44.1 (+); IR (/cm-1): 3500 – 3300, 3063, 2973, 2868, 2836, 1686, 1610, 1510, 1462, 1337, 
1302, 1246, 1173, 1125, 1078, 1030, 1000, 830, 804, 749, 710; HRMS (ESI) m/z calculated 
for C18H19O3 [MH
+]: 283.1329, found: 283.1329. 
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2-(Furan-2-yl(hydroxy)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165k): 
 
According to general procedure 7 enone (±)-138 (438 mg, 3.00 mmol), furfural (0.37 mL, 
4.50 mmol), phenol (56 mg, 0.60 mmol) and Bu3P (0.30 mL, 1.20 mmol) were used and the 
reaction was complete after 3 d. Purification via flash chromatography (silica, PE/EA = 3:1) 
yielded a yellow solid (653 mg, 2.70 mmol, 90%): mp 89.8 – 91.4 °C; Rf = 0.34 (PE/EA = 3:1); 
1H NMR (300 MHz, CDCl3) δH = 7.36 (dd, J = 1.8, 0.9 Hz, 1H), 7.22 – 7.19 (m, 1H), 6.31 (dd, 
J = 3.2, 1.8 Hz, 1H), 6.22 (dt, J = 3.3, 0.7 Hz, 1H), 5.94 (dd, J = 5.6, 2.9 Hz, 1H), 5.80 
(dd, J = 5.6, 2.9 Hz, 1H), 5.43 (s, 1H), 3.40 – 3.33 (m, 1H), 3.27 – 3.21 (m, 1H), 3.01 – 2.96 
(m, 1H), 2.92 (t, J = 4.9 Hz, 1H), 1.76 (dt, J = 8.5, 1.7 Hz, 1H), 1.66 – 1.60 (m, 1H); 
13C NMR (75 MHz, CDCl3) δC = 209.8 (Cq), 159.9 (+), 154.0 (Cq), 147.2 (Cq), 142.3 (+), 132.6 
(+), 132.5 (+), 110.3 (+), 107.1 (+), 64.2 (+), 52.7 (-), 51.5 (+), 45.8 (+), 45.2 (+), 44.2 (+); 
IR (/cm-1): 3500 – 3200, 2977, 2937, 2870, 1685, 1626, 1501, 1338, 1293, 1228, 1201, 1145, 
1081, 1011, 742; HRMS (ESI) m/z calculated for C15H15O3 [MH
+]: 243.1016, found: 243.1011. 
 
6a-(1-Hydroxyethyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170a): 
 
According to general procedure 6 (±)-165a (3.81 g, 20.0 mmol), 2 M NaOH (12.0 mL, 
24.0 mmol) and H2O2 (11.0 mL, 30% in water, 108 mmol) were used and stirred for 30 min to 
afford a colorless oil (3.75 g, 18.2 mmol, 91%): Rf = 0.47 (PE/EA = 2:1); 
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1H NMR (300 MHz, CDCl3) δH = 6.08 (dd, J = 5.5, 2.8 Hz, 1H), 6.04 (dd, J = 5.6, 2.8 Hz, 1H), 
4.03 – 3.91 (m, 1H), 3.64 (d, J = 1.7 Hz, 1H), 3.29 – 3.22 (m, 1H), 3.12 – 3.07 (m, 1H), 
3.05 – 2.99 (m, 1H), 2.90 – 2.84 (m, 1H), 2.09 (d, J = 8.0 Hz, 1H), 1.65 – 1.62 (dt, J = 8.6, 1.8 
Hz, 1H), 1.49 – 1.43 (m, 1H), 1.26 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.9 
(Cq), 135.1 (+), 133.7 (+), 68.5 (Cq), 64.9 (+), 63.9 (+), 51.8 (-), 50.9 (+), 45.9 (+), 43.5 (+), 
43.0 (+), 19.2 (+); IR (/cm-1): 3600 – 3300, 2978, 2940, 2870, 1730, 1454, 1417, 1121, 1041, 
724, 633; HRMS (ESI) m/z calculated for C12H15O3 [MH
+]: 207.1016, found: 207.1017. 
 
6a-(1-Hydroxypropyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170b): 
 
According to general procedure 6 (±)-165b (4.09 g, 20.0 mmol), 2 M NaOH (12.0 mL, 
24.0 mmol) and H2O2 (11.0 mL, 30% in water, 108 mmol) were used and stirred for 30 min to 
afford a colorless oil (4.04 g, 18.3 mmol, 92%): Rf = 0.50 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 6.02 (dd, J = 5.6, 2.8 Hz, 1H), 5.97 (dd, J = 5.6, 2.8 Hz, 1H), 
3.61 (dd, J = 9.8, 3.3 Hz, 1H), 3.56 (d, J = 1.6 Hz, 1H), 3.21 – 3.15 (m, 1H), 3.06 – 3.00 (m, 1H), 
2.98 – 2.92 (m, 1H), 2.83 – 2.77 (m, 1H), 2.17 – 2.08 (bs, 1H), 1.65 – 1.52 (m, 2H), 1.43 – 1.33 
(m, 2H), 0.92 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 211.0 (Cq), 135.1 (+), 133.8 
(+), 69.3 (+), 68.0 (Cq), 64.7 (+), 51.9 (-), 50.9 (+), 45.9 (+), 43.5 (+), 43.1 (+), 26.1 (-), 10.2 
(+); IR (/cm-1): 3600 – 3300, 2970, 2937, 2876, 1730, 1457, 1336, 1235, 1122, 1038, 975, 
766, 728, 633; HRMS (ESI) m/z calculated for C13H17O3 [MH
+]: 221.1172, found: 221.1171. 
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6a-(1-Hydroxy-2-methylpropyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170c): 
 
According to general procedure 6 (±)-165c (218 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
afford a white solid (227 mg, 0.97 mmol, 97%): mp 54.1 – 56.8 °C; Rf = 0.82 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 6.05 (dd, J = 5.7, 2.9 Hz, 1H), 5.99 (dd, J = 5.7, 2.8 Hz, 1H), 
3.59 (d, J = 1.7 Hz, 1H), 3.56 (d, J = 4.9 Hz, 1H), 3.22 – 3.16 (m, 1H), 3.07 – 3.02 (m, 1H), 
2.98 – 2.92 (m, 1H), 2.86 – 2.79 (m, 1H), 2.20 – 2.03 (m, 1H), 1.98 – 1.82 (bs, 1H), 1.57 
(dt, J = 8.6, 1.7 Hz, 1H), 1.45 – 1.37 (m, 1H), 0.90 (d, J = 6.9 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.6 (Cq), 135.1 (+), 134.0 (+), 71.6 (+), 67.7 (Cq), 64.3 (+), 
51.9 (-), 50.9 (+), 45.8 (+), 43.5 (+), 43.0 (+), 29.9 (+), 20.0 (+), 16.5 (+); IR (/cm-1): 
3500 – 3200, 2981, 2961, 2933, 2863, 1736, 1467, 1414, 1386, 1335, 1246, 1227, 1139, 1061, 
1020, 928, 739, 719, 702; HRMS (ESI) m/z calculated for C14H19O3 [MH
+]: 235.1329, found: 
235.1326. 
 
6a-(1-Hydroxybutyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170d): 
 
According to general procedure 6 (±)-165d (218 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
afford a colorless oil (222 mg, 0.95 mmol, 95%): Rf = 0.59 (PE/EA = 2:1); 
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1H NMR (300 MHz, CDCl3) δH = 6.01 (dd, J = 5.7, 2.9 Hz, 1H), 5.97 (dd, J = 5.6, 2.8 Hz, 1H), 
3.72 (d, J = 9.1 Hz, 1H), 3.56 (d, J = 1.6 Hz, 1H), 3.20 – 3.16 (m, 1H), 3.05 – 3.00 (m, 1H), 
2.97 – 2.92 (m, 1H), 2.82 – 2.77 (m, 1H), 2.12 – 2.06 (bs, 1H), 1.55 (dt, J = 8.6, 1.8 Hz, 1H), 
1.53 – 1.45 (m, 2H), 1.42 – 1.38 (m, 1H), 1.37 – 1.24 (m, 2H), 0.85 (t, J = 7.1 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 211.0 (Cq), 135.1 (+), 133.8 (+), 68.2 (Cq), 67.5 (+), 64.7 (+), 
51.8 (-), 50.9 (+), 45.9 (+), 43.5 (+), 43.1 (+), 34.9 (-), 18.7 (-), 13.8 (+); IR (/cm-1): 
3600 – 3300, 2959, 2938, 2872, 1730, 1458, 1414, 133, 1123, 1075, 1033, 952, 911, 845, 776, 
715; HRMS (ESI) m/z calculated for C14H19O3 [MH
+]: 235.1329, found: 235.1328. 
 
6a-(1-Hydroxypentyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170e): 
 
According to general procedure 6 (±)-165e (4.65 g, 20.0 mmol), 2 M NaOH (12.0 mL, 
24.0 mmol) and H2O2 (11.0 mL, 30% in water, 108 mmol) were used and stirred for 30 min to 
afford a colorless oil (4.58 g, 18.4 mmol, 92%): Rf = 0.76 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 6.08 (dd, J = 5.5, 2.8 Hz, 1H), 6.04 (dd, J = 5.6, 2.7 Hz, 1H), 
3.77 (dd, J = 9.4, 3.0 Hz, 1H), 3.63 (d, J = 1.5 Hz, 1H), 3.28 – 3.22 (m, 1H), 3.12 – 3.07 (m, 1H), 
3.04 – 2.98 (m, 1H), 2.89 – 2.832 (m, 1H), 1.93 – 1.82 (bs, 1H), 1.63 – 1.25 (m, 8H), 0.89 
(t, J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 211.1 (Cq), 135.1 (+), 133.8 (+), 68.1 
(Cq), 67.9 (+), 64.8 (+), 51.9 (-), 50.9 (+), 45.9 (+), 43.5 (+), 43.1 (+), 32.6 (-), 27.7 (-), 22.5 (-), 
14.0 (+); IR (/cm-1): 3600 – 3300, 2934, 2871, 1731, 1457, 1336, 1125, 1039, 717; 
HRMS (ESI) m/z calculated for C15H21O3 [MH
+]: 249.1485, found: 249.1488. 
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6a-(1-Hydroxyheptyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170f): 
 
According to general procedure 6 (±)-165f (5.21 g, 20.0 mmol), 2 M NaOH (12.0 mL, 
24.0 mmol) and H2O2 (11.0 mL, 30% in water, 108 mmol) were used and stirred for 30 min to 
afford a colorless oil (5.33 g, 19.3 mmol, 96%): Rf = 0.79 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 6.07 (dd, J = 5.6, 2.8 Hz, 1H), 6.03 (dd, J = 5.6, 2.7 Hz, 1H), 
3.76 (dd, J = 9.5, 2.9 Hz, 1H), 3.62 (d, J = 1.6 Hz, 1H), 3.27 – 3.21 (m, 1H), 3.12 – 3.06 (m, 1H), 
3.04 – 2.97 (m, 1H), 2.90 – 2.82 (m, 1H), 2.10 – 1.97 (bs, 1H), 1.67 – 1.18 (m, 12H), 0.87 (t, 
J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 211.1 (Cq), 135.1 (+), 133.8 (+), 68.1 (Cq), 
67.9 (+), 64.8 (+), 51.9 (-), 50.9 (+), 45.9 (+), 43.5 (+), 43.1 (+), 33.0 (-), 31.8 (-), 29.1 (-), 25.5 
(-), 22.6 (-), 14.1 (+); IR (/cm-1): 3600 – 3300, 2930, 2859, 1733, 1461, 1416, 1338, 1234, 
1200, 1126, 1085, 1029, 913, 865, 775, 716; HRMS (EI) m/z calculated for C17H25O3 [MH
+]: 
277.1798, found: 277.1803. 
 
6a-(Hydroxy(phenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170g): 
 
According to general procedure 6 (±)-165g (5.05 g, 20.0 mmol), 2 M NaOH (12.0 mL, 
24.0 mmol) and H2O2 (11.0 mL, 30% in water, 108 mmol) were used and stirred for 30 min to 
afford a white solid (5.14 g, 19.2 mmol, 96%): mp 121.5 – 123.0 °C; Rf = 0.63 (PE/EA = 2:1); 
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1H NMR (300 MHz, CDCl3) δH = 7.36 – 7.26 (m, 5H), 5.74 (dd, J = 5.7, 2.8 Hz, 1H), 5.68 (dd, 
J = 5.7, 2.8 Hz, 1H), 4.94 (s, 1H), 3.39 (d, J = 1.6 Hz, 1H), 3.20 – 3.15 (m, 1H), 3.02 – 2.97 
(m, 1H), 2.96 – 2.91 (m, 1H), 2.87 – 2.81 (m, 1H), 1.54 (dt, J = 8.6, 1.7 Hz, 1H), 1.41 – 1.36 
(m, 1H); 13C NMR (75 MHz, CDCl3) δC = 211.2 (Cq), 138.5 (Cq), 134.6 (+), 133.5 (+), 128.2 
(+), 128.1 (+) 126.9 (+), 70.7 (+), 67.7 (Cq), 64.9 (+), 51.7 (-), 50.9 (+), 45.9 (+), 43.4 (+), 43.0 
(+); IR (/cm-1): 3600 – 3400, 2979, 2941, 2868, 1739, 1495, 1451, 1407, 1339, 1307, 1197, 
1036, 912, 866, 843, 757, 725, 704; HRMS (ESI) m/z calculated for C17H17O3 [MH
+]: 
269.1172, found: 269.1175. 
 
6a-((4-Chlorophenyl)(hydroxy)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170h): 
 
According to general procedure 6 (±)-165h (287 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
afford a white solid (274 mg, 0.91 mmol, 91%): mp 128.8 – 130.9  °C; Rf = 0.32 (PE/EA = 5:1); 
1H NMR (300 MHz, CDCl3) δH = 7.34 – 7.28 (m, 2H), 7.26 – 7.21 (m, 2H), 5.82 (dd, J = 5.6, 
2.8 Hz, 1H), 5.77 (dd, J = 5.6, 2.8 Hz, 1H), 4.97 (s, 1H), 3.35 (d, J = 1.6 Hz, 1H), 3.23 – 3.18 
(m, 1H), 3.05 – 2.99 (m, 1H), 2.98 – 2.93 (m, 1H), 2.89 – 2.83 (m, 1H), 1.57 (dt, J = 8.6, 1.7 
Hz, 1H), 1.44 – 1.38 (m, 1H); 13C NMR (75 MHz, CDCl3) δC = 211.1 (Cq), 136.9 (Cq), 134.8 
(+), 133.9 (Cq), 133.6 (+), 128.3 (+), 128.2 (+), 69.6 (+), 67.6 (Cq), 64.8 (+), 51.8 (-), 50.9 (+), 
45.9 (+), 43.4 (+), 42.9 (+); IR (/cm-1): 3600 – 3400, 2984, 2929, 2872, 1723, 1489, 1404, 
1334, 1275, 1258, 1213, 1198, 1089, 1060, 1033, 1016, 939, 898, 850, 820, 745, 723; 
HRMS (ESI) m/z calculated for C17H16ClO3 [MH
+]: 303.0782, found: 303.0791. 
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6a-(Hydroxy(4-nitrophenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170i): 
 
According to general procedure 6 (±)-165i (297 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
afford a yellow solid (279 mg, 0.89 mmol, 89%): mp 141.6 – 143.4 °C; Rf = 0.56 
(PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 8.23 – 8.17 (m, 2H), 7.54 – 7.47 (m, 2H), 
5.88 (dd, J = 5.6, 2.8 Hz, 1H), 5.82 (dd, J = 5.7, 2.8 Hz, 1H), 5.16 (s, 1H), 3.33 (d, J = 1.6 Hz, 
1H), 3.25 – 3.20 (m, 1H), 3.06 – 3.01 (m, 1H), 3.00 – 2.95 (m, 1H), 2.91 – 2.85 (m, 1H), 1.60 
(dt, J = 8.7, 1.7 Hz, 1H), 1.46 – 1.40 (m, 1H); 13C NMR (75 MHz, CDCl3) δC = 210.7 (Cq), 
147.7 (Cq), 145.4 (Cq), 135.0 (+), 133.6 (+), 127.8 (+), 123.3 (+), 68.9 (+), 67.4 (Cq), 64.7 (+), 
51.8 (-), 50.8 (+), 45.9 (+), 43.4 (+), 42.8 (+); IR (/cm-1): 3600 – 3400, 2962, 2937, 2872, 
1725, 1602, 1509, 1397, 1346, 1260, 1235, 1193, 1106, 1064, 1034, 899, 834, 806, 754, 718; 
HRMS (ESI) m/z calculated for C17H16NO5 [MH
+]: 314.1023, found: 314.1026. 
 
6a-(Hydroxy(4-methoxyphenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170j): 
 
According to general procedure 6 (±)-165j (282 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
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afford a colorless oil (273 mg, 0.92 mmol, 92%): Rf = 0.64 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.25 – 7.19 (m, 2H), 6.90 – 6.83 (m, 2H), 5.80 (dd, J = 5.6, 
2.8 Hz, 1H), 5.75 (dd, J = 5.6, 2.8 Hz, 1H), 4.91 (s, 1H), 3.80 (s, 3H), 3.39 (d, J = 1.6 Hz, 1H), 
3.22 – 3.16 (m, 1H), 3.04 – 2.99 (m, 1H), 2.98 – 2.92 (m, 1H), 2.88 – 2.82 (m, 1H), 1.55 
(dt, J = 8.6, 1.7 Hz, 1H), 1.43 – 1.37 (m, 1H); 13C NMR (75 MHz, CDCl3) δC = 211.25 (Cq), 
159.4 (Cq), 134.7 (+), 133.5 (+), 130.7 (Cq), 128.1 (+), 113.6 (+), 70.1 (+), 67.9 (Cq), 64.9 (+), 
55.3 (+), 51.7 (-), 50.9 (+), 45.9 (+), 43.4 (+), 42.9 (+); IR (/cm-1): 3600 – 3400, 2984, 2938, 
2867, 1720, 1613, 1587, 1511, 1462, 1416, 1335, 1306, 1245, 1200, 1170, 1126, 1062, 1034, 
939, 898, 866, 827, 712; HRMS (ESI) m/z calculated for C18H18NaO4 [MNa
+]: 321.1097, 
found: 321.1093. 
 
6a-(furan-2-yl(hydroxy)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170k): 
 
According to general procedure 6 (±)-165k (242 mg, 1.00 mmol), 2 M NaOH (0.6 mL, 
1.20 mmol) and H2O2 (0.55 mL, 30% in water, 5.40 mmol) were used and stirred for 30 min to 
afford a yellowish oil (251 mg, 0.97 mmol, 97%): Rf = 0.50 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.38 (dd, J = 1.8, 0.8 Hz, 1H), 6.36 (dd, J = 3.3, 1.8 Hz, 1H), 
6.34 – 6.31 (m, 1H), 5.85 (dd, J = 5.7, 2.8 Hz, 1H), 5.74 (dd, J = 5.7, 2.8 Hz, 1H), 4.83 (s, 1H), 
3.68 (d, J = 1.6 Hz, 1H), 3.22 – 3.17 (m, 1H), 3.09 – 3.04 (m, 1H), 3.04 – 2.99 (m, 1H), 
2.89 – 2.83 (m, 1H), 1.57 (dt, J = 8.6, 1.7 Hz, 1H), 1.45 – 1.40 (m, 1H); 13C NMR (75 MHz, 
CDCl3) δC = 210.5 (Cq), 151.9 (Cq), 142.1 (+), 134.5 (+), 133.2 (+), 110.6 (+), 108.0 (+), 66.5 
(Cq), 65.7 (+), 64.9 (+), 51.7 (-), 50.9 (+), 45.8 (+), 43.5 (+), 43.3 (+); IR (/cm
-1): 3600 – 3300, 
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2970, 2937, 2870, 1734, 1502, 1421, 1374, 1338, 1230, 1145, 1126, 1011, 912, 831, 729, 715; 
HRMS (ESI) m/z calculated for C15H15O4 [MH
+]: 259.0965, found: 259.0962. 
 
6-(1-Hydroxyethyl)-2H-pyran-2-one ((±)-171a): 
 
Following general procedure 1 (±)-170a (1.65 g, 8.00 mmol) was used to give rise to a brownish 
oil (1.10 g, 7.84 mmol, 98%): Rf = 0.29 (PE/EA = 1:1); 1H NMR (300 MHz, CDCl3) δH = 7.34 
(dd, J = 9.4, 6.6 Hz, 1H), 6.29 (dt, J = 6.6, 0.9 Hz, 1H), 6.21 (d, J = 9.4 Hz, 1H), 4.60 
(q, J = 6.6 Hz, 1H), 2.46 – 2.29 (bs, 1H), 1.51 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 167.7 (Cq), 162.3 (Cq), 144.0 (+), 114.2 (+), 100.6 (+), 66.7 (+), 21.4 (+); IR (/cm-1): 
3500 – 3200, 2982, 2932, 1698, 1630, 1558, 1453, 1409, 1366, 1309, 1214, 1093, 1015, 976, 
906, 858, 804; HRMS (EI) m/z calculated for C7H9O3 [MH
+]: 141.0546, found: 141.0547. 
 
6-(1-Hydroxypropyl)-2H-pyran-2-one ((±)-171b): 
 
Following general procedure 1 (±)-170b (1.76 g, 8.00 mmol) was used to give rise to a 
brownish oil (1.13 g, 7.36 mmol, 92%): Rf = 0.39 (PE/EA = 1:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.34 (dd, J = 9.4, 6.6 Hz, 1H), 6.28 (d, J = 6.6 Hz, 1H), 6.21 (d, J = 9.4 Hz, 1H), 4.37 (dd, 
J = 7.3, 5.1 Hz, 1H), 2.29 – 2.15 (bs, 1H), 1.98 – 1.69 (m, 2H), 0.98 (t, J = 7.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 166.8 (Cq), 162.4 (Cq), 143.9 (+), 114.1 (+), 101.6 (+), 71.9 
(+), 28.3 (-), 9.4 (+); IR (/cm-1): 3500 – 3200, 2968, 2934, 2878, 1707, 1631, 1557, 1462, 
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1412, 1313, 1210, 1094, 1050, 995, 808, 633; HRMS (EI) m/z calculated for C8H11O3 [MH
+]: 
155.0703, found: 155.0704. 
 
6-(1-Hydroxy-2-methylpropyl)-2H-pyran-2-one ((±)-171c): 
 
Following general procedure 1 (±)-170c (117 mg, 0.50 mmol) was used to give rise to a 
brownish oil (81 mg, 0.48 mmol, 96%): Rf = 0.44 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.33 (dd, J = 9.4, 6.6 Hz, 1H), 6.27 (dt, J = 6.6, 0.8 Hz, 1H), 6.19 (dd, J = 9.4, 0.5 Hz, 1H), 
4.18 (d, J = 5.4 Hz, 1H), 2.54 – 2.38 (bs, 1H), 2.22 – 2.06 (m, 1H), 0.97 (d, J = 6.9 Hz, 3H), 
0.93 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 166.3 (Cq), 162.1 (Cq), 143.6 (+), 
114.1 (+), 102.3 (+), 75.8 (+), 32.3 (+), 19.0 (+), 16.6 (+); IR (/cm-1): 3500 – 3200, 2963, 
2930, 2875, 1708, 1629, 1557, 1467, 1410, 1386, 1368, 1259, 1212, 1177, 1095, 1027, 937, 
900, 869, 804; HRMS (ESI) m/z calculated for C9H13O3 [MH
+]: 169.0859, found: 169.0859. 
 
6-(1-Hydroxybutyl)-2H-pyran-2-one ((±)-171d): 
 
Following general procedure 1 (±)-170d (117 mg, 0.50 mmol) was used to give rise to a 
brownish oil (77 mg, 0.49 mmol, 92%): Rf = 0.27 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.33 (dd, J = 9.4, 6.6 Hz, 1H), 6.28 (d, J = 6.6 Hz, 1H), 6.19 (d, J = 9.3 Hz, 1H), 4.41 (dd, 
J = 8.0, 4.8 Hz, 1H), 2.83 – 2.50 (bs, 1H), 1.86 – 1.65 (m, 2H), 1.53 – 1.34 (m, 2H), 0.94 (t, 
J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 167.1 (Cq), 162.2 (Cq), 143.7 (+), 114.2 (+), 
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101.3 (+), 70.7 (+), 37.4 (-), 18.4 (-), 13.8 (+); IR (/cm-1): 3500 – 3200, 2961, 2935, 2873, 
1704, 1630, 1556, 1465, 1413, 1380, 1315, 1259, 1209, 1094, 1035, 864, 806; HRMS (EI) m/z 
calculated for C9H13O3 [MH
+]: 169.0859, found: 169.0858. 
 
6-(1-Hydroxypentyl)-2H-pyran-2-one ((±)-171e): 
 
Following general procedure 1 (±)-170e (1.99 g, 8.00 mmol) was used to give rise to a brownish 
oil (1.33 g, 7.28 mmol, 91%): Rf = 0.35 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.34 
(dd, J = 9.4, 6.6 Hz, 1H), 6.27 (d, J = 6.6 Hz, 1H), 6.21 (d, J = 9.3 Hz, 1H), 4.41 (dd, J = 7.9, 
4.8 Hz, 1H), 2.19 – 2.06 (bs, 1H), 1.93 – 1.66 (m, 2H), 1.47 – 1.30 (m, 4H), 0.91 (t, J = 7.0 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δC = 167.0 (Cq), 162.2 (Cq), 143.8 (+), 114.2 (+), 101.3 (+), 
70.9 (+), 35.0 (-), 27.3 (-), 22.4 (-), 14.0 (+); IR (/cm-1): 3500 – 3200, 2960, 2936, 2863, 1703, 
1633, 1558, 1461, 1409, 1316, 1264, 1208, 1092, 1044, 865, 805; HRMS (EI) m/z calculated 
for C10H15O3 [MH
+]: 183.1016, found: 183.1019. 
 
6-(1-Hydroxyheptyl)-2H-pyran-2-one ((±)-171f): 
 
Following general procedure 1 (±)-170f (2.21 g, 8.00 mmol) was used to give rise to a brownish 
oil (1.51 g, 7.19 mmol, 90%): Rf = 0.47 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.33 
(dd, J = 9.4, 6.6 Hz, 1H), 6.27 (d, J = 6.6 Hz, 1H), 6.19 (d, J = 9.4, 1H), 4.40 (dd, J = 7.9, 4.8 
Hz, 1H), 2.94 – 2.72 (s, 1H), 1.91 – 1.63 (m, 2H), 1.42 – 1.21 (m, 8H), 0.86 (t, J = 6.7 Hz, 3H); 
E Experimental  
133 
 
13C NMR (75 MHz, CDCl3) δC = 167.0 (Cq), 162.2 (Cq), 143.8 (+), 114.2 (+), 101.3 (+), 70.9 
(+), 35.3 (-), 31.7 (-), 29.0 (-), 25.1 (-), 22.6 (-), 14.1 (+); IR (/cm-1): 3500 – 3200, 2926, 2859, 
1703, 1633, 1558, 1461, 1409, 1316, 1211, 1092, 1047, 913, 865, 805; HRMS (ESI) m/z 
calculated for C12H19O3 [MH
+]: 211.1329, found: 211.1334. 
 
6-(Hydroxy(phenyl)methyl)-2H-pyran-2-one ((±)-171g): 
 
Following general procedure 1 (±)-170g (2.15 g, 8.00 mmol) was used to give rise to an orange 
solid (1.59 g, 7.85 mmol, 98%): mp 78.4 – 79.8 °C; Rf = 0.19 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.47 – 7.30 (m, 6H), 6.33 (dt, J = 6.6, 1.0 Hz, 1H), 
6.23 – 6.15 (m, 1H), 5.50 (s, 1H), 2.65 – 2.45 (bs, 1H); 13C NMR (75 MHz, CDCl3) δC = 165.5 
(Cq), 161.8 (Cq), 143.5 (+), 139.1 (Cq), 128.9 (+), 126.9 (+), 114.5 (+), 101.7 (+), 73.0 (+); 
IR (/cm-1): 3400 – 3200, 1687, 1630, 1557, 1491, 1454, 1423, 1329, 1258, 1213, 1099, 1033, 
903, 796, 750, 707; HRMS (EI) m/z calculated for C12H11O3 [MH
+]: 203.0703, found: 
203.0700. 
 
6-((4-Chlorophenyl)(hydroxy)methyl)-2H-pyran-2-one ((±)-171h): 
 
Following general procedure 1 (±)-170h (151 mg, 0.50 mmol) was used to give rise to an 
orange solid (114 mg, 0.48 mmol, 97%): mp 98.6 – 101.7 °C; Rf = 0.39 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.33 – 7.24 (m, 5H), 6.26 (dt, J = 6.6, 0.9 Hz, 1H), 6.18 – 6.12 
E Experimental  
134 
 
(m, 1H), 5.43 (s, 1H), 3.24 – 2.54 (bs, 1H); 13C NMR (75 MHz, CDCl3) δC = 165.0 (Cq), 161.7 
(Cq), 143.6 (+), 137.5 (Cq), 134.7 (Cq), 129.0 (+), 128.2 (+), 114.7 (+), 101.8 (+), 72.2 (+); 
IR (/cm-1): 3400 – 3200, 2865, 1695, 1625, 1554, 1483, 1408, 1271, 1237, 1191, 1086, 1013, 
885, 868, 846, 798, 782; HRMS (ESI) m/z calculated for C12H10ClO3 [MH
+]: 237.0313, found: 
237.0313. 
 
6-(Hydroxy(4-nitrophenyl)methyl)-2H-pyran-2-one ((±)-171i): 
 
Following general procedure 1 (±)-170i (157 mg, 0.50 mmol) was used to give rise to an orange 
solid (109 mg, 0.43 mmol, 88%): mp 118.4 – 120.7 °C; Rf = 0.33 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 8.27 – 8.21 (m, 2H), 7.69 – 7.62 (m, 2H), 7.34 (dd, J = 9.4, 
6.6 Hz, 1H), 6.33 (dt, J = 6.6, 0.8 Hz, 1H), 6.22 (d, J = 9.4 Hz, 1H), 5.62 (s, 1H), 3.22 – 2.72 
(bs, 1H); 13C NMR (75 MHz, CDCl3) δC = 163.9 (Cq), 161.3 (Cq), 148.1 (Cq), 145.8 (Cq), 143.4 
(+), 127.7 (+), 124.0 (+), 115.3 (+), 102.0 (+), 72.0 (+); IR (/cm-1): 3500 – 3300, 3107, 3076, 
1716, 1632, 1600, 1556, 1515, 1409, 1344, 1289, 1232, 1213, 1197, 1097, 1064, 1037, 986, 
907, 856, 821, 801, 740; HRMS (ESI) m/z calculated for C12H10NO5 [MH
+]: 248.0553, found: 
248.0556. 
 
6-(Hydroxy(4-methoxyphenyl)methyl)-2H-pyran-2-one ((±)-171j): 
 
Following general procedure 1 (±)-170j (149 mg, 0.50 mmol) was used to give rise to an orange 
solid (114 mg, 0.49 mmol, 98%): mp 109.6 – 111.4 °C; Rf = 0.31 (PE/EA = 1:1); 
E Experimental  
135 
 
1H NMR (300 MHz, CDCl3) δH = 7.37 – 7.30 (m, 3H), 6.94 – 6.87 (m, 2H), 6.33 (dt, J = 6.6, 
0.9 Hz, 1H), 6.19 (d, J = 9.3 Hz, 1H), 5.45 (s, 1H), 3.81 (s, 3H), 2.05 – 1.69 (bs, 1H); 
13C NMR (75 MHz, CDCl3) δC = 165.7 (Cq), 161.8 (Cq), 160.0 (Cq), 143.5 (+), 131.3 (Cq), 
128.3 (+), 114.4 (+), 114.3 (+), 101.4 (+), 72.6 (+), 55.4 (+); IR (/cm-1): 3500 – 3300, 3080, 
2963, 1690, 1626, 1553, 1509, 1410, 1306, 1287, 1249, 1228, 1173, 1098, 1066, 1022, 876, 
839, 792; HRMS (ESI) m/z calculated for C13H13O4 [MH
+]: 233.0808, found: 233.0808. 
 
6-(Furan-2-yl(hydroxy)methyl)-2H-pyran-2-one ((±)-171k): 
 
Following general procedure 1 (±)-170k (129 mg, 0.50 mmol) was used to give rise to a yellow 
oil (59 mg, 0.31 mmol, 62%) after purification via flash chromatography (silica, PE/EA = 2:1): 
Rf = 0.21 (PE/EA = 2:1); 1H NMR (400 MHz, CDCl3) δH = 7.42 (dd, J = 1.7, 0.7 Hz, 1H), 7.36 
(dd, J = 9.4, 6.6 Hz, 1H), 6.43 – 6.37 (m, 3H), 6.25 (d, J = 9.4 Hz, 1H), 5.53 (s, 1H), 2.03 – 1.64 
(bs, 1H); 13C NMR (101 MHz, CDCl3) δC = 162.6 (Cq), 161.4 (Cq), 151.2 (Cq), 143.4 (+), 143.3 
(+), 115.2 (+), 110.8 (+), 109.1 (+), 102.3 (+), 67.0 (+); IR (/cm-1): 3500 – 3200, 1700, 1633, 
1558, 1521, 1409, 1208, 1148, 1092, 1062, 883, 809, 738; HRMS (ESI) m/z calculated for 
C10H9O4 [MH
+]: 193.0495, found: 193.0496. 
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(R)-1-(2-Oxo-2H-pyran-6-yl)ethyl acetate (174): 
 
(S)-6-(1-Hydroxyethyl)-2H-pyran-2-one (171a): 
 
To a solution of (±)-171a (140 mg, 1.0 mmol) in abs. toluene (8 mL) Novozym 435 (200 mg, 
immobilized on acrylic resin), molecular sieves 4 Å (1.00 g), and isopropenyl acetate (0.44 mL, 
4.0 mmol) were added. The reaction mixture was stirred at 40 °C for 18 h. After filtration and 
evaporation of the solvent the products were separated via flash chromatography (silica, PE/EA 
= 1:1) to yield (R)-174 (81 mg, 0.45 mmol, 45%) as a colorless oil and (S)-171a 
(53 mg, 0.38 mmol, 38%) as a brownish oil: 
 
(R)-174: Rf = 0.50 (PE/EA = 1:1); 1H NMR (300 MHz, CDCl3) δH = 7.29 (dd, J = 9.4, 6.6 Hz, 
1H), 6.23 (d, J = 9.0 Hz, 1H), 6.20 – 6.16 (m, 1H), 5.55 (q, J = 6.7 Hz, 1H), 2.09 (s, 3H), 1.52 
(d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 169.8 (Cq), 162.7 (Cq), 161.5 (Cq), 143.2 
(+), 115.4 (+), 102.2 (+), 68.2 (+), 21.0 (+), 18.3 (+); IR (/cm-1): 3092, 2993, 2940, 1727, 
1640, 1561, 1370, 1321, 1227, 1085, 1066, 1043, 943, 868, 801, 726, 610, 542, 442; 
HRMS (APCI) m/z calculated for C9H11O4 [MH
+]: 183.0652, found: 183.0656; 
Chiral HPLC 84% ee (tR major, minor = 42.1, 69.5 min, Chiralpak AS-H 4.6 x 250 mm 
10 μm, n-heptane:i-PrOH 90:10, 0.5 mL/min); [α]D
25 = -142.1 (c = 1.0, CHCl3). 
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(S)-171a: Chiral HPLC >99% ee (tR major, minor = 46.9, 52.0 min, Chiralpak AS-H 
4.6 x 250 mm 10 μm, n-heptane:i-PrOH 90:10, 0.5 mL/min); [α]D
25 = +52.6 (c = 1.0, CHCl3). 
 
(S)-1-(2-Oxo-2H-pyran-6-yl)ethyl 4-nitrobenzoate (175): 
 
To a solution of (S)-171a >99% ee (70 mg, 0.50 mmol) and Et3N (0.1 mL, 0.7 mmol) in DCM 
(2 mL) a solution of 4-nitrobenzoyl chloride (111 mg, 0.60 mmol) in DCM (2 mL) was added. 
The reaction mixture was stirred at room temperature for 15 h and the product was purified via 
flash chromatography (silica, PE/EA = 2:1) to yield (S)-175 (116 mg, 0.40 mmol, 80%) as a 
white solid: mp 162.3 – 164.1 °C; Rf = 0.40 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.34 – 8.28 (m, 2H), 8.28 – 8.19 (m, 2H), 7.33 (dd, J = 9.4, 6.6 Hz, 1H), 6.33 – 6.30 (m, 
1H), 6.30 – 6.26 (m, 1H), 5.86 (q, J = 6.7 Hz, 1H), 1.72 (d, J = 6.7 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 163.6 (Cq), 161.6 (Cq), 161.3 (Cq), 150.8 (Cq), 143.0 (+), 
134.8 (Cq), 131.0 (+), 123.7 (+), 116.0 (+), 102.9 (+), 69.8 (+), 18.2 (+); IR (/cm-1): 3116, 
2986, 2941, 2863, 1715, 1636, 1607, 1558, 1525, 1346, 1312, 1267, 1103, 1015, 891, 839, 805, 
716; HRMS (CI) m/z calculated for C14H12NO6 [MH
+]: 290.06591, found: 290.06596; 
Chiral HPLC >99% ee (tR major, minor = 29.0, 36.4 min, Chiralpak AS-H 4.6 x 250 mm 
10 μm, n-heptane:i-PrOH 50:50, 0.5 mL/min); [α]D
25 = -65.9 (c = 1.0, CHCl3). 
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1-(2-Oxo-2H-pyran-6-yl)pentyl acetate ((±)-179): 
 
To a solution of (±)-171e (1.09 g, 6.00 mmol) in DCM (40 mL) Et3N (4.2 mL, 30.0 mmol), and 
Ac2O (2.8 mL, 30.0 mmol) were added. The reaction mixture was stirred at room temperature 
for 18 h. The solvent was evaporated and the product was purified via flash chromatography 
(silica, PE/EA = 3:1) to yield (±)-179 (1.28 g, 5.70 mmol, 95%) as a yellowish oil: Rf = 0.62 
(PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.24 (dd, J = 9.4, 6.5 Hz, 1H), 6.17 (dd, 
J = 9.4, 0.9 Hz, 1H), 6.11 (d, J = 6.5 Hz, 1H), 5.41 – 5.34 (m, 1H), 2.05 (s, 3H), 1.89 – 1.74 (m, 
2H), 1.35 – 1.15 (m, 4H), 0.83 (t, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 170.0 (Cq), 
162.1 (Cq), 161.6 (Cq), 143.1 (+), 115.3 (+), 102.9 (+), 71.9 (+), 31.9 (-), 27.1 (-), 22.3 (-), 20.9 
(+), 13.9 (+); IR (/cm-1): 2958, 2934, 2873, 1730, 1639, 1561, 1371, 1221, 1092, 1022, 803; 
HRMS (ESI) m/z calculated for C12H17O4 [MH
+]: 225.1121, found: 225.1116. 
 
(S)-1-(2-Oxo-2H-pyran-6-yl)pentyl acetate (179): 
 
(R)-6-(1-Hydroxypentyl)-2H-pyran-2-one (171e): 
 
To a solution of (±)-179 (224 mg, 1.0 mmol) in acetone (5 mL), phosphate buffer (25 mL, 
50 mM, pH 8), and Amano lipase from Burkholderia cepacia (200 mg) were added and the 
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reaction mixture was stirred at 25 °C for 7 d. After filtration, the mixture was extracted with 
DCM (3x) and dried over MgSO4. The products were separated via flash chromatography 
(silica, PE/EA = 2:1) to yield (S)-179 (87 mg, 0.39 mmol, 39%) as a yellowish oil and (R)-171e 
(80 mg, 0.44 mmol, 44%) as a brownish oil: 
 
(S)-179: Chiral HPLC >99% ee (tR major, minor = 28.9, 37.1 min, Chiralpak AS-H 
4.6 x 250 mm 10 μm, n-heptane:i-PrOH 90:10, 0.5 mL/min); [α]D
25  +127.3 (c = 1.0, CHCl3). 
 
(R)-171e: Chiral HPLC 75% ee (tR major, minor = 33.4, 40.2 min, Chiralpak AS-H 
4.6 x 250 mm 10 μm, n-heptane:i-PrOH 90:10, 0.5 mL/min); [α]D
25 –62.2 (c = 1.0, CHCl3). 
 
(2-Oxo-2H-pyran-6-yl)(phenyl)methyl acetate ((±)-180): 
 
To a solution of (±)-171g (404 mg, 2.00 mmol) in DCM (12 mL) Et3N (1.4 mL, 10.0 mmol), 
and Ac2O (1.0 mL, 10.0 mmol) were added. The reaction mixture was stirred at room 
temperature for 18 h. The solvent was evaporated and the product was purified via flash 
chromatography (silica, PE/EA = 2:1) to yield (±)-180 (441 mg, 1.81 mmol, 90%) as a 
brownish oil: Rf = 0.45 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.48 – 7.36 (m, 5H), 
7.29 (dd, J = 9.3, 6.6 Hz, 1H), 6.48 (s, 1H), 6.25 – 6.19 (m, 2H), 2.18 (s, 3H); 
13C NMR (75 MHz, CDCl3) δC = 169.4 (Cq), 161.6 (Cq), 161.3 (Cq), 142.9 (+), 135.4 (Cq), 
129.2 (+), 128.9 (+), 127.5 (+), 115.5 (+), 103.0 (+), 73.3 (+), 21.0 (+); IR (/cm-1): 3090, 3035, 
1726, 1638, 1558, 1496, 1455, 1371, 1218, 1094, 1024, 800, 744, 698, 604, 581, 527; 
HRMS (APCI) m/z calculated for C14H13O4 [MH
+]: 245.0808, found: 245.0808. 
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tert-Butyl (1-(2-oxo-2H-pyran-6-yl)pentyl) carbonate ((±)-190) 
 
Under nitrogen atmosphere (±)-171e (547 mg, 3.00 mmol) was dissolved in dry THF and 
Boc2O (786 mg, 3.60 mmol), Et3N (0.5 mL, 3.60 mmol) and DMAP (6 mg, 0.05 mmol) were 
added. The reaction mixture was stirred for 20 h at room temperature, the solvent was 
evaporated and the crude product was purified via flash chromatography (silica, PE/EA = 5:1) 
to yield (±)-190 (784 mg, 2.78 mmol, 93%) as a yellowish oil: Rf = 0.40 (PE/EA = 5:1); 
1H NMR (300 MHz, CDCl3) δH = 7.30 (dd, J = 9.4, 6.6 Hz, 1H), 6.28 – 6.15 (m, 2H), 5.25 (dd, 
J = 7.6, 5.6 Hz, 1H), 1.99 – 1.80 (m, 2H), 1.49 (s, 9H), 1.38 – 1.27 (m, 4H), 0.89 (t, J = 7.0 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δC = 162.7 (Cq), 161.5 (Cq), 152.6 (Cq), 143.1 (+), 115.1 (+), 
102.2 (+), 83.2 (Cq), 74.6 (+), 32.3 (-), 27.7 (+), 27.0 (-), 22.3 (-), 13.9 (+); IR (/cm
-1): 2960, 
2934, 2873, 1733, 1640, 1560, 1459, 1370, 1272, 1253, 1158, 1089, 863, 803, 539; 
HRMS (APCI) m/z calculated for C15H23O5 [MH
+]: 283.1540, found: 283.1540. 
 
6-Acetyl-2H-pyran-2-one ((±)-195a) 
 
Following general procedure 8 (±)-171a (114 mg, 1.0 mmol) was used to give rise to a white 
solid (96 mg, 0.70 mmol, 70%): mp 107.5 – 108.3 °C; Rf = 0.27 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.46 (dd, J = 9.4, 6.6 Hz, 1H), 7.01 (dd, J = 6.6, 1.0 Hz, 1H), 
6.57 (dd, J = 9.4, 1.0 Hz, 1H), 2.54 (s, 3H); 13C NMR (75 MHz, CDCl3) δC = 191.5 (Cq), 
159.8 (Cq), 155.1 (Cq), 142.2 (+), 121.2 (+), 106.4 (+), 25.9 (+);IR (/cm
-1): 3078, 3059, 2942, 
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1720, 1682, 1628, 1368, 1343, 1257, 1096, 1038, 988, 954, 818, 693, 597, 556, 503, 439; 
HRMS (APCI) m/z calculated for C7H7O3 [MH
+]: 139.0390, found: 139.0394. 
 
6-Pentanoyl-2H-pyran-2-one ((±)-195b) 
 
Following general procedure 8 (±)-171e (182 mg, 1.0 mmol) was used to give rise to a white 
solid (121 mg, 0.67 mmol, 67%): mp 70.5 – 70.8 °C; Rf = 0.56 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.45 (dd, J = 9.4, 6.6 Hz, 1H), 7.00 (dd, J = 6.6, 1.0 Hz, 1H), 
6.56 (dd, J = 9.4, 1.0 Hz, 1H), 2.91 (t, J = 7.3 Hz, 2H), 1.71 – 1.61 (m, 2H), 1.44 – 1.33 (m, 
2H), 0.94 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 194.0 (Cq), 159.9 (Cq), 
155.3 (Cq), 142.3 (+), 121.0 (+), 106.2 (+), 37.8 (-), 25.2 (-), 22.2 (-), 13.9 (+); IR (/cm
-1): 
3114, 3080, 3060, 2953, 2932, 2873, 1719, 1689, 1631, 1404, 1383, 1337, 1273, 1218, 1108, 
1055, 1009, 953, 846, 820, 799, 732, 644, 573, 505, 459; HRMS (APCI) m/z calculated for 
C10H13O3 [MH
+]: 181.0859, found: 181.0861. 
 
6-Benzoyl-2H-pyran-2-one ((±)-195c) 
 
Following general procedure 8 (±)-171g (202 mg, 1.0 mmol) was used to give rise to a white 
solid (147 mg, 0.73 mmol, 73%): mp 113.1 – 115.4 °C; Rf = 0.40 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 8.04 – 7.93 (m, 2H), 7.67 – 7.59 (m, 1H), 7.55 – 7.47 (m, 
3H), 7.04 (dd, J = 6.6, 1.0 Hz, 1H), 6.59 (dd, J = 9.4, 1.0 Hz, 1H); 13C NMR (75 MHz, CDCl3) 
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δC = 185.7 (Cq), 159.7 (Cq), 156.3 (Cq), 142.3 (+), 134.8 (Cq), 133.9 (+), 130.1 (+), 128.7 (+), 
120.5 (+), 109.9 (+); IR (/cm-1): 3120, 3088, 3063, 1729, 1649, 1596, 1577, 1448, 1344, 1325, 
1273, 1185, 1100, 1003, 934, 812, 726, 699, 685, 596, 549; HRMS (APCI) m/z calculated for 
C12H9O3 [MH
+]: 201.0546, found: 201.0549. 
 
1-(Furan-2-yl)ethan-1-ol ((±)-199):144 
 
To a solution of 198 (50.0 g, 454 mmol) in ethanol (400 mL) NaBH4 (8.6 g, 227 mmol) was 
added over a period of 1 h and stirred for 2 h at room temperature. Acetone (75 mL) was slowly 
added, and the mixture was stirred for additional 30 min. Subsequently, water (200 mL) was 
added to the solution, and the organic solvent was evaporated under reduced pressure. The 
remaining aqueous phase was extracted with ethyl acetate (5x), and the combined organic layers 
were washed with brine (1x) and dried over Na2SO4. The crude was distilled under reduced 
pressure to afford a yellowish oil (41.1 g, 366 mmol, 81%): 1H NMR (300 MHz, CDCl3) 
δH = 7.36 (dd, J = 1.8, 0.8 Hz, 1H), 6.32 (dd, J = 3.2, 1.8 Hz, 1H), 6.24 – 6.19 (m, 1H), 4.86 (q, 
J = 6.6 Hz, 1H), 2.30 – 2.10 (bs, 1H), 1.53 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 157.6 (Cq), 141.9 (+), 110.1 (+), 105.1 (+), 63.6 (+), 21.3 (+). 
 
4-Hydroxy-5-methylcyclopent-2-en-1-one ((±)-200):145 
 
A solution of (±)-199 (16.8 g, 150 mmol) in toluene (45 mL, flowrate: 0.3 mL/min) was mixed 
with acidulated water pH 4 (630 mL, flowrate: 3.5 mL/min) in a microreactor setup (stainless 
steel capillary tube, heated zone: 10 m x 1.0 mm) at 240 °C. The solvent was evaporated and 
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the crude product was distilled under reduced pressure to afford a yellowish oil 
(12.2 g, 109 mmol, 71%): 1H NMR (300 MHz, CDCl3) δH = 7.50 (dd, J = 5.8, 2.1 Hz, 1H), 
6.22 (dd, J = 5.8, 1.2 Hz, 1H), 4.60 – 4.55 (m, 1H), 2.27 (qd, J = 7.5, 2.6 Hz, 1H), 2.13 – 1.92 
(bs, 1H), 1.26 (d, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 208.0 (Cq), 161.3 (+), 
134.1 (+), 78.4 (+), 50.5 (+), 12.6 (+). 
 
4-Hydroxy-2-methylcyclopent-2-en-1-one ((±)-201):145 
 
Adsorption of (±)-200 (5.61 g, 50.0 mmol) on alumina (200 g, Brockman grade III) for 24 h 
and elution with benzene/diethyl ether 4:1 yielded pure (±)-201 (5.10 g, 45.5 mmol) as a 
yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.17 – 7.12 (m, 1H), 4.94 – 4.81 (m, 1H), 2.73 
(dd, J = 18.6, 6.0 Hz, 1H), 2.64 – 2.50 (bs, 1H), 2.23 (dd, J = 18.6, 1.9 Hz, 1H), 1.73 
(t, J = 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 206.9 (Cq), 157.1 (+), 143.6 (Cq), 68.4 
(+), 44.5 (-), 10.0 (+). 
 
3-Methyl-4-oxocyclopent-2-en-1-yl acetate ((±)-202):145 
 
According to general procedure 4 (±)-201 (2.24 g, 20.0 mmol) was used to afford a yellowish 
oil (2.48 g, 16.1 mmol, 81%): 1H NMR (300 MHz, CDCl3) δH = 7.17 – 7.05 (m, 1H), 
5.74 – 5.56 (m, 1H), 2.82 – 2.71 (m, 1H), 2.30 – 2.21 (m, 1H), 2.02 – 1.97 (m, 3H), 1.77 – 1.72 
(m, 3H); 13C NMR (75 MHz, CDCl3) δC = 205.0 (Cq), 170.5 (Cq), 152.5 (+), 145.5 (Cq), 70.3 
(+), 41.1 (-), 20.9 (+), 10.0 (+). 
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2-(1-((Trimethylsilyl)oxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-204): 
 
Under nitrogen atmosphere (±)-165a (4.76 g, 25.0 mmol) was dissolved in DCM (100 mL) 
TMSCl (4.13 mL, 32.5 mmol) and Et3N (4.51 mL, 32.5 mmol) were added at 0 °C. The 
reaction mixture was stirred for 1 h at the same temperature and quenched with water (25 mL). 
The water phase was extracted with DCM (3x) and the organic phase was dried over MgSO4. 
The crude product was purified via flash chromatography (silica, PE/EA = 20:1) yielding a 
colorless oil (5.88 g, 22.4 mmol, 90%): Rf = 0.42 (PE/EA = 20:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.25 – 7.13 (m, 1H), 5.88 (dd, J = 5.6, 2.9 Hz, 1H), 5.74 (dd, J = 5.6, 3.0 Hz, 1H), 4.39 
(qt, J = 6.4, 1.3 Hz, 1H), 3.30 – 3.23 (m, 1H), 3.23 – 3.17 (m, 1H), 2.98 – 2.92 (m, 1H), 2.86 
(t, J = 5.1 Hz, 1H), 1.74 (dt, J = 8.4, 1.7 Hz, 1H), 1.63 – 1.58 (m, 1H), 1.22 (d, J = 6.5 Hz, 3H), 
0.07 (s, 9H); 13C NMR (75 MHz, CDCl3) δC = 208.8 (Cq), 157.5 (+), 154.0 (Cq), 132.9 (+), 
132.4 (+), 63.9 (+), 52.9 (-), 52.2 (+), 45.4 (+), 45.1 (+), 44.2 (+), 23.8 (+), 0.0 (+); IR (/cm-1): 
3064, 2960, 2870, 1696, 1629, 1450, 1372, 1338, 1252, 1204, 1100, 1051, 985, 910, 835, 738; 
HRMS (CI) m/z calculated for C15H23O2Si [MH
+]: 263.14618, found: 263.14658. 
 
7a-Methyl-2-(1-((trimethylsilyl)oxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-
one ((±)-205): 
 
Under nitrogen atmosphere diisopropylamine (3.16 mL, 22.5 mmol) was dissolved in dry THF 
(30 mL) at -78 °C n-BuLi (10.9 mL, 2.7 M in toluene, 21.0  mmol) was added and the mixture 
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was stirred for 10 min. To the solution (±)-204 (3.94 g, 15.0 mmol) in dry THF (30 mL) was 
added slowly and stirred for 45 min. Then MeI (4.67 mL, 75.0 mmol) was added and stirred for 
30 min. The reaction was quenched slowly with 1 M HCl (25 mL). The water phase was 
extracted with ethyl acetate (3x), the organic phase was washed with brine (1x) and dried over 
MgSO4. The crude was purified via flash chromatography (silica, PE/EA = 20:1) yielding a 
colorless oil (2.22 g, 8.02 mmol, 53%): Rf = 0.40 (PE/EA = 20:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.14 (dd, J = 2.7, 1.5 Hz, 1H), 5.96 (dd, J = 5.6, 3.0 Hz, 1H), 5.68 (dd, J = 5.6, 2.9 Hz, 
1H), 4.42 (qt, J = 6.4, 1.3 Hz, 1H), 2.97 – 2.92 (m, 1H), 2.87 – 2.82 (m, 1H), 2.68 (s, 1H), 
1.89 – 1.83 (m, 1H), 1.75 (dt, J = 8.7, 1.7 Hz, 1H), 1.28 (s, 3H), 1.22 (d, J = 6.5 Hz, 3H), 0.07 
(s, 9H); 13C NMR (75 MHz, CDCl3) δC = 211.3 (Cq), 155.9 (+), 152.0 (Cq), 134.7 (+), 133.0 
(+), 63.8 (+), 56.1 (Cq), 53.6 (+), 51.1 (-), 50.3 (+), 45.2 (+), 23.6 (+), 21.0 (+), 0.0 (+); 
IR (/cm-1): 3064, 2960, 2900, 2870, 1700, 1633, 1454, 1372, 1252, 1185, 1159, 1100, 1044, 
947, 835, 731, 671; HRMS (CI) m/z calculated for C16H25O2Si [MH
+]: 277.16183, found: 
277.16124. 
 
6a-(1-Hydroxyethyl)-5a-methyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-197): 
 
To a solution of (±)-205 (1.11 g, 4.00 mmol) in DCM/MeOH 1:1 (20 mL) 2 M NaOH (2.4 mL, 
4.80 mmol), and H2O2 (30% in water, 2.2 mL, 21.6 mmol) were added and the reaction mixture 
was stirred for 1 h at room temperature. The reaction mixture was poured into DCM (120 mL) 
and washed with brine (1x). The organic layer was dried over MgSO4 and concentrated under 
vacuum to yield pure (±)-197 (876 mg, 3.98 mmol 100%) as a colorless oil: Rf = 0.35 
(PE/EA = 5:1); 1H NMR (300 MHz, CDCl3) δH = 6.02 (dd, J = 5.4, 2.8 Hz, 1H), 5.99 (dd, 
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J = 5.2, 2.8 Hz, 1H), 4.06 – 3.74 (m, 1H), 3.57 (s, 1H), 3.01 – 2.93 (m, 1H), 2.77 – 2.66 (m, 
1H), 2.51 (d, J = 4.0 Hz, 1H), 2.06 (d, J = 8.0 Hz, 1H), 1.67 – 1.61 (m, 1H), 1.60 – 1.57 (m, 
1H), 1.25 (s, 3H), 1.23 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 213.6 (Cq), 135.8 
(+), 133.7 (+), 77.2 (Cq), 68.7 (Cq), 64.3 (+), 64.1 (+), 56.0 (Cq), 52.0 (+), 50.0 (-), 44.2 (+), 
23.6 (+), 19.2 (+); IR (/cm-1): 3700 – 3300, 3064, 2971, 2874, 1730, 1454, 1416, 1372, 1334, 
1297, 1249, 1118, 1033, 958, 887, 753, 716; HRMS (ESI) m/z calculated for C13H16O3 [MH
+]: 
221.1172, found: 221.1179. 
 
6-(1-Hydroxyethyl)-3-methyl-2H-pyran-2-one ((±)-196): 
 
Following general procedure 1 (±)-197 (661 mg, 3.00 mmol) was used to afford a colorless oil 
(445 mg, 2.89 mmol, 96%): Rf = 0.29 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 7.13 
(dq, J = 6.6, 1.2 Hz, 1H), 6.18 (d, J = 6.7 Hz, 1H), 4.58 (q, J = 6.6 Hz, 1H), 2.57 – 2.11 (bs, 
1H), 2.08 (s, 3H), 1.49 (d, J = 6.6 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 164.3 (Cq), 163.4 
(Cq), 139.6 (+), 124.1 (Cq), 100.7 (+), 66.7 (+), 21.3 (+), 16.7 (+); IR (/cm
-1): 3600 – 3200, 
2982, 2930, 1689, 1640, 1580, 1454, 1364, 1308, 1163, 1103, 1025, 995, 947, 891, 828, 760, 
727; HRMS (CI) m/z calculated for C8H11O3 [MH
+]: 155.07027, found: 155.07042. 
 
6-Acetyl-3-methyl-2H-pyran-2-one (3a):104 
 
Following general procedure 8 (±)-196 (154 mg, 1.0 mmol) was used to give rise to a yellowish 
solid (129 mg, 0.85 mmol, 85%): 1H NMR (300 MHz, CDCl3) δH = 7.20 (dq, J = 6.7, 1.3 Hz, 
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1H), 6.91 (d, J = 6.7 Hz, 1H), 2.47 (s, 3H), 2.14 (d, J = 1.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 191.4 (Cq), 161.3 (Cq), 153.3 (Cq), 138.0 (+), 132.0 (Cq), 107.2 (+), 25.9 (+), 17.5 (+). 
 
1-(2-Oxo-2H-pyran-6-yl)propyl 4-methylbenzenesulfonate ((±)-189a): 
 
Following general procedure 9 (±)-171b (154 mg, 1.0 mmol) was used to give rise to a white 
solid (249 mg, 0.81 mmol, 81%): mp 69.7 – 71.1 °C; Rf = 0.43 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.77 – 7.69 (m, 2H), 7.34 – 7.27 (m, 2H), 7.21 (dd, J = 9.3, 
6.7 Hz, 1H), 6.23 – 6.11 (m, 2H), 5.00 (t, J = 6.5 Hz, 1H), 2.41 (s, 3H), 1.90 (qui, J = 7.3 Hz, 
2H), 0.84 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 160.93 (Cq), 160.0 (Cq), 
145.3 (Cq), 142.8 (+), 133.3 (Cq), 129.9 (+), 127.9 (+), 115.6 (+), 104.0 (+), 79.9 (+), 26.3 (-), 
21.7 (+), 9.0 (+); IR (/cm-1): 3097, 2974, 2937, 2881, 1730, 1640, 1595, 1562, 1461, 1409, 
1361, 1215, 1174, 1096, 890, 850; HRMS (ESI) m/z calculated for C15H17O5S [MH
+]: 
309.0791, found: 309.0792. 
 
1-(2-Oxo-2H-pyran-6-yl)pentyl 4-methylbenzenesulfonate ((±)-189b): 
 
Following general procedure 9 (±)-171e (182 mg, 1.0 mmol) was used to give rise to a white 
solid (278 mg, 0.83 mmol, 83%): mp 63.4 – 65.1 °C; Rf = 0.48 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 7.77 – 7.71 (m, 2H), 7.34 – 7.27 (m, 2H), 7.20 (dd, J = 9.2, 
6.8 Hz, 1H), 6.17 – 6.13 (m, 2H), 5.05 (t, J = 6.2 Hz, 1H), 2.43 (s, 3H), 1.92 – 1.80 (m, 2H), 
1.31 – 1.12 (m, 4H), 0.82 (t, J = 7.0 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 160.8 (Cq), 
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160.3 (Cq), 145.2 (Cq), 142.7 (+), 133.4 (Cq), 129.8 (+), 127.9 (+), 115.6 (+), 103.7 (+), 78.8 
(+), 32.8 (-), 26.6 (-), 22.0 (-), 21.7 (+), 13.8 (+); IR (/cm-1): 2960, 2933, 2870, 1737, 1640, 
1599, 1558, 1461, 1405, 1364, 1174, 1092, 1036, 992, 805; HRMS (ESI) m/z calculated for 
C17H21O5S [MH
+]: 337.1104, found: 337.1106. 
 
1-(2-Oxo-2H-pyran-6-yl)heptyl 4-methylbenzenesulfonate ((±)-189c): 
 
Following general procedure 9 (±)-171f (210 mg, 1.0 mmol) was used to give rise to a colorless 
oil (291 mg, 0.80 mmol, 80%): Rf = 0.46 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.77 – 7.71 (m, 2H), 7.34 – 7.28 (m, 2H), 7.21 (dd, J = 9.3, 6.6 Hz, 1H), 6.20 – 6.13 (m, 
2H), 5.04 (t, J = 7.2 Hz, 1H), 2.42 (s, 3H), 1.93 – 1.78 (m, 2H), 1.33 – 1.06 (m, 8H), 0.84 (t, 
J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 161.0 (Cq), 160.4 (Cq), 145.3 (Cq), 142.9 (+), 
133.3 (Cq), 129.8 (+), 127.9 (+), 115.6 (+), 103.8 (+), 78.8 (+), 33.1 (-), 31.5 (-), 28.5 (-), 24.5 
(-), 22.4 (-), 21.7 (+), 14.0 (+); IR (/cm-1): 2930, 2859, 1737, 1640, 1599, 1558, 1461, 1364, 
1174, 1096, 1006, 887, 805; HRMS (ESI) m/z calculated for C19H25O5S [MH
+]: 365.1417, 
found: 365.1411. 
 
(E)-6-(prop-1-en-1-yl)-2H-pyran-2-one (7a):146 
 
Following general procedure 10 (±)-189a (154 mg, 0.50 mmol) was used to give rise to a white 
solid (58 mg, 0.43 mmol, 85%): 1H NMR (300 MHz, CDCl3) δH = 7.22 (dd, J = 9.3, 6.7 Hz, 
1H), 6.62 (dq, J = 14.0, 7.0 Hz, 1H), 6.08 (d, J = 9.3 Hz, 1H), 5.98 – 5.91 (m, 1H), 5.89 (d, 
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J = 6.7 Hz, 1H), 1.83 (dd, J = 7.0, 1.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 162.1 (Cq), 
159.7 (Cq), 143.9 (+), 134.7 (+), 122.9 (+), 113.7 (+), 102.9 (+), 18.5 (+). 
 
(E)-6-(Pent-1-en-1-yl)-2H-pyran-2-one (7b):5 
 
Following general procedure 10 (±)-189b (168 mg, 0.50 mmol) was used to give rise to a 
colorless oil (68 mg, 0.41 mmol, 83%): 1H NMR (300 MHz, CDCl3) δH = 7.23 (dd, J = 9.3, 
6.7 Hz, 1H), 6.63 (dt, J = 15.6, 7.2 Hz, 1H), 6.09 (d, J = 9.2 Hz, 1H), 5.96 – 5.88 (m, 2H), 2.13 
(dq, J = 7.3, 1.5 Hz, 2H), 1.42 (sext, J = 7.4 Hz, 2H), 0.87 (t, J = 7.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 162.1 (Cq), 159.7 (Cq), 143.9 (+), 139.7 (+), 121.7 (+), 113.7 
(+), 103.1 (+), 34.9 (-), 21.9 (-), 13.7 (+). 
 
(E)-6-(Hept-1-en-1-yl)-2H-pyran-2-one (7c):5 
 
Following general procedure 10 (±)-189c (182 mg, 0.50 mmol) was used to give rise to a 
colorless oil (81 mg, 0.42 mmol, 84%): 1H NMR (300 MHz, CDCl3) δH = 7.22 (dd, J = 9.3, 
6.7 Hz, 1H), 6.63 (dt, J = 15.6, 7.2 Hz, 1H), 6.09 (d, J = 9.2 Hz, 1H), 5.96 – 5.87 (m, 2H), 2.14 
(dq, J = 7.3, 1.4 Hz, 2H), 1.44 – 1.33 (m, 2H), 1.31 – 1.15 (m, 4H), 0.82 (t, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 162.1 (Cq), 159.7 (Cq), 143.9 (+), 139.9 (+), 121.5 (+), 113.6 
(+), 103.1 (+), 32.8 (-), 31.3 (-), 28.3 (-), 22.5 (-), 14.0 (+). 
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3-Ethoxy-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-212): 
 
To a solution of (±)-211 (7.00 g, 43.2 mmol) in DCM (70 mL) Et3N (7.80 mL, 56.3 mmol), and 
Et3OBF4 (9.84 g, 51.8 mmol) were added and stirred for 1 h at room temperature. The mixture 
was washed with water (5x), dried over MgSO4 and concentrated under reduced pressure to 
yield pure (±)-212 (7.74 g, 40.7 mmol, 94%) as a yellow solid: mp 63.3 – 64.7 °C; Rf = 0.45 
(PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 5.98 (dd, J = 5.6, 2.9 Hz, 1H), 5.81 (dd, 
J = 5.6, 2.9 Hz, 1H), 5.00 (s, 1H), 3.96 – 3.80 (m, 2H), 3.19 – 3.11 (m, 2H), 3.05 – 2.96 (m, 
1H), 2.89 (dd, J = 6.2, 4.6 Hz, 1H), 1.69 (dt, J = 8.5, 1.6 Hz, 1H), 1.50 – 1.45 (m, 1H), 1.31 (t, 
J = 7.1 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 206.4 (Cq), 189.8 (Cq), 133.9 (+), 131.9 (+), 
107.0 (+), 67.4 (-), 52.1 (-), 50.9 (+), 46.6 (+), 43.8 (+), 43.5 (+), 14.1 (+); IR (/cm-1): 3078, 
3060, 2984, 2952, 2929, 2879, 1663, 1588, 1490, 1443, 1390, 1372, 1339, 1289, 1237, 1222, 
1189, 1130, 1088, 1056, 1021, 985, 834, 779, 732, 655, 600; HRMS (APCI) m/z calculated for 
C12H15O2 [MH
+]: 191.1067, found: 191.1070. 
 
3-Ethyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-213): 
 
Magnesium shavings (194 mg, 8.00 mmol) were suspended in dry Et2O (15 mL) and a catalytic 
amount iodine was added. Bromoethane (0.72 mL; 9.60 mmol) was dissolved in dry Et2O 
(10 mL) and added dropwise to the suspension. When the suspension stopped boiling it was 
refluxed for 1 h and afterwards cooled down to 0 °C. A solution of (±)-212 (4 mmol) in dry 
Et2O (25 mL) was slowly dropped into the suspension and stirred for 20 h at room temperature. 
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The reaction was quenched with HCl solution (25 mL, 1 M) and the phases were separated. The 
water phase was extracted with Et2O (3x) and the combined organic layers were washed 
successively with sat. NaHCO3 solution, brine and water and dried over MgSO4. The crude 
product was purified via flash chromatography (silica, PE/EA = 10:1) yielding a yellowish oil 
(569 mg, 3.27 mmol, 82%): Rf = 0.24 (PE/EA = 10:1); 1H NMR (300 MHz, CDCl3) δH = 5.97 
(dd, J = 5.6, 2.9 Hz, 1H), 5.75 (dd, J = 5.6, 2.9 Hz, 1H), 5.73 – 5.64 (m, 1H), 3.25 (t, J = 4.9 
Hz, 1H), 3.20 – 3.14 (m, 1H), 3.01 – 2.96 (m, 1H), 2.84 (t, J = 5.2 Hz, 1H), 2.27 (q, J = 7.5 Hz, 
2H), 1.74 (dt, J = 8.4, 1.7 Hz, 1H), 1.59 – 1.55 (m, 1H), 1.12 (t, J = 7.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 210.1 (Cq), 184.0 (Cq), 133.5 (+), 131.7 (+), 131.0 (+), 52.4 
(-), 51.4 (+), 50.0 (+), 44.2 (+), 43.6 (+), 25.6 (-), 11.3 (+); IR (/cm-1): 3064, 2971, 2940, 2878, 
1685, 1607, 1461, 1420, 1372, 1338, 1297, 1178, 1122, 1092, 910, 869, 783, 731; 
HRMS (EI) m/z calculated for C12H14O [M
+∙]: 174.10392, found: 174.103660. 
 
1a-Ethyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one ((±)-214): 
 
According to general procedure 6 (±)-213 (348 mg, 2.00 mmol), 2 M NaOH 
(1.2 mL, 2.4 mmol) and H2O2 (1.1 mL, 30% in water, 10.8 mmol) were used and stirred for 
24 h to afford a yellowish oil (374 mg, 1.97 mmol, 98%): Rf = 0.62 (PE/EA = 10:1); 
1H NMR (300 MHz, CDCl3) δH = 6.15 – 5.97 (m, 2H), 3.23 – 3.16 (m, 1H), 3.11 – 2.98 (m, 
3H), 2.85 (dd, J = 6.7, 4.9 Hz, 1H), 2.10 – 1.96 (m, 1H), 1.69 – 1.55 (m, 2H), 1.49 – 1.42 (m, 
1H), 1.01 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 210.6 (Cq), 136.4 (+), 133.1 
(+), 71.7 (Cq), 63.4 (+), 51.7 (-), 50.4 (+), 46.1 (+), 45.4 (+), 43.5 (+), 23.0 (-), 8.9 (+); 
IR (/cm-1): 3064, 2974, 2941, 2870, 1737, 1461, 1398, 1338, 1282, 1234, 1182, 1126, 1092, 
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999, 939, 910, 857, 775, 712, 678; HRMS (EI) m/z calculated for C12H14O2 [M
+∙]: 190.9883, 
found: 190.09964. 
 
5-Ethyl-2H-pyran-2-one (215):147 
 
3-Ethyl-2H-pyran-2-one (216):63 
 
Following general procedure 1 (±)-214 (190 mg, 1.0 mmol) was used. Purification of the crude 
product via flash chromatography (silica, PE/EA = 5:1) gave rise to 215 (26 mg, 0.21 mmol, 
21%) and 216 (57 mg, 0.46 mmol, 46%) as colorless oils: 
 
215: 1H NMR (300 MHz, CDCl3) δH = 7.27 – 7.21 (m, 2H), 6.31 (dd, J = 8.8, 2.0 Hz, 1H), 2.33 
(q, J = 7.5 Hz, 2H), 1.15 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 162.1 (Cq), 147.4 
(+), 145.3 (+), 120.7 (Cq), 116.4 (+), 22.6 (-), 13.8 (+). 
 
216: 1H NMR (300 MHz, CDCl3) δH = 7.36 – 7.30 (m, 1H), 7.07 – 7.01 (m, 1H), 6.12 (dd, 
J = 6.5, 5.2 Hz, 1H), 2.44 (q, J = 7.4 Hz, 2H), 1.13 (t, J = 7.5 Hz, 3H); 13C NMR 
(75 MHz, CDCl3) δC = 163.0 (Cq), 149.1 (+), 136.9 (+), 131.9 (Cq), 106.2 (+), 23.7 (-), 12.1 (+). 
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3-Phenyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-224):114 
 
Under nitrogen atmosphere (±)-212 (2.09 g, 11.0 mmol) was dissolved in dry Et2O (30 mL). 
The reaction mixture was cooled to 0 °C, PhLi (12.2 mL, 1.8 M in dibutyl ether, 22.0 mmol) 
was added dropwise and stirred for 6 h at room temperature. An ice-cold sulphuric acid solution 
(20 mL, 10%) was added and the mixture was stirred vigorously for 1 h. The aqueous layer was 
extracted with DCM (3x) and the combined organic layers were washed successively with sat. 
NaHCO3 solution, brine and water and were dried over MgSO4. The crude product was purified 
via flash chromatography (silica, PE/EA = 5:1) yielding a yellowish solid (2.29 g, 10.3 mmol, 
94%): 1H NMR (300 MHz, CDCl3) δH = 7.69 – 7.62 (m, 2H), 7.51 – 7.40 (m, 3H), 6.32 (s, 1H), 
6.03 (dd, J = 5.6, 2.9 Hz, 1H), 5.64 (dd, J = 5.6, 2.9 Hz, 1H), 3.88 – 3.82 (m, 1H), 3.32 – 3.24 
(m, 1H), 3.21 – 3.15 (m, 1H), 3.05 (t, J = 5.2 Hz, 1H), 1.79 (dt, J = 8.4, 1.5 Hz, 1H), 1.71 (m, 
1H); 13C NMR (75 MHz, CDCl3) δC = 209.5 (Cq), 173.9 (Cq), 133.7 (Cq), 133.5 (+), 132.1 (+), 
131.1 (+), 129.8 (+), 128.9 (+), 127.1 (+), 52.2 (-), 52.0 (+), 47.5 (+), 44.8 (+), 44.3 (+). 
 
1a-Phenyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-225): 
 
According to general procedure 6 (±)-224 (445 mg, 2.00 mmol), 2 M NaOH (1.2 mL, 
2.40 mmol) and H2O2 (1.1 mL, 30% in water, 10.8 mmol) were used and stirred for 24 h to 
afford a yellow oil (451 mg, 1.89 mmol, 95%): Rf = 0.67 (PE/EA = 5:1): 
1H NMR (300 MHz, CDCl3) δH = 7.46 – 7.37 (m, 5H), 6.09 (dd, J = 5.7, 2.9 Hz, 1H), 5.89 (dd, 
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J = 5.7, 2.9 Hz, 1H), 3.68 (d, J = 1.0 Hz, 1H), 3.54 (ddd, J = 7.1, 4.0, 0.9 Hz, 1H), 3.33 – 3.21 
(m, 1H), 3.02 (dd, J = 7.1, 4.9 Hz, 1H), 2.96 – 2.84 (m, 1H), 1.61 (dt, J = 1.8, 8.6 Hz, 1H), 
1.54 – 1.48 (m, J = 8.6 Hz, 1H); 13C NMR (75 MHz, CDCl3) δC = 209.6 (Cq), 135.8 (+), 133.8 
(Cq), 133.6 (+) 129.3 (+), 128.8 (+), 128.2 (+), 71.7 (Cq), 63.5 (+), 51.7 (-), 50.9 (+), 47.5 (+), 
45.8 (+), 44.3 (+); IR (/cm-1): 3064, 2982, 2941, 2870, 1737, 1498, 1450, 1398, 1339, 1256, 
1230, 1178, 1074, 1029, 969, 936, 861, 768, 697; HRMS (EI) m/z calculated for C16H14O2 
[M+∙]: 238.09883, found: 238.09871. 
 
3 Synthesis of -alkylidenebutenolides 
 
General Procedure 1: Flash Vacuum Thermolysis: For flash vacuum thermolysis a 
high-quality glass tube (length 90 cm, diameter 1 cm) open at both ends was fixed horizontally 
in a tube furnace connected to a cooling trap and a flask containing the epoxide. The tube 
furnace was heated to 650 °C and connected to a high-vacuum line at 2∙10-2 mbar. The starting 
material was slowly evaporated through the tube furnace, and the product was collected in a 
trap cooled with liquid nitrogen. The product was washed off the cooling trap with DCM, the 
solvent was removed, and the product was dried under reduced pressure. The crude product 
was purified via flash chromatography by an appropriate PE/EA mixture. 
 
General Procedure 2: Esterification using acetic anhydride: The Diels-Alder adduct 
(1.0 equiv) was dissolved in Ac2O (2.5 M) and stirred for 20 h at 50 °C. The reaction mixture 
was dried under reduced pressure to yield the pure product. 
 
General Procedure 3: Esterification of (±)-211 to (±)-240: To a solution of (±)-211 
(4.0 mmol) in DCM (16 mL) Et3N (0.8 mL, 5.8 mmol), and a solution of the acyl chloride 
(4.8 mmol) in DCM (16 mL) was added dropwise. The reaction mixture was stirred for 15 h at 
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room temperature. The reaction was diluted with DCM (40 mL) and washed (1x) with sat. 
KHSO4 solution (100 mL). The organic phase was dried over MgSO4. 
 
Cyclopent-4-ene-1,3-dione (234):120 
 
To a solution of (±)-150 (9.81 g, 0.10 mol) in DCM (100 mL) TEMPO-OH (861 mg, 
5.00 mmol), FeCl3∙6H2O (1.35 g, 5.0 mmol), and NaNO2 (207 mg, 3.0 mmol) were added and 
stirred for 24 h at room temperature under oxygen atmosphere (1 atm). The reaction mixture 
was washed with water, and the aqueous phase was extracted with DCM (3x). The combined 
organic phases were dried over MgSO4 and concentrated under reduced pressure to yield pure 
234 (6.64 g, 69 mmol, 69%) as a yellow solid: 1H NMR (300 MHz, CDCl3) δH = 7.30 (s, 2H), 
2.89 (s, 2H); 13C NMR (75 MHz, CDCl3) δC = 200.71 (Cq), 150.55 (+), 41.54 (-). 
 
3-(Hydroxy-d)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one-2-d ((±)-244): 
 
A solution of dione 234 (480 mg, 5.00 mmol) in D2O (5 mL) was stirred at room temperature. 
After 4 h cyclopentadiene (4.13 mL, 50.0 mmol) was added and the reaction mixture was 
stirred for additional 15 h at room temperature. The formed precipitate was filtered off and was 
with Et2O to obtain (±)-244 as a white solid (617 mg, 3.78 mmol, 76%): 
1H NMR (300 MHz, CDCl3) δH = 5.96 (s, 2H), 3.16 (s, 4H), 1.80 (d, J = 8.5 Hz, 1H), 1.59 (d, 
J = 8.6 Hz, 1H). 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl-2-d propionate ((±)-245): 
 
To a solution of (±)-244 (326 mg, 2.00 mmol) in DCM (8 mL) Et3N (0.40 mL, 2.89 mmol), and 
a solution of propionyl chloride (0.21 mL, 2.40 mmol) in DCM (8 mL) was added dropwise. 
The reaction mixture was stirred for 15 h at room temperature. The reaction was diluted with 
DCM (40 mL) and washed (1x) with sat. KHSO4 solution (100 mL). The organic phase was 
dried over MgSO4 to afford a brownish oil (397 mg, 1.81 mmol, 91%): 
1H NMR (300 MHz, CDCl3) δH = 6.05 (dd, J = 5.6, 2.9 Hz, 1H), 5.87 (dd, J = 5.6, 2.9 Hz, 1H), 
3.40 (dd, J = 6.0, 4.3 Hz, 1H), 3.25 – 3.19 (m, 1H), 3.07 – 3.01 (m, 1H), 2.92 (dd, J = 5.9, 
4.8 Hz, 1H), 2.55 (q, J = 7.5 Hz, 2H), 1.78 (dt, J = 8.5, 1.7 Hz, 1H), 1.59 – 1.55 (m, 1H), 1.22 
(t, J = 7.5 Hz, 3H). 
 
(E)-5-(2-Oxopropylidene-1-d)furan-2(5H)-one (246): 
 
(Z)-5-(2-Oxopropylidene-1-d)furan-2(5H)-one (247): 
 
Following general procedure 1 (±)-245 (219 mg, 1.00 mmol) was used. Purification of the crude 
product via flash chromatography (silica, PE/EA = 2:1) gave rise to E isomer 246 
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(24 mg, 0.16 mmol, 16%) and Z isomer 247 (13 mg, 0.09 mmol, 9%) as yellow solid 
compounds: 
 
E isomer 246: 1H NMR (300 MHz, CDCl3) δH = 8.37 (d, J = 5.6 Hz, 1H), 6.51 (d, J = 5.6 Hz, 
1H), 2.67 (q, J = 7.3 Hz, 2H), 1.18 (t, J = 7.3 Hz, 3H). 
 
Z isomer 247: 1H NMR (300 MHz, CDCl3) δH = 7.54 (d, J = 5.5 Hz, 1H), 6.48 (d, J = 5.5 Hz, 
1H), 2.99 (q, J = 7.2 Hz, 2H), 1.18 (t, J = 7.2 Hz, 3H). 
 
3-Hydroxy-5,6-dimethyl-3a,4,7,7a-tetrahydro-1H-inden-1-one ((±)-256): 
 
Dione 234 (288 mg, 3.00 mmol) was dissolved in 2,3-Dimethyl-1,3-butadiene (3.00 mL, 
26.4 mmol) and stirred for 3 d at room temperature. The formed precipitated was filtered off 
and washed with Et2O (3x) to yield (±)-256 (372 mg, 2.09 mmol, 70%) as a white solid: 
1H NMR (400 MHz, CDCl3) δH = 12.57 – 12.30 (bs, 1H), 5.20 (s, 1H), 2.85 (s, 2H), 2.29 – 
2.14 (m, 4H), 1.63 (s, 6H); 13C NMR (101 MHz, CDCl3) δC = 204.3 (Cq), 126.1 (Cq), 106.5 
(+), 43.2 (+), 31.2 (-), 19.2 (+). 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-epoxyinden-3-yl acetate ((±)-257): 
 
Following general procedure 2 (±)-209 (1.31 g, 8.00 mmol) was used to give a brown solid 
(1.56 g, 7.56 mmol, 95%): mp 132.1 – 132.6 °C; Rf = 0.25 (PE/EA = 2:1); 
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1H NMR (300 MHz, CDCl3) δH = 6.49 (dd, J = 5.8, 1.6 Hz, 1H), 6.46 (dd, J = 5.8, 1.5 Hz, 1H), 
6.26 (d, J = 0.7 Hz, 1H), 5.05 (d, J = 1.1 Hz, 1H), 4.95 (d, J = 1.1 Hz, 1H), 2.97 (dd, J = 5.3, 
0.6 Hz, 1H), 2.51 (d, J = 5.3 Hz, 1H), 2.31 (s, 3H); 13C NMR (75 MHz, CDCl3) δC = 204.5 
(Cq), 177.2 (Cq), 166.1 (Cq), 136.5 (+), 136.3 (+), 119.3 (+), 80.1 (+), 77.9 (+), 50.7 (+), 48.8 
(+), 21.5 (+); IR (/cm-1): 3101, 3002, 1784, 1691, 1592, 1425, 1381, 1339, 1301, 1283, 1197, 
1183, 1154, 1089, 1048, 1012, 960, 933, 907, 885, 860, 830, 813, 719, 683, 585; HRMS (APCI) 
m/z calculated for C11H11O4 [MH
+]: 207.0652, found: 207.0653. 
 
5,6-Dimethyl-1-oxo-3a,4,7,7a-tetrahydro-1H-inden-3-yl acetate ((±)-258): 
 
Following general procedure 2 (±)-256 (357 mg, 2.00 mmol) was used to give an brownish oil 
(440 mg, 2.00 mmol, 100%): Rf = 0.64 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 6.21 
(d, J = 1.2 Hz, 1H), 3.20 – 3.13 (m, 1H), 2.65 – 2.58 (m, 1H), 2.29 (s, 3H), 2.28 – 2.07 (m, 4H), 
1.64 (d, J = 0.7 Hz, 3H), 1.61 (d, J = 0.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 209.1 (Cq), 
179.9 (Cq), 166.4 (Cq), 127.4 (Cq), 124.8 (Cq), 117.4 (+), 44.1 (+), 40.9 (+), 31.3 (-), 30.9 (-), 
21.4 (+), 19.29 (+), 19.26 (+); IR (/cm-1): 2978, 2938, 2858, 1789, 1744, 1699, 1589, 1436, 
1370, 1352, 1300, 1183, 1138, 1074, 1007, 843, 701, 609, 579, 558, 451; HRMS (APCI) m/z 
calculated for C13H17O3 [MH
+]: 221.1172, found: 221.1172. 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl acetate ((±)-240a):125 
 
Following general procedure 2 (±)-211 (1.30 g, 8.00 mmol) was used to give an orange solid 
(1.63 g, 7.97 mmol, 100%): 1H NMR (300 MHz, CDCl3) δH = 6.05 (dd, J = 5.6, 2.9 Hz, 1H), 
5.97 (s, 1H), 5.87 (dd, J = 5.6, 2.9 Hz, 1H), 3.43 – 3.37 (m, 1H), 3.25 – 3.19 (m, 1H), 3.07 – 3.02 
(m, 1H), 2.92 (dd, J = 6.0, 4.7 Hz, 1H), 2.26 (s, 3H), 1.78 (dt, J = 8.5, 1.6 Hz, 1H), 1.60 – 1.55 
(m, 1H); 13C NMR (75 MHz, CDCl3) δC = 207.1 (Cq), 179.1 (Cq), 166.3 (Cq), 134.0 (+), 131.9 
(+), 118.7 (+), 52.3 (-), 50.0 (+), 47.0 (+), 44.1 (+), 43.5 (+), 21.5 (+). 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl propionate ((±)-240b): 
 
According to general procedure 3 propionyl chloride (0.42 mL, 4.80 mmol) was used to afford 
a yellowish oil (854 mg, 3.91 mmol, 98%): Rf = 0.48 (PE/EA = 3:1); 1H NMR (300 MHz, 
CDCl3) δH = 6.04 (dd, J = 5.6, 2.9 Hz, 1H), 5.97 (s, 1H), 5.86 (dd, J = 5.6, 2.9 Hz, 1H), 
3.43 – 3.37 (m, 1H), 3.24 – 3.18 (m, 1H), 3.06 – 3.00 (m, 1H), 2.91 (dd, J = 6.0, 4.7 Hz, 1H), 
2.54 (q, J = 7.5 Hz, 2H), 1.77 (dt, J = 8.5, 1.6 Hz, 1H), 1.59 – 1.54 (m, 1H), 1.21 (t, J = 7.5 Hz, 
3H); 13C NMR (75 MHz, CDCl3) δC = 207.2 (Cq), 179.3 (Cq), 170.0 (Cq), 134.0 (+), 131.9 (+), 
118.5 (+), 52.3 (-), 49.9 (+), 47.0 (+), 44.1 (+), 43.5 (+), 28.0 (+), 8.6 (+); IR (/cm-1): 2985, 
2943, 2883, 1781, 1735, 1696, 1586, 1462, 1418, 1333, 1282, 1190, 1146, 1099, 1068, 1007, 
971, 951, 857, 830, 778, 733; HRMS (APCI) m/z calculated for C13H15O3 [MH
+]: 219.1016, 
found: 219.1017. 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl isobutyrate ((±)-240c): 
 
According to general procedure 3 isobutyryl chloride (0.51 mL, 4.80 mmol) was used to afford 
a brownish oil (926 mg, 3.99 mmol, 100%): Rf = 0.76 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 6.02 (dd, J = 5.6, 2.9 Hz, 1H), 5.94 (s, 1H), 5.84 (dd, J = 5.6, 
2.9 Hz, 1H), 3.44 – 3.38 (m, 1H), 3.23 – 3.17 (m, 1H), 3.04 – 2.99 (m, 1H), 2.90 (dd, J = 6.0, 
4.7 Hz, 1H), 2.72 (hept, J = 7.0 Hz, 1H), 1.75 (dt, J = 8.5, 1.5 Hz, 1H), 1.60 – 1.51 (m, 1H), 
1.24 (d, J = 7.0 Hz, 6H); 13C NMR (75 MHz, CDCl3) δC = 207.3 (Cq), 179.6 (Cq), 172.5 (Cq), 
133.9 (+), 131.9 (+), 118.4 (+), 52.3 (-), 49.9 (+), 47.0 (+), 44.1 (+), 43.4 (+), 34.5 (+), 18.60 
(+), 18.55 (+); IR (/cm-1): 2979, 2940, 2878, 1775, 1696, 1591, 1469, 1389, 1332, 1281, 1191, 
1148, 1124, 1063, 898, 862, 816, 777, 731, 660; HRMS (APCI) m/z calculated for C14H17O3 
[MH+]: 233.1172, found: 233.1173. 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl pivalate ((±)-240d): 
 
According to general procedure 3 pivaloyl chloride (0.59 mL, 4.80 mmol) was used to afford a 
brownish oil (984 mg, 3.99 mmol, 100%): Rf = 0.65 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 5.98 (dd, J = 5.6, 2.9 Hz, 1H), 5.89 (s, 1H), 5.79 (dd, J = 5.6, 
2.9 Hz, 1H), 3.43 – 3.35 (m, 1H), 3.20 – 3.12 (m, 1H), 3.02 – 2.93 (m, 1H), 2.86 (dd, J = 6.0, 
4.7 Hz, 1H), 1.72 (dt, J = 8.5, 1.6 Hz, 1H), 1.55 – 1.49 (m, 1H), 1.23 (s, 9H); 
13C NMR (75 MHz, CDCl3) δC = 207.1 (Cq), 179.7 (Cq), 173.9 (Cq), 134.0 (+), 131.9 (+), 118.4 
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(+), 52.3 (-), 49.9 (+), 46.9 (+), 44.1 (+), 43.4 (+), 39.7 (Cq), 26.8 (+); IR (/cm
-1): 2977, 2938, 
2874, 1771, 1699, 1591, 1480, 1462, 1399, 1334, 1269, 1150, 1125, 1069, 1026, 861, 777, 731, 
667; HRMS (APCI) m/z calculated for C15H19O3 [MH
+]: 247.1329, found: 247.1324. 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl acrylate ((±)-240e): 
 
According to general procedure 3 acryloyl chloride (0.39 mL, 4.80 mmol) was used. Further 
purification via flash chromatography (silica, PE/EA = 3:1) yielded a yellowish solid (862 mg, 
3.99 mmol, 100%): mp 54.1 – 55.3 °C; Rf = 0.43 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 6.60 (dd, J = 17.1, 1.2 Hz, 1H), 6.28 – 6.17 (m, 1H), 6.13 – 5.99 (m, 3H), 5.88 (dd, J = 5.6, 
2.9 Hz, 1H), 3.50 – 3.43 (m, 1H), 3.26 – 3.21 (m, 1H), 3.10 – 3.04 (m, 1H), 2.95 (dd, J = 6.0, 
4.7 Hz, 1H), 1.79 (dt, J = 8.6, 1.6 Hz, 1H), 1.61 – 1.56 (m, 1H); 13C NMR (75 MHz, CDCl3) 
δC = 207.1 (Cq), 179.1 (Cq), 161.4 (Cq), 134.6 (-), 134.0 (+), 131.9 (+), 126.9 (+), 118.8 (+), 
52.3 (-), 50.0 (+), 47.0 (+), 44.1 (+), 43.5 (+); IR (/cm-1): 3107, 3060, 2978, 2949, 2876, 1758, 
1683, 1576, 1409, 1348, 1334, 1300, 1284, 1216, 1194, 1152, 1106, 1065, 1014, 983, 869, 819, 
802, 775, 733, 663; HRMS (APCI) m/z calculated for C13H13O3 [MH
+]: 217.0859, found: 
217.0859. 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl hexanoate ((±)-240f): 
 
According to general procedure 3 hexanoyl chloride (0.67 mL, 4.80 mmol) was used. Further 
purification via flash chromatography (silica, PE/EA = 3:1) yielded a yellowish oil 
(979 mg, 3.76 mmol, 94%): Rf = 0.59 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) δH = 6.05 
(dd, J = 5.6, 2.9 Hz, 1H), 5.97 (s, 1H), 5.86 (dd, J = 5.6, 2.9 Hz, 1H), 3.44 – 3.37 (m, 1H), 
3.25 – 3.19 (m, 1H), 3.06 – 3.00 (m, 1H), 2.92 (dd, J = 6.0, 4.7 Hz, 1H), 2.50 (t, J = 7.4 Hz, 
2H), 1.77 (dt, J = 8.5, 1.6 Hz, 1H), 1.72 – 1.64 (m, 2H), 1.59 – 1.54 (m, 1H), 1.37 – 1.30 (m, 
4H), 0.92 (t, J = 6.7 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 207.2 (Cq), 179.3 (Cq), 169.3 
(Cq), 134.0 (+), 131.9 (+), 118.6 (+), 52.3 (-), 49.9 (+), 47.0 (+), 44.1 (+), 43.5 (+), 34.6 (-), 
31.1 (-), 24.2 (-), 22.3 (-), 13.9 (+); IR (/cm-1): 2958, 2935, 2872, 1781, 1698, 1591, 1459, 
1414, 1334, 1281, 1246, 1191, 1145, 1124, 1078, 861, 778, 731, 662; HRMS (APCI) m/z 
calculated for C16H21O3 [MH
+]: 261.1485, found: 261.1486. 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl benzoate ((±)-240g): 
 
According to general procedure 3 benzoyl chloride (0.55 mL, 4.80 mmol) was used. Further 
purification via flash chromatography (silica, PE/EA = 3:1) yielded a white solid (967 mg, 
3.63 mmol, 91%): mp 107.2 – 108.9 °C; Rf = 0.35 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.17 – 8.07 (m, 2H), 7.73 – 7.62 (m, 1H), 7.58 – 7.48 (m, 2H), 6.14 (s, 1H), 6.09 (dd, 
J = 5.6, 2.9 Hz, 1H), 5.93 (dd, J = 5.6, 2.9 Hz, 1H), 3.66 – 3.54 (m, 1H), 3.33 – 3.22 (m, 1H), 
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3.20 – 3.11 (m, 1H), 3.00 (dd, J = 5.9, 4.7 Hz, 1H), 1.86 – 1.77 (m, 1H), 1.68 – 1.59 (m, 1H); 
13C NMR (75 MHz, CDCl3) δC = 207.1 (Cq), 179.4 (Cq), 162.1 (Cq), 134.5 (+), 134.0 (+), 132.0 
(+), 130.4 (+), 128.9 (+), 128.3 (Cq), 118.8 (+), 52.4 (-), 50.1 (+), 47.1 (+), 44.2 (+), 43.6 (+); 
IR (/cm-1): 3060, 2987, 2947, 1759, 1679, 1582, 1452, 1340, 1233, 1143, 1054, 1040, 1019, 
969, 861, 846, 819, 778, 737, 700, 666; HRMS (APCI) m/z calculated for C17H15O3 [MH
+]: 
267.1016, found: 267.1017. 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl 4-methoxybenzoate ((±)-240h): 
 
According to general procedure 3 4-methoxybenzoyl chloride (0.82 mL, 4.80 mmol) was used. 
Further purification via flash chromatography (silica, PE/EA = 2:1) yielded a white solid 
(1.13 g, 3.82 mmol, 96%): mp 136.7 – 138.0 °C; Rf = 0.66 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 8.09 – 8.03 (m, 2H), 7.01 – 6.96 (m, 2H), 6.11 (s, 1H), 6.08 
(dd, J = 5.6, 2.9 Hz, 1H), 5.92 (dd, J = 5.6, 2.9 Hz, 1H), 3.90 (s, 3H), 3.60 – 3.54 (m, 1H), 
3.29 – 3.23 (m, 1H), 3.16 – 3.11 (m, 1H), 2.98 (dd, J = 5.8, 4.8 Hz, 1H), 1.84 – 1.77 (m, 1H), 
1.64 – 1.61 (m, 1H); 13C NMR (75 MHz, CDCl3) δC = 207.2 (Cq), 179.7 (Cq), 164.6 (Cq), 161.8 
(Cq), 134.0 (+), 132.6 (+), 132.0 (+), 120.4 (Cq), 118.5 (+), 114.2 (+), 55.7 (+), 52.4 (-), 50.1 
(+), 47.2 (+), 44.2 (+), 43.6 (+); IR (/cm-1): 2981, 2940, 2845, 1743, 1677, 1605, 1585, 1510, 
1466, 1452, 1345, 1318, 1241, 1190, 1166, 1142, 1103, 1040, 1020, 971, 932, 907, 844, 761, 
734, 693, 661; HRMS (ESI) m/z calculated for C18H17O4 [MH
+]: 297.1121, found: 297.1126. 
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Ethyl (1-oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl) carbonate ((±)-240i): 
 
To a solution of (±)-211 (324 mg, 2.00 mmol) in DCM (8 mL) Et3N (0.40 mL, 2.89 mmol), and 
a solution of ethyl chloroformate (0.23 mL, 2.40 mmol) in DCM (8 mL) was added dropwise. 
The reaction mixture was stirred for 15 h at room temperature. The reaction was diluted with 
DCM (20 mL) and washed (1x) with sat. KHSO4 solution (50 mL). The organic phase was 
dried over MgSO4 and concentrated under reduced pressure to yield (±)-240i (466 mg, 
1.99 mmol, 100%) as a yellowish oil: Rf = 0.45 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 5.99 (dd, J = 5.6, 2.9 Hz, 1H), 5.91 (s, 1H), 5.85 (dd, J = 5.6, 2.9 Hz, 1H), 4.26 (qd, J = 7.1, 
0.6 Hz, 2H), 3.39 – 3.32 (m, 1H), 3.19 – 3.13 (m, 1H), 3.05 – 3.00 (m, 1H), 2.89 (dd, J = 6.0, 
4.7 Hz, 1H), 1.72 (dt, J = 8.5, 1.5 Hz, 1H), 1.54 – 1.48 (m, 1H), 1.32 (t, J = 7.1 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 206.5 (Cq), 179.6 (Cq), 150.3 (Cq), 133.9 (+), 132.0 (+), 117.6 
(+), 65.7 (-), 52.3 (-), 50.4 (+), 46.6 (+), 44.1 (+), 43.5 (+), 14.0 (+); IR (/cm-1): 2984, 2942, 
2872, 1775, 1698, 1599, 1337, 1209, 1153, 1124, 1094, 1043, 994, 951, 885, 861, 829, 778, 
732, 654; HRMS (APCI) m/z calculated for C13H15O4 [MH
+]: 235.0965, found: 235.0970. 
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(E)-5-(2-Oxopropylidene)furan-2(5H)-one (241a):129 
 
(Z)-5-(2-Oxopropylidene)furan-2(5H)-one (242a):129 
 
Following general procedure 1 (±)-240a (817 mg, 4.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 2:1) gave rise to E isomer 241a (118 mg, 
0.85 mmol, 21%) and Z isomer 242a (71 mg, 0.51 mmol, 13%) as yellow solid compounds: 
 
E isomer 241a: mp 90.3 – 92.8 °C; Rf = 0.60 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.30 (dd, J = 5.6, 0.6 Hz, 1H), 6.48 (dd, J = 5.6, 1.8 Hz, 1H), 6.25 (d, J = 1.5 Hz, 1H), 2.35 
(s, 3H); 13C NMR (75 MHz, CDCl3) δC = 197.1 (Cq), 168.0 (Cq), 158.7 (Cq), 142.8 (+), 125.3 
(+), 108.0 (+), 32.3 (+); IR (/cm-1): 3151, 3122, 3077, 3051, 1787, 1770, 1683, 1611, 1550, 
1484, 1422, 1385, 1356, 1300, 1242, 1172, 1093, 1057, 1020, 952, 892, 839, 742, 710, 575; 
HRMS (APCI) m/z calculated for C7H7O3 [MH
+]: 139.0390, found: 139.0393. 
 
Z isomer 242a: mp 75.9 – 78.6 °C; Rf = 0.33 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.50 (d, J = 5.5 Hz, 1H), 6.46 (dd, J = 5.5, 0.7 Hz, 1H), 5.56 (s, 1H), 2.57 (s, 3H); 
13C NMR (75 MHz, CDCl3) δC = 196.5 (Cq), 167.7 (Cq), 155.1 (Cq), 145.6 (+), 123.5 (+), 110.9 
(+), 31.3 (+); IR (/cm-1): 3142, 3016, 3083, 3007, 1770, 1696, 1632, 1561, 1425, 1374, 1355, 
1236, 1175, 1097, 1074, 1020, 990, 929, 908, 861, 837, 763, 740, 684, 571; HRMS (APCI) m/z 
calculated for C7H7O3 [MH
+]: 139.0390, found: 139.0394. 
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(E)-5-(2-Oxobutylidene)furan-2(5H)-one (241b): 
 
(Z)-5-(2-Oxobutylidene)furan-2(5H)-one (242b): 
 
Following general procedure 1 (±)-240b (218 mg, 1.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 2:1) gave rise to E isomer 241b 
(36 mg, 0.24 mmol, 24%) and Z isomer 242b (15 mg, 0.10 mmol, 10%) as yellow solid 
compounds: 
 
E isomer 241b: mp 112.2 – 114.6 °C; Rf = 0.72 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.31 (dd, J = 5.6, 0.7 Hz, 1H), 6.46 (dd, J = 5.6, 1.8 Hz, 1H), 6.23 (dd, J = 1.7, 0.7 Hz, 
1H), 2.62 (q, J = 7.3 Hz, 2H), 1.12 (t, J = 7.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 200.1 
(Cq), 168.1 (Cq), 158.5 (Cq), 142.8 (+), 125.1 (+), 107.6 (+), 38.4 (-), 7.8 (+); IR (/cm
-1): 3113, 
2981, 2942, 2883, 1828, 1766, 1713, 1624, 1600, 1459, 1407, 1368, 1245, 1201, 1149, 1118, 
1090, 1032, 1015, 915, 888, 842, 813; HRMS (APCI) m/z calculated for C8H9O3 [MH
+]: 
153.0546, found: 153.0549. 
 
Z isomer 242b: mp 77.0 – 78.6 °C; Rf = 0.41 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.53 (d, J = 5.5 Hz, 1H), 6.49 (dd, J = 5.5, 0.8 Hz, 1H), 5.62 (s, 1H), 2.99 (q, J = 7.2 Hz, 
2H), 1.18 (t, J = 7.2 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 199.4 (Cq), 167.9 (Cq), 154.5 
(Cq), 145.8 (+), 123.3 (+), 110.5 (+), 36.9 (-), 7.8 (+); IR (/cm
-1): 3143, 3111, 2982, 2943, 
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2894, 1818, 1773, 1721, 1698, 1632, 1562, 1459, 1409, 1369, 1341, 1260, 1160, 1127, 1096, 
1051, 1014, 939, 869, 857, 828; HRMS (APCI) m/z calculated for C8H9O3 [MH
+]: 153.0546, 
found: 153.0546. 
 
(E)-5-(3-Methyl-2-oxobutylidene)furan-2(5H)-one (241c): 
 
(Z)-5-(3-Methyl-2-oxobutylidene)furan-2(5H)-one (242c): 
 
Following general procedure 1 (±)-240c (465 mg, 2.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 3:1) gave rise to E isomer 241c (62 mg, 
0.37 mmol, 19%) and Z isomer 242c (27 mg, 0.16 mmol, 8%) as yellow solid compounds: 
 
E isomer 241c: mp 170.4 – 172.7 °C; Rf = 0.80 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.32 (dd, J = 5.6, 0.7 Hz, 1H), 6.47 (dd, J = 5.6, 1.8 Hz, 1H), 6.31 (dd, J = 1.7, 0.7 Hz, 
1H), 2.73 (hept, J = 6.9 Hz, 1H), 1.16 (d, J = 6.9 Hz, 6H); 13C NMR (75 MHz, CDCl3) 
δC = 203.4 (Cq), 168.1 (Cq), 159.2 (Cq), 142.9 (+), 125.0 (+), 106.8 (+), 42.5 (+), 17.9 (+); 
IR (/cm-1): 3134, 2974, 2936, 2875, 1810, 1770, 1687, 1625, 1465, 1384, 1364, 1283, 1157, 
1112, 1045, 948, 853, 828, 633; HRMS (APCI) m/z calculated for C9H11O3 [MH
+]: 167.0703, 
found: 167.0703. 
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Z isomer 242c: mp 107.1 – 108.9 °C; Rf = 0.32 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.48 (d, J = 5.5 Hz, 1H), 6.45 (dd, J = 5.5, 0.8 Hz, 1H), 5.59 (s, 1H), 3.32 (hept, J = 6.8 Hz, 
1H), 1.16 (d, J = 6.9 Hz, 6H); 13C NMR (75 MHz, CDCl3) δC = 202.7 (Cq), 168.1 (Cq), 153.9 
(Cq), 145.8 (+), 123.3 (+), 109.4 (+), 40.3 (+), 18.3 (+); IR (/cm
-1): 3144, 3111, 3089, 2969, 
2933, 2876, 1776, 1689, 1627, 1562, 1466, 1385, 1366, 1094, 1066, 1050, 940, 873, 835; 
HRMS (APCI) m/z calculated for C9H11O3 [MH
+]: 167.0703, found: 167.0701. 
 
(E)-5-(3,3-Dimethyl-2-oxobutylidene)furan-2(5H)-one (241d): 
 
(Z)-5-(3,3-Dimethyl-2-oxobutylidene)furan-2(5H)-one (242d): 
 
Following general procedure 1 (±)-240d (493 mg, 2.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 3:1) gave rise to E isomer 241d (78 mg, 
0.43 mmol, 22%) and Z isomer 242d (46 mg, 0.26 mmol, 13%) as yellow solid compounds: 
 
E isomer 241d: mp 151.4 – 153.2 °C; Rf = 0.87 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.31 (dd, J = 5.6, 0.7 Hz, 1H), 6.51 (dd, J = 1.7, 0.7 Hz, 1H), 6.46 (dd, J = 5.6, 1.8 Hz, 
1H), 1.20 (s, 9H); 13C NMR (75 MHz, CDCl3) δC = 204.8 (Cq), 168.1 (Cq), 159.7 (Cq), 142.9 
(+), 125.0 (+), 104.8 (+), 44.6 (Cq), 26.1 (+); IR (/cm
-1): 2975, 2937, 2873, 1829, 1769, 1699, 
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1615, 1476, 1369, 1282, 1249, 1154, 1122, 1095, 1061, 1010, 916, 852, 814, 793, 675; 
HRMS (APCI) m/z calculated for C10H13O3 [MH
+]: 181.0859, found: 181.0861. 
 
Z isomer 242d: mp 192.8 – 194.6 °C; Rf = 0.40 (PE/EA = 2:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.44 (d, J = 5.5 Hz, 1H), 6.45 (dd, J = 5.5, 0.7 Hz, 1H), 6.00 (s, 1H), 1.20 (s, 9H); 
13C NMR (75 MHz, CDCl3) δC = 202.4 (Cq), 168.8 (Cq), 155.0 (Cq), 145.2 (+), 123.9 (+), 104.6 
(+), 44.4 (Cq), 26.1 (+); IR (/cm
-1): 2974, 2935, 2909, 2873, 1821, 1786, 1768, 1687, 1615, 
1475, 1367, 1163, 1140, 1084, 1057, 1010, 953, 917, 857, 815, 658, 629; HRMS (APCI) m/z 
calculated for C10H13O3 [MH
+]: 181.0859, found: 181.0861. 
 
(E)-5-(2-Oxoheptylidene)furan-2(5H)-one (241f): 
 
(Z)-5-(2-Oxoheptylidene)furan-2(5H)-one (242f): 
 
Following general procedure 1 (±)-240f (521 mg, 2.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 3:1) gave rise to E isomer 241f 
(90 mg, 0.46 mmol, 23%) and Z isomer 242f (45 mg, 0.23 mmol, 12%) as yellow solid 
compounds: 
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E isomer 241f: mp 72.1 – 73.6 °C; Rf = 0.78 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) 
δH = 8.32 (dd, J = 5.6, 0.6 Hz, 1H), 6.47 (dd, J = 5.6, 1.7 Hz, 1H), 6.24 (d, J = 1.1 Hz, 1H), 2.58 
(t, J = 7.4 Hz, 2H), 1.67 – 1.61 (m, 2H), 1.35 – 1.28 (m, 4H), 0.90 (t, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 199.9 (Cq), 168.1 (Cq), 158.6 (Cq), 142.9 (+), 125.1 (+), 107.8 
(+), 45.2 (-), 31.3 (-), 23.6 (-), 22.5 (-), 13.9 (+); IR (/cm-1): 3152, 3123, 3081, 2956, 2932, 
2862, 1776, 1680, 1612, 1553, 1467, 1389, 1317, 1303, 1249, 1223, 1134, 1109, 1063, 950, 
892, 878, 847, 833, 745, 721, 666; HRMS (APCI) m/z calculated for C11H15O3 [MH
+]: 
195.1016, found: 195.1015. 
 
Z isomer 242f: mp 80.2 – 82.8 °C; Rf = 0.38 (PE/EA = 3:1); 1H NMR (300 MHz, CDCl3) 
δH = 7.49 (d, J = 5.5 Hz, 1H), 6.44 (dd, J = 5.5, 0.7 Hz, 1H), 5.56 (s, 1H), 2.89 (t, J = 7.3 Hz, 
2H), 1.70 – 1.58 (m, 2H), 1.37 – 1.25 (m, 4H), 0.89 (t, J = 6.9 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 199.1 (Cq), 167.9 (Cq), 154.3 (Cq), 145.8 (+), 123.3 (+), 110.6 
(+), 43.5 (-), 31.3 (-), 23.5 (-), 22.5 (-), 14.0 (+); IR (/cm-1): 3147, 3188, 3090, 2954, 2936, 
2874, 1780, 1687, 1623, 1563, 1468, 1406, 1354, 1314, 1248, 1214, 1132, 1089, 936, 866, 844, 
823, 765, 725, 650; HRMS (APCI) m/z calculated for C11H15O3 [MH
+]: 195.1016, found: 
195.1014. 
 
(E)-5-(2-Oxo-2-phenylethylidene)furan-2(5H)-one (241g): 
 
Following general procedure 1 (±)-240g (266 mg, 1.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 5:1) gave rise to E isomer 241g 
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(61 mg, 0.31 mmol, 31%) as a yellow solid: mp 157.6 – 159.3 °C; Rf = 0.44 (PE/EA = 5:1); 
1H NMR (300 MHz, CDCl3) δH = 8.43 (dd, J = 5.6, 0.7 Hz, 1H), 7.99 – 7.94 (m, 2H), 
7.68 – 7.59 (m, 1H), 7.56 – 7.49 (m, 2H), 7.03 (dd, J = 1.7, 0.7 Hz, 1H), 6.54 (dd, J = 5.6, 1.7 
Hz, 1H); 13C NMR (75 MHz, CDCl3) δC = 189.3 (Cq), 168.9 (Cq), 160.4 (Cq), 143.1 (+), 137.9 
(Cq), 133.8 (+), 128.9 (+), 128.3 (+), 125.3 (+), 105.6 (+); IR (/cm
-1): 3154, 3123, 3083, 3040, 
1789, 1769, 1660, 1605, 1578, 1555, 1448, 1390, 1300, 1264, 1199, 1096, 1063, 1038, 1025, 
1000, 909, 889, 852, 828, 781, 734, 694, 646; HRMS (APCI) m/z calculated for C12H9O3 
[MH+]: 201.0546, found: 201.0551. 
 
(E)-5-(2-(4-Methoxyphenyl)-2-oxoethylidene)furan-2(5H)-one (241h): 
 
Following general procedure 1 (±)-240h (593 mg, 2.00 mmol) was used. Purification of the 
crude via flash chromatography (silica, PE/EA = 3:1) gave rise to E isomer 241h (164 mg, 
0.70 mmol, 35%) as a yellow solid: mp 180.7 – 182.4 °C; Rf = 0.71 (PE/EA = 2:1); 
1H NMR (300 MHz, CDCl3) δH = 8.43 (dd, J = 5.6, 0.7 Hz, 1H), 7.99 – 7.94 (m, 2H), 
7.01 – 6.96 (m, 3H), 6.51 (dd, J = 5.6, 1.7 Hz, 1H), 3.90 (s, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 187.5 (Cq), 168.1 (Cq), 164.1 (Cq), 159.9 (Cq), 143.2 (+), 131.0 (Cq), 130.8 (+) 124.9 (+), 
114.1 (+), 105.8 (+), 55.6 (+); IR (/cm-1): 3146, 3121, 3077, 2984, 2942, 2847, 1790, 1767, 
1661, 1607, 1571, 1549, 1422, 1389, 1300, 1253, 1193, 1175, 1102, 1062, 1040, 1016, 912, 
892, 831, 816, 732, 682, 607; HRMS (APCI) m/z calculated for C13H11O4 [MH
+]: 231.0652, 
found: 231.0654. 
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4 Redox isomerization of 4-hydroxy-2-cyclopentenone derivatives 
 
General Procedure 1: Grignard reaction of 140 to (±)-142: Magnesium shavings (1.3 equiv) 
were suspended in dry Et2O (2.50 M), and a catalytic amount iodine was added. The bromide 
(1.6 equiv) was dissolved in dry Et2O (1.25 M) and added dropwise to the suspension. When 
the suspension stopped boiling it was refluxed for 1 h and afterward cooled down to 0 °C. A 
solution of furfural (140) (1.0 equiv) in dry Et2O (1.25 M) was slowly dropped into the 
suspension and stirred for 15 min. The reaction was quenched with water, and the phases were 
separated. The water phase was extracted with Et2O (3x), and the combined organic layers were 
dried over MgSO4. The crude was purified via flash chromatography (silica, PE/EA = 5:1). 
 
General Procedure 2: Piancatelli rearrangement of (±)-142 to (±)-149: To a solution of 
furfuryl alcohol (±)-142 (5.00 mmol) in acetone (5 mL) water (15 mL) was added, and the 
mixture was heated in the microwave at 180 °C for 15 min. This procedure was repeated as 
often as necessary, and the combined layers were extracted with DCM (3x). The combined 
organic layers were dried over MgSO4, and the crude product was purified via flash 
chromatography (silica, PE/EA = 2:1). 
 
General Procedure 3: Redox isomerization: Under a nitrogen atmosphere, the 
4-hydroxy-2-cyclopentenone derivative (1.0 mmol) was dissolved in water (5 mL). After 
adding catalyst 280 and the reaction mixture was heated to reflux. The progress of the reaction 
was monitored by TLC. After completion of the reaction, most of the solvent was evaporated, 
and the residue was cooled down forming a precipitate, which was filtrated and washed with 
cold water (3x) to obtain the pure product.  
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1-(Furan-2-yl)propan-1-ol ((±)-142d):140 
 
Following general procedure 1 magnesium shavings (1.51 g, 62.4 mmol), bromoethane 
(5.73 mL, 76.8 mmol) and furfural (140) (3.98 mL, 48.0 mmol) were used to yield (±)-142d 
(3.78 g, 29.9 mmol, 62%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.37 (dd, 
J = 1.8, 0.8 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.25 – 6.20 (dt, J = 3.2, 0.7 Hz, 1H), 4.60 
(t, J = 6.8 Hz, 1H), 1.96 – 1.80 (m, 3H), 0.95 (t, J = 7.4 Hz, 3H); 13C NMR (75 MHz, CDCl3) 
δC = 156.7 (Cq), 141.9 (+), 110.1 (+), 105.9 (+), 69.2 (+), 28.6 (-), 10.0 (+). 
 
1-(Furan-2-yl)-2-methylpropan-1-ol ((±)-142e):140 
 
Following general procedure 1 magnesium shavings (1.51 g, 62.4 mmol), 2-bromopropane 
(5.73 mL, 76.8 mmol) and furfural (140) (3.98 mL, 48.0 mmol) were used to yield (±)-142e 
(3.73 g, 26.6 mmol, 55%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.36 (dd, 
J = 1.8, 0.9 Hz, 1H), 6.33 (dd, J = 3.2, 1.8 Hz, 1H), 6.25 – 6.19 (dt, J = 3.2, 0.7 Hz, 1H), 4.37 
(d, J = 7.1 Hz, 1H), 2.19 – 2.02 (m, 1H), 1.98 – 1.81 (bs, 1H), 1.02 (d, J = 6.7 Hz, 3H), 0.85 (d, 
J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 156.2 (Cq), 141.7 (+), 110.1 (+), 106.5 (+), 
73.5 (+), 33.4 (+), 18.7 (+), 18.3 (+). 
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1-(Furan-2-yl)but-3-en-1-ol ((±)-142f):148 
 
Following general procedure 1 magnesium shavings (1.51 g, 62.4 mmol), allyl bromide 
(6.64 mL, 76.8 mmol) and furfural (140) (3.98 mL, 48.0 mmol) were used to yield (±)-142f 
(4.05 g, 29.3 mmol, 61%) as a yellowish oil: 1H NMR (300 MHz, CDCl3) δH = 7.38 (dd, 
J = 1.8, 0.8 Hz, 1H), 6.34 (dd, J = 3.2, 1.8 Hz, 1H), 6.26 (dt, J = 3.2, 0.7 Hz, 1H), 5.89 – 5.74 
(m, 1H), 5.23 – 5.12 (m, 2H), 4.76 (t, J = 6.5 Hz, 1H), 2.67 – 2.59 (m, 2H), 2.21 – 1.90 (bs, 
1H); 13C NMR (75 MHz, CDCl3) δC = 156.0 (Cq), 142.0 (+), 133.7 (+), 118.7 (-), 110.2 (+), 
106.1 (+), 66.9 (+), 40.1 (-). 
 
5-Ethyl-4-hydroxycyclopent-2-en-1-one ((±)-149d):83 
 
According to general procedure 2 (±)-142d (2.52 g, 20.0 mmol) was used to afford a yellowish 
oil (1.91 g, 15.1 mmol, 76%): 1H NMR (300 MHz, CDCl3) δH = 7.51 (dd, J = 5.8, 2.2 Hz, 1H), 
6.18 (dd, J = 5.8, 0.7 Hz, 1H), 4.72 – 4.65 (m, 1H), 2.70 – 2.49 (bs, 1H), 2.19 (ddd, J = 8.6, 4.7, 
2.4 Hz, 1H), 1.96 – 1.79 (m, 1H), 1.61 – 1.45 (m, 1H), 1.01 (t, J = 7.4 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δC = 208.4 (Cq), 162.1 (+), 134.4 (+), 76.2 (+), 56.6 (+), 21.4 (-), 
11.5 (+). 
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4-Hydroxy-5-isopropylcyclopent-2-en-1-one ((±)-149e):149 
 
According to general procedure 2 (±)-142e (2.80 g, 20.0 mmol) was used to afford a yellowish 
oil (1.93 g, 13.8 mmol, 69%): 1H NMR (300 MHz, CDCl3) δH = 7.51 (dd, J = 5.8, 2.3 Hz, 1H), 
6.21 – 6.11 (m, 1H), 4.80 (s, 1H), 2.72 – 2.34 (bs, 1H), 2.33 – 2.24 (m, 1H), 2.23 – 2.18 (m, 
1H), 1.09 (d, J = 6.9 Hz, 3H), 0.83 (d, J = 6.8 Hz, 3H); 13C NMR (75 MHz, CDCl3) δC = 208.4 
(Cq), 162.4 (+), 134.9 (+), 72.8 (+), 60.8 (+), 27.1 (+), 20.7 (+), 18.2 (+). 
 
5-Allyl-4-hydroxycyclopent-2-en-1-one ((±)-149f):149 
 
According to general procedure 2 (±)-142f (2.76 g, 20.0 mmol) was used to afford a yellowish 
oil (1.57 g, 11.4 mmol, 57%): 1H NMR (300 MHz, CDCl3) δH = 7.51 (dd, J = 5.8, 2.2 Hz, 1H), 
6.20 (d, J = 5.8 Hz, 1H), 5.89 – 5.71 (m, 1H), 5.19 – 5.05 (m, 2H), 4.77 – 4.62 (m, 1H), 
2.69 – 2.59 (m, 1H), 2.40 – 2.17 (m, 3H); 13C NMR (75 MHz, CDCl3) δC = 207.2 (Cq), 162.0 
(+), 135.2 (+), 134.2 (+), 117.5 (-), 75.7 (+), 54.8 (+), 32.6 (-). 
 
Cyclopentane-1,3-dione (238):132,132 
 
Following general procedure 3 (±)-150 (98 mg, 1.00 mmol) and catalyst 280 (30.8 mg, 
0.05 mmol) were used. After 8 h, the reaction was complete and 238 (78 mg, 0.80 mmol, 80%) 
was obtained after recrystallization from MeOH/PE as a white solid: 
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1H NMR (300 MHz, DMSO) δH = 13.33 – 10.33 (bs, 1H), 5.08 (s, 1H), 2.37 (s, 4H); 
13C NMR (75 MHz, DMSO) δC = 197.6 (Cq), 104.9 (+), 31.2 (-). 
 
2-Methylcyclopentane-1,3-dione (282a):150 
 
Following general procedure 3 (±)-200 (112 mg, 1.00 mmol) and catalyst 280 (30.8 mg, 
0.05 mmol) were used. After 15 h, the reaction was complete and 282a (102 mg, 0.91 mmol, 
91%) was obtained as a brownish solid: 1H NMR (300 MHz, DMSO) δH = 12.01 – 10.07 (bs, 
1H), 2.33 (s, 4H), 1.45 (s, 3H); 13C NMR (75 MHz, DMSO) δC = 194.2 (Cq) 111.5 (Cq), 29.98 
(-), 5.66 (+). 
 
2-Propylcyclopentane-1,3-dione (282b):151 
 
Following general procedure 3 (±)-149a (140 mg, 1.00 mmol) and catalyst 280 (30.8 mg, 
0.05 mmol) were used. After 30 h, the reaction was complete and 282b (113 mg, 0.81 mmol, 
81%) was obtained as a white solid: 1H NMR (300 MHz, DMSO) δH = 11.58 – 11.24 (bs, 1H), 
2.33 (s, 4H), 1.95 (t, J = 7.2 Hz, 2H), 1.37 – 1.25 (sext, J = 7.5 Hz, 3H), 0.80 (t, J = 7.4 Hz, 
3H); 13C NMR (75 MHz, DMSO) δC =197.6 (Cq), 116.1 (Cq), 29.9 (-), 22.7 (-), 20.8 (-), 13.9 
(+). 
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2-Pentylcyclopentane-1,3-dione (282c):151 
 
Following general procedure 3 (±)-149b (168 mg, 1.00 mmol) and catalyst 280 (61.6 mg, 
0.1 mmol) were used. After 15 h, the reaction was complete and 282c (121 mg, 0.72 mmol, 
72%) was obtained as a white solid: 1H NMR (400 MHz, DMSO) δH = 11.67 – 10.95 (bs, 1H), 
2.31 (s, 4H), 1.96 (t, J = 7.4 Hz, 2H), 1.32 – 1.14 (m, 6H), 0.82 (t, J = 7.1 Hz, 3H); 
13C NMR (101 MHz, DMSO) δC =193.3 (Cq), 116.3 (Cq), 31.2 (-), 30.1 (-), 27.2 (-), 21.9 (-), 
20.5 (-), 13.9 (+). 
 
2-Ethylcyclopentane-1,3-dione (282e):151 
 
Following general procedure 3 (±)-149d (126 mg, 1.00 mmol) and catalyst 280 (30.8 mg, 
0.05 mmol) were used. After 15 h, the reaction was complete and 282e (109 mg, 0.86 mmol, 
86%) was obtained as a brownish solid: 1H NMR (300 MHz, DMSO) δH = 12.43 – 10.36 (bs, 
1H), 2.32 (s, 4H), 1.99 (q, J = 7.5 Hz, 2H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR (75 MHz, DMSO) 
δC = 193.7 (Cq), 117.6 (Cq), 30.0 (-), 13.9 (-), 12.7 (+). 
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2-Isopropylcyclopentane-1,3-dione (282f):151 
 
Following general procedure 3 (±)-149e (140 mg, 1.00 mmol) and catalyst 280 (61.6 mg, 
0.1 mmol) were used. After 30 h, the reaction was complete and 282f (72 mg, 0.51 mmol, 51%) 
was obtained as a white solid: 1H NMR (300 MHz, DMSO) δH = 11.84 – 10.81 (bs, 1H), 
2.69 – 2.54 (m, 1H), 2.30 (s, 4H), 1.05 (d, J = 7.0 Hz, 6H); 13C NMR (75 MHz, DMSO) 
δC = 192.6 (Cq), 120.9 (Cq), 30.0 (-), 22.2 (+), 20.3 (+). 
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F Appendix 
1 NMR-spectra 
 
1H NMR spectra upper image 
 
13C NMR spectra lower image 
 
Solvent and frequency are given at the spectra. 
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4-Hydroxycyclopent-2-en-1-one ((±)-150) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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4-Oxocyclopent-2-en-1-yl acetate ((±)-153) 
 1H NMR (400 MHz, CDCl3) 
 
 13C NMR (101 MHz, CDCl3) 
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3a,4,7,7a-Tetrahydro-1H-4,7-methanoinden-1-one ((±)-138) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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a,1b,2,5,5a,6a-Hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one ((±)-137)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2H-Pyran-2-one (1) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)butan-1-ol ((±)-142a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)hexan-1-ol ((±)-142b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)octan-1-ol ((±)-142c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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4-Hydroxy-5-propylcyclopent-2-en-1-one ((±)-149a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
189 
 
4-Hydroxy-5-pentylcyclopent-2-en-1-one ((±)-149b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5-Heptyl-4-hydroxycyclopent-2-en-1-one ((±)-149c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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4-Oxo-5-propylcyclopent-2-en-1-yl acetate ((±)-154a)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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4-Oxo-5-pentylcyclopent-2-en-1-yl acetate ((±)-154b)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5-Heptyl-4-oxocyclopent-2-en-1-yl acetate ((±)-154c)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-Propyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-Pentyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155b)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-Heptyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-155c)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-Propyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156a)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-Pentyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156b)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-Heptyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-156c)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Propyl-2H-pyran-2-one (2a)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
201 
 
6-Pentyl-2H-pyran-2-one (2b)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Heptyl-2H-pyran-2-one (2c)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxyethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165a)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxypropyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxy-2-methylpropyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165c) 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxybutyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxypentyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165e) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-Hydroxyheptyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(Hydroxy(phenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-165g) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-((4-Chlorophenyl)(hydroxy)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165h)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(Hydroxy(4-nitrophenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165i)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(Hydroxy(4-methoxyphenyl)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165j)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(Furan-2-yl(hydroxy)methyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-165k) 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxyethyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170a)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxypropyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170b)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxy-2-methylpropyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170c)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxybutyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170d)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxypentyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170e)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxyheptyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-
one ((±)-170f)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(Hydroxy(phenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170g)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-((4-Chlorophenyl)(hydroxy)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170h)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(Hydroxy(4-nitrophenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170i)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(Hydroxy(4-methoxyphenyl)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-
methanoindeno[1,2-b]oxiren-6-one ((±)-170j)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(furan-2-yl(hydroxy)methyl)-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-170k)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxyethyl)-2H-pyran-2-one ((±)-171a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxypropyl)-2H-pyran-2-one ((±)-171b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxy-2-methylpropyl)-2H-pyran-2-one ((±)-171c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxybutyl)-2H-pyran-2-one ((±)-171d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxypentyl)-2H-pyran-2-one ((±)-171e) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxyheptyl)-2H-pyran-2-one ((±)-171f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(Hydroxy(phenyl)methyl)-2H-pyran-2-one ((±)-171g)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-((4-Chlorophenyl)(hydroxy)methyl)-2H-pyran-2-one ((±)-171h) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(Hydroxy(4-nitrophenyl)methyl)-2H-pyran-2-one ((±)-171i) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(Hydroxy(4-methoxyphenyl)methyl)-2H-pyran-2-one ((±)-171j) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(Furan-2-yl(hydroxy)methyl)-2H-pyran-2-one ((±)-171k) 
 1H NMR (400 MHz, CDCl3) 
 
 13C NMR (101 MHz, CDCl3) 
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(R)-1-(2-Oxo-2H-pyran-6-yl)ethyl acetate (174)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(S)-1-(2-Oxo-2H-pyran-6-yl)ethyl 4-nitrobenzoate (175)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(2-Oxo-2H-pyran-6-yl)(phenyl)methyl acetate ((±)-180)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(S)-1-(2-Oxo-2H-pyran-6-yl)pentyl acetate (179)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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tert-Butyl (1-(2-oxo-2H-pyran-6-yl)pentyl) carbonate ((±)-190)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Acetyl-2H-pyran-2-one (195a)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Pentanoyl-2H-pyran-2-one (195b)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Benzoyl-2H-pyran-2-one (195c)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)ethan-1-ol ((±)-199) 
 1H NMR (300 MHz, CDCl3) 
 
 
 13C NMR (75 MHz, CDCl3) 
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4-Hydroxy-5-methylcyclopent-2-en-1-one ((±)-200) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
246 
 
4-Hydroxy-2-methylcyclopent-2-en-1-one ((±)-201) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
247 
 
3-Methyl-4-oxocyclopent-2-en-1-yl acetate ((±)-202) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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2-(1-((Trimethylsilyl)oxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one 
((±)-204) 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
249 
 
7a-Methyl-2-(1-((trimethylsilyl)oxy)ethyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-
one ((±)-205)  1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6a-(1-Hydroxyethyl)-5a-methyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-
b]oxiren-6-one ((±)-197) 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-(1-Hydroxyethyl)-3-methyl-2H-pyran-2-one ((±)-196) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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6-Acetyl-3-methyl-2H-pyran-2-one (3a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
253 
 
1-(2-Oxo-2H-pyran-6-yl)propyl 4-methylbenzenesulfonate ((±)-189a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(2-Oxo-2H-pyran-6-yl)pentyl 4-methylbenzenesulfonate ((±)-189b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
 
F Appendix  
255 
 
1-(2-Oxo-2H-pyran-6-yl)heptyl 4-methylbenzenesulfonate ((±)-189c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-6-(prop-1-en-1-yl)-2H-pyran-2-one (7a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-6-(Pent-1-en-1-yl)-2H-pyran-2-one (7b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-6-(Hept-1-en-1-yl)-2H-pyran-2-one (7c)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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3-Ethoxy-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-212)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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3-Ethyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-213) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1a-Ethyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one ((±)-214) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5-Ethyl-2H-pyran-2-one (215)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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3-Ethyl-2H-pyran-2-one: (216) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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3-Phenyl-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-224) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1a-Phenyl-1a,1b,2,5,5a,6a-hexahydro-6H-2,5-methanoindeno[1,2-b]oxiren-6-one 
((±)-225) 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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Cyclopent-4-ene-1,3-dione (234) 
 1H NMR (300 MHz, CDCl3) 
 
 
 13C NMR (75 MHz, CDCl3) 
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3-Hydroxy-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one ((±)-211) 
 1H NMR (300 MHz, DMSO) 
 
 13C NMR (75 MHz, DMSO) 
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3-Hydroxy-3a,4,7,7a-tetrahydro-1H-4,7-epoxyinden-1-one ((±)-209) 
 1H NMR (300 MHz, DMSO) 
 
 13C NMR (75 MHz, DMSO) 
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3-(Hydroxy-d)-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-1-one-2-d ((±)-244) 
 1H NMR (300 MHz, CDCl3) 
 
1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl-2-d propionate ((±)-245) 
 1H NMR (300 MHz, CDCl3) 
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(E)-5-(2-Oxopropylidene-1-d)furan-2(5H)-one (246) 
 1H NMR (300 MHz, CDCl3) 
 
(Z)-5-(2-Oxopropylidene-1-d)furan-2(5H)-one (247) 
 1H NMR (300 MHz, CDCl3) 
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3-Hydroxy-5,6-dimethyl-3a,4,7,7a-tetrahydro-1H-inden-1-one ((±)-256) 
 1H NMR (400 MHz, CDCl3) 
 
 13C NMR (101 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-epoxyinden-3-yl acetate ((±)-257) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5,6-Dimethyl-1-oxo-3a,4,7,7a-tetrahydro-1H-inden-3-yl acetate ((±)-258) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl acetate ((±)-240a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl propionate ((±)-240b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl isobutyrate ((±)-240c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl pivalate ((±)-240d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl acrylate ((±)-240e) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl hexanoate ((±)-240f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl benzoate ((±)-240g) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-Oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl 4-methoxybenzoate ((±)-240h) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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Ethyl (1-oxo-3a,4,7,7a-tetrahydro-1H-4,7-methanoinden-3-yl) carbonate ((±)-240i) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(2-Oxopropylidene)furan-2(5H)-one (241a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(Z)-5-(2-Oxopropylidene)furan-2(5H)-one (242a) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(2-Oxobutylidene)furan-2(5H)-one (241b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(Z)-5-(2-Oxobutylidene)furan-2(5H)-one (242b) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(3-Methyl-2-oxobutylidene)furan-2(5H)-one (241c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(Z)-5-(3-Methyl-2-oxobutylidene)furan-2(5H)-one (242c) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(3,3-Dimethyl-2-oxobutylidene)furan-2(5H)-one (241d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(Z)-5-(3,3-Dimethyl-2-oxobutylidene)furan-2(5H)-one (242d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(2-Oxoheptylidene)furan-2(5H)-one (241f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(Z)-5-(2-Oxoheptylidene)furan-2(5H)-one (242f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(2-Oxo-2-phenylethylidene)furan-2(5H)-one (241g) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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(E)-5-(2-(4-Methoxyphenyl)-2-oxoethylidene)furan-2(5H)-one (241h) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)propan-1-ol ((±)-142d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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1-(Furan-2-yl)-2-methylpropan-1-ol ((±)-142e) 
 1H NMR (400 MHz, CDCl3) 
 
 13C NMR (101 MHz, CDCl3) 
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1-(Furan-2-yl)but-3-en-1-ol ((±)-142f)  
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5-Ethyl-4-hydroxycyclopent-2-en-1-one ((±)-149d) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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4-Hydroxy-5-isopropylcyclopent-2-en-1-one ((±)-149e) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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5-Allyl-4-hydroxycyclopent-2-en-1-one ((±)-149f) 
 1H NMR (300 MHz, CDCl3) 
 
 13C NMR (75 MHz, CDCl3) 
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Cyclopentane-1,3-dione (238) 
 1H NMR (300 MHz, DMSO) 
 
 13C NMR (75 MHz, DMSO) 
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2-Methylcyclopentane-1,3-dione (282a) 
  1H NMR (300 MHz, DMSO) 
 
 13C NMR (75 MHz, DMSO) 
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2-Propylcyclopentane-1,3-dione (282b) 
 1H NMR (300 MHz, DMSO) 
 
 
 13C NMR (75 MHz, DMSO) 
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2-Pentylcyclopentane-1,3-dione (282c) 
 1H NMR (300 MHz, DMSO) 
 
 
 13C NMR (75 MHz, DMSO) 
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2-Ethylcyclopentane-1,3-dione (282e) 
 1H NMR (300 MHz, DMSO) 
 
 
 13C NMR (75 MHz, DMSO) 
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2-Isopropylcyclopentane-1,3-dione (282f) 
 1H NMR (300 MHz, DMSO) 
 
 13C NMR (75 MHz, DMSO) 
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2 GC-spectra 
 
2H-Pyran-2-one (1) 
 
 
 
Peak RT Area %Ar Height 
1 3.304 311.528 99.63 133.688 
2 11.192 1.157 0.37 0.118 
 
GC-Analysis: purity >99%, RT = 3.304 
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3 Chiral HPLC data 
 
1-(2-Oxo-2H-pyran-6-yl)ethyl acetate 
 
(R)-1-(2-Oxo-2H-pyran-6-yl)ethyl acetate (174) 
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6-(1-Hydroxyethyl)-2H-pyran-2-one ((±)-171a)  
 
(S)-6-(1-Hydroxyethyl)-2H-pyran-2-one (171a) 
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1-(2-Oxo-2H-pyran-6-yl)ethyl 4-nitrobenzoate 
 
(S)-1-(2-Oxo-2H-pyran-6-yl)ethyl 4-nitrobenzoate (175) 
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1-(2-Oxo-2H-pyran-6-yl)pentyl acetate ((±)-179) 
 
(S)-1-(2-Oxo-2H-pyran-6-yl)pentyl acetate (179) 
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6-(1-Hydroxypentyl)-2H-pyran-2-one ((±)-171e) 
 
(R)-6-(1-Hydroxypentyl)-2H-pyran-2-one (171e) 
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4 X-ray data 
 
X-ray crystallography structure of (±)-165g (the ellipsoid contour percent probability level is 
50%) 
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Formula  C17H16O2  
Dcalc./ g cm
-3  1.307  
/mm-1  0.670  
Formula Weight  252.30  
Colour  clear colourless  
Shape  plate  
Max Size/mm  0.11  
Mid Size/mm  0.08  
Min Size/mm  0.04  
T/K  123.00(10)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  11.2968(4)  
b/Å  10.0528(3)  
c/Å  11.7838(4)  
/°  90  
/°  106.701(4)  
/°  90  
V/Å3  1281.77(8)  
Z  4  
Z'  1  
min/°  4.086  
max/°  73.509  
Measured Refl.  11218  
Independent Refl.  2541  
Reflections Used  2172  
Rint  0.0317  
Parameters  173  
Restraints  0  
Largest Peak  0.254  
Deepest Hole  -0.208  
GooF  1.052  
wR2 (all data)  0.0909  
wR2  0.0852  
R1 (all data)  0.0437  
R1  0.0358  
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X-ray crystallography structure of (±)-170g (the ellipsoid contour percent probability level is 
50%) 
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Formula  C17H16O3  
Dcalc./ g cm
-3  1.3473  
/mm-1  0.741  
Formula Weight  268.31  
Colour  colourless  
Shape  irregular  
Max Size/mm  0.24  
Mid Size/mm  0.15  
Min Size/mm  0.10  
T/K  123.01(10)  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  9.9767(2)  
b/Å  11.8794(2)  
c/Å  11.9166(3)  
/°  90  
/°  110.522(3)  
/°  90  
V/Å3  1322.70(6)  
Z  4  
Z'  1  
min/°  5.00  
max/°  73.41  
Measured Refl.  12773  
Independent Refl.  2633  
Reflections Used  2262  
Rint  0.0286  
Parameters  181  
Restraints  0  
Largest Peak  0.2605  
Deepest Hole  -0.2237  
GooF  1.0660  
wR2 (all data)  0.0959  
wR2  0.0910  
R1 (all data)  0.0420  
R1  0.0357  
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X-ray crystallography structure of (±)-171j (the ellipsoid contour percent probability level is 
50%) 
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Formula  C13H12O4  
Dcalc./ g cm
-3  1.443  
/mm-1  0.895  
Formula Weight  232.23  
Colour  clear colourless  
Shape  needle  
Max Size/mm  0.13  
Mid Size/mm  0.03  
Min Size/mm  0.02  
T/K  123.00(10)  
Crystal System  orthorhombic  
Flack Parameter  0.15(12)  
Hooft Parameter  0.12(12)  
Space Group  P212121  
a/Å  6.4205(3)  
b/Å  11.7811(6)  
c/Å  14.1339(6)  
/°  90  
/°  90  
/°  90  
V/Å3  1069.10(8)  
Z  4  
Z'  1  
min/°  4.887  
max/°  66.606  
Measured Refl.  4585  
Independent Refl.  1836  
Reflections Used  1732  
Rint  0.0275  
Parameters  156  
Restraints  0  
Largest Peak  0.352  
Deepest Hole  -0.154  
GooF  1.054  
wR2 (all data)  0.0791  
wR2  0.0767  
R1 (all data)  0.0335  
R1  0.0305  
 
  
F Appendix  
319 
 
 
X-ray crystallography structure of (S)-175 (the ellipsoid contour percent probability level is 
50%) 
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Formula  C14H11NO6  
Dcalc./ g cm
-3  1.497  
/mm-1  1.017  
Formula Weight  289.24  
Colour  clear colourless  
Shape  irregular  
Size/mm3  0.22×0.09×0.05  
T/K  123.01(10)  
Crystal System  monoclinic  
Flack Parameter  0.02(7)  
Hooft Parameter  0.05(6)  
Space Group  P21  
a/Å  4.25027(12)  
b/Å  29.6140(5)  
c/Å  10.3858(2)  
/°  90  
/°  100.939(3)  
/°  90  
V/Å3  1283.49(5)  
Z  4  
Z'  2  
Wavelength/Å  1.54184  
Radiation type  CuK  
min/°  4.336  
max/°  73.606  
Measured Refl.  16728  
Independent Refl.  4990  
Reflections Used  4811  
Rint  0.0322  
Parameters  381  
Restraints  1  
Largest Peak  0.216  
Deepest Hole  -0.213  
GooF  1.065  
wR2 (all data)  0.0983  
wR2  0.0966  
R1 (all data)  0.0376  
R1  0.0361  
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X-ray crystallography structure of (±)-240g (the ellipsoid contour percent probability level is 
50%) 
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Formula  C17H14O3  
Dcalc./ g cm
-3  1.323  
/mm-1  0.733  
Formula Weight  266.28  
Colour  colourless  
Shape  plate  
Max Size/mm  0.19  
Mid Size/mm  0.15  
Min Size/mm  0.02  
T/K  123.02(16)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  18.1617(4)  
b/Å  6.28851(16)  
c/Å  11.7251(3)  
/°  90  
/°  92.979(2)  
/°  90  
V/Å3  1337.32(6)  
Z  4  
Z'  1  
min/°  2.436  
max/°  74.115  
Measured Refl.  22420  
Independent Refl.  2718  
Reflections Used  2377  
Rint  0.0490  
Parameters  263  
Restraints  156  
Largest Peak  0.285  
Deepest Hole  -0.168  
GooF  1.080  
wR2 (all data)  0.1272  
wR2  0.1215  
R1 (all data)  0.0505  
R1  0.0440  
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X-ray crystallography structure of 241a (the ellipsoid contour percent probability level is 80%) 
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Formula  C7H6O3  
Dcalc./ g cm
-3  1.414  
/mm-1  0.953  
Formula Weight  138.12  
Colour  clear colourless  
Shape  needle  
Max Size/mm  0.23  
Mid Size/mm  0.06  
Min Size/mm  0.04  
T/K  122.9(2)  
Crystal System  monoclinic  
Flack Parameter  0.11(11)  
Space Group  P21  
a/Å  6.4211(2)  
b/Å  5.5763(2)  
c/Å  9.0881(3)  
/°  90  
/°  94.595(3)  
/°  90  
V/Å3  324.362(19)  
Z  2  
Z'  1  
min/°  4.882  
max/°  66.588  
Measured Refl.  3661  
Independent Refl.  1142  
Reflections Used  1107  
Rint  0.0251  
Parameters  92  
Restraints  1  
Largest Peak  0.111  
Deepest Hole  -0.140  
GooF  1.060  
wR2 (all data)  0.0587  
wR2  0.0580  
R1 (all data)  0.0250  
R1  0.0238  
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X-ray crystallography structure of 242a (the ellipsoid contour percent probability level is 50%) 
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Formula  C7H6O3  
Dcalc./ g cm
-3  1.342  
/mm-1  0.904  
Formula Weight  138.12  
Colour  clear colourless  
Shape  plate  
Max Size/mm  0.56  
Mid Size/mm  0.20  
Min Size/mm  0.03  
T/K  293(1)  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  6.7141(6)  
b/Å  5.6388(3)  
c/Å  18.1251(12)  
/°  90  
/°  94.998(7)  
/°  90  
V/Å3  683.59(9)  
Z  4  
Z'  1  
min/°  4.899  
max/°  66.647  
Measured Refl.  4120  
Independent Refl.  1181  
Reflections Used  929  
Rint  0.0485  
Parameters  92  
Restraints  0  
Largest Peak  0.194  
Deepest Hole  -0.202  
GooF  1.063  
wR2 (all data)  0.1507  
wR2  0.1399  
R1 (all data)  0.0672  
R1  0.0550  
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